id	sid	tid	token	lemma	pos
cord-297652-ut6e1ysz	1	1	key	key	NN
cord-297652-ut6e1ysz	1	2	:	:	:
cord-297652-ut6e1ysz	1	3	cord-297652-ut6e1ysz	cord-297652-ut6e1ysz	NNP
cord-297652-ut6e1ysz	1	4	authors	author	NNS
cord-297652-ut6e1ysz	1	5	:	:	:
cord-297652-ut6e1ysz	1	6	Vanden	Vanden	NNP
cord-297652-ut6e1ysz	1	7	Eynde	Eynde	NNP
cord-297652-ut6e1ysz	1	8	,	,	,
cord-297652-ut6e1ysz	1	9	Jean	Jean	NNP
cord-297652-ut6e1ysz	1	10	Jacques	Jacques	NNP
cord-297652-ut6e1ysz	1	11	title	title	NN
cord-297652-ut6e1ysz	1	12	:	:	:
cord-297652-ut6e1ysz	2	1	COVID-19	covid-19	VB
cord-297652-ut6e1ysz	2	2	:	:	:
cord-297652-ut6e1ysz	2	3	A	a	DT
cord-297652-ut6e1ysz	2	4	Brief	Brief	NNP
cord-297652-ut6e1ysz	2	5	Overview	Overview	NNP
cord-297652-ut6e1ysz	2	6	of	of	IN
cord-297652-ut6e1ysz	2	7	the	the	DT
cord-297652-ut6e1ysz	2	8	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	2	9	Clinical	Clinical	NNP
cord-297652-ut6e1ysz	2	10	Trial	Trial	NNP
cord-297652-ut6e1ysz	2	11	date	date	NN
cord-297652-ut6e1ysz	2	12	:	:	:
cord-297652-ut6e1ysz	2	13	2020	2020	CD
cord-297652-ut6e1ysz	2	14	-	-	HYPH
cord-297652-ut6e1ysz	2	15	04	04	CD
cord-297652-ut6e1ysz	2	16	-	-	SYM
cord-297652-ut6e1ysz	2	17	10	10	CD
cord-297652-ut6e1ysz	2	18	journal	journal	NN
cord-297652-ut6e1ysz	2	19	:	:	:
cord-297652-ut6e1ysz	3	1	Pharmaceuticals	pharmaceutical	NNS
cord-297652-ut6e1ysz	3	2	(	(	-LRB-
cord-297652-ut6e1ysz	3	3	Basel	Basel	NNP
cord-297652-ut6e1ysz	3	4	)	)	-RRB-
cord-297652-ut6e1ysz	3	5	DOI	DOI	NNP
cord-297652-ut6e1ysz	3	6	:	:	:
cord-297652-ut6e1ysz	3	7	10.3390	10.3390	CD
cord-297652-ut6e1ysz	3	8	/	/	SYM
cord-297652-ut6e1ysz	3	9	ph13040065	ph13040065	NNP
cord-297652-ut6e1ysz	3	10	sha	sha	NNP
cord-297652-ut6e1ysz	3	11	:	:	:
cord-297652-ut6e1ysz	3	12	9c4f2427952aeac0d4852c3a08e28b85fe2bf3dd	9c4f2427952aeac0d4852c3a08e28b85fe2bf3dd	CD
cord-297652-ut6e1ysz	3	13	doc_id	doc_id	CD
cord-297652-ut6e1ysz	3	14	:	:	:
cord-297652-ut6e1ysz	4	1	297652	297652	CD
cord-297652-ut6e1ysz	4	2	cord_uid	cord_uid	NNS
cord-297652-ut6e1ysz	4	3	:	:	:
cord-297652-ut6e1ysz	5	1	ut6e1ysz	ut6e1ysz	NNP
cord-297652-ut6e1ysz	6	1	The	the	DT
cord-297652-ut6e1ysz	6	2	outbreak	outbreak	NN
cord-297652-ut6e1ysz	6	3	of	of	IN
cord-297652-ut6e1ysz	6	4	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	6	5	is	be	VBZ
cord-297652-ut6e1ysz	6	6	leading	lead	VBG
cord-297652-ut6e1ysz	6	7	to	to	IN
cord-297652-ut6e1ysz	6	8	a	a	DT
cord-297652-ut6e1ysz	6	9	tremendous	tremendous	JJ
cord-297652-ut6e1ysz	6	10	search	search	NN
cord-297652-ut6e1ysz	6	11	for	for	IN
cord-297652-ut6e1ysz	6	12	curative	curative	JJ
cord-297652-ut6e1ysz	6	13	treatments	treatment	NNS
cord-297652-ut6e1ysz	6	14	.	.	.
cord-297652-ut6e1ysz	7	1	The	the	DT
cord-297652-ut6e1ysz	7	2	urgency	urgency	NN
cord-297652-ut6e1ysz	7	3	of	of	IN
cord-297652-ut6e1ysz	7	4	the	the	DT
cord-297652-ut6e1ysz	7	5	situation	situation	NN
cord-297652-ut6e1ysz	7	6	favors	favor	VBZ
cord-297652-ut6e1ysz	7	7	a	a	DT
cord-297652-ut6e1ysz	7	8	repurposing	repurposing	NN
cord-297652-ut6e1ysz	7	9	of	of	IN
cord-297652-ut6e1ysz	7	10	active	active	JJ
cord-297652-ut6e1ysz	7	11	drugs	drug	NNS
cord-297652-ut6e1ysz	7	12	but	but	CC
cord-297652-ut6e1ysz	7	13	not	not	RB
cord-297652-ut6e1ysz	7	14	only	only	RB
cord-297652-ut6e1ysz	7	15	antivirals	antiviral	NNS
cord-297652-ut6e1ysz	7	16	.	.	.
cord-297652-ut6e1ysz	8	1	This	this	DT
cord-297652-ut6e1ysz	8	2	short	short	JJ
cord-297652-ut6e1ysz	8	3	communication	communication	NN
cord-297652-ut6e1ysz	8	4	focuses	focus	VBZ
cord-297652-ut6e1ysz	8	5	on	on	IN
cord-297652-ut6e1ysz	8	6	four	four	CD
cord-297652-ut6e1ysz	8	7	treatments	treatment	NNS
cord-297652-ut6e1ysz	8	8	recommended	recommend	VBN
cord-297652-ut6e1ysz	8	9	by	by	IN
cord-297652-ut6e1ysz	8	10	WHO	who	WP
cord-297652-ut6e1ysz	8	11	and	and	CC
cord-297652-ut6e1ysz	8	12	included	include	VBN
cord-297652-ut6e1ysz	8	13	in	in	IN
cord-297652-ut6e1ysz	8	14	the	the	DT
cord-297652-ut6e1ysz	8	15	first	first	JJ
cord-297652-ut6e1ysz	8	16	clinical	clinical	JJ
cord-297652-ut6e1ysz	8	17	trial	trial	NN
cord-297652-ut6e1ysz	8	18	of	of	IN
cord-297652-ut6e1ysz	8	19	the	the	DT
cord-297652-ut6e1ysz	8	20	European	European	NNP
cord-297652-ut6e1ysz	8	21	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	8	22	project	project	NN
cord-297652-ut6e1ysz	8	23	.	.	.
cord-297652-ut6e1ysz	9	1	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	9	2	(	(	-LRB-
cord-297652-ut6e1ysz	9	3	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	9	4	disease	disease	NN
cord-297652-ut6e1ysz	9	5	2019	2019	CD
cord-297652-ut6e1ysz	9	6	)	)	-RRB-
cord-297652-ut6e1ysz	9	7	is	be	VBZ
cord-297652-ut6e1ysz	9	8	a	a	DT
cord-297652-ut6e1ysz	9	9	worldwide	worldwide	JJ
cord-297652-ut6e1ysz	9	10	outbreak	outbreak	NN
cord-297652-ut6e1ysz	9	11	of	of	IN
cord-297652-ut6e1ysz	9	12	pneumonia	pneumonia	NN
cord-297652-ut6e1ysz	9	13	and	and	CC
cord-297652-ut6e1ysz	9	14	acute	acute	JJ
cord-297652-ut6e1ysz	9	15	respiratory	respiratory	JJ
cord-297652-ut6e1ysz	9	16	distress	distress	NN
cord-297652-ut6e1ysz	9	17	syndrome	syndrome	NN
cord-297652-ut6e1ysz	9	18	.	.	.
cord-297652-ut6e1ysz	10	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	10	2	is	be	VBZ
cord-297652-ut6e1ysz	10	3	unambiguously	unambiguously	RB
cord-297652-ut6e1ysz	10	4	linked	link	VBN
cord-297652-ut6e1ysz	10	5	to	to	IN
cord-297652-ut6e1ysz	10	6	the	the	DT
cord-297652-ut6e1ysz	10	7	human	human	JJ
cord-297652-ut6e1ysz	10	8	-	-	HYPH
cord-297652-ut6e1ysz	10	9	human	human	JJ
cord-297652-ut6e1ysz	10	10	transmission	transmission	NN
cord-297652-ut6e1ysz	10	11	of	of	IN
cord-297652-ut6e1ysz	10	12	a	a	DT
cord-297652-ut6e1ysz	10	13	novel	novel	JJ
cord-297652-ut6e1ysz	10	14	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	10	15	.	.	.
cord-297652-ut6e1ysz	11	1	Mutagenomic	mutagenomic	JJ
cord-297652-ut6e1ysz	11	2	analyses	analyse	VBZ
cord-297652-ut6e1ysz	11	3	[	[	-LRB-
cord-297652-ut6e1ysz	11	4	1	1	CD
cord-297652-ut6e1ysz	11	5	]	]	-RRB-
cord-297652-ut6e1ysz	11	6	demonstrated	demonstrate	VBD
cord-297652-ut6e1ysz	11	7	that	that	IN
cord-297652-ut6e1ysz	11	8	79.6	79.6	CD
cord-297652-ut6e1ysz	11	9	%	%	NN
cord-297652-ut6e1ysz	11	10	of	of	IN
cord-297652-ut6e1ysz	11	11	the	the	DT
cord-297652-ut6e1ysz	11	12	genome	genome	NN
cord-297652-ut6e1ysz	11	13	sequences	sequence	NNS
cord-297652-ut6e1ysz	11	14	were	be	VBD
cord-297652-ut6e1ysz	11	15	identical	identical	JJ
cord-297652-ut6e1ysz	11	16	to	to	IN
cord-297652-ut6e1ysz	11	17	those	those	DT
cord-297652-ut6e1ysz	11	18	found	find	VBN
cord-297652-ut6e1ysz	11	19	in	in	IN
cord-297652-ut6e1ysz	11	20	the	the	DT
cord-297652-ut6e1ysz	11	21	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	11	22	responsible	responsible	JJ
cord-297652-ut6e1ysz	11	23	for	for	IN
cord-297652-ut6e1ysz	11	24	the	the	DT
cord-297652-ut6e1ysz	11	25	severe	severe	JJ
cord-297652-ut6e1ysz	11	26	acute	acute	JJ
cord-297652-ut6e1ysz	11	27	respiratory	respiratory	JJ
cord-297652-ut6e1ysz	11	28	syndrome	syndrome	NN
cord-297652-ut6e1ysz	11	29	(	(	-LRB-
cord-297652-ut6e1ysz	11	30	SARS	SARS	NNP
cord-297652-ut6e1ysz	11	31	)	)	-RRB-
cord-297652-ut6e1ysz	11	32	,	,	,
cord-297652-ut6e1ysz	11	33	which	which	WDT
cord-297652-ut6e1ysz	11	34	spread	spread	VBD
cord-297652-ut6e1ysz	11	35	in	in	IN
cord-297652-ut6e1ysz	11	36	2002	2002	CD
cord-297652-ut6e1ysz	11	37	.	.	.
cord-297652-ut6e1ysz	12	1	Hence	hence	RB
cord-297652-ut6e1ysz	12	2	the	the	DT
cord-297652-ut6e1ysz	12	3	classification	classification	NN
cord-297652-ut6e1ysz	12	4	as	as	IN
cord-297652-ut6e1ysz	12	5	2019-nCoV	2019-ncov	CD
cord-297652-ut6e1ysz	12	6	(	(	-LRB-
cord-297652-ut6e1ysz	12	7	n	n	NN
cord-297652-ut6e1ysz	12	8	for	for	IN
cord-297652-ut6e1ysz	12	9	novel	novel	NN
cord-297652-ut6e1ysz	12	10	)	)	-RRB-
cord-297652-ut6e1ysz	12	11	and	and	CC
cord-297652-ut6e1ysz	12	12	the	the	DT
cord-297652-ut6e1ysz	12	13	name	name	NN
cord-297652-ut6e1ysz	12	14	SARS	SARS	NNP
cord-297652-ut6e1ysz	12	15	-	-	HYPH
cord-297652-ut6e1ysz	12	16	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	12	17	[	[	-LRB-
cord-297652-ut6e1ysz	12	18	2	2	CD
cord-297652-ut6e1ysz	12	19	]	]	-RRB-
cord-297652-ut6e1ysz	12	20	.	.	.
cord-297652-ut6e1ysz	13	1	Combatting	combat	VBG
cord-297652-ut6e1ysz	13	2	SARS	SARS	NNP
cord-297652-ut6e1ysz	13	3	-	-	HYPH
cord-297652-ut6e1ysz	13	4	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	13	5	has	have	VBZ
cord-297652-ut6e1ysz	13	6	emerged	emerge	VBN
cord-297652-ut6e1ysz	13	7	as	as	IN
cord-297652-ut6e1ysz	13	8	a	a	DT
cord-297652-ut6e1ysz	13	9	tremendous	tremendous	JJ
cord-297652-ut6e1ysz	13	10	challenge	challenge	NN
cord-297652-ut6e1ysz	13	11	,	,	,
cord-297652-ut6e1ysz	13	12	gathering	gather	VBG
cord-297652-ut6e1ysz	13	13	efforts	effort	NNS
cord-297652-ut6e1ysz	13	14	from	from	IN
cord-297652-ut6e1ysz	13	15	academia	academia	NN
cord-297652-ut6e1ysz	13	16	,	,	,
cord-297652-ut6e1ysz	13	17	pharmaceutical	pharmaceutical	NN
cord-297652-ut6e1ysz	13	18	companies	company	NNS
cord-297652-ut6e1ysz	13	19	,	,	,
cord-297652-ut6e1ysz	13	20	hospitals	hospital	NNS
cord-297652-ut6e1ysz	13	21	,	,	,
cord-297652-ut6e1ysz	13	22	international	international	JJ
cord-297652-ut6e1ysz	13	23	organizations	organization	NNS
cord-297652-ut6e1ysz	13	24	,	,	,
cord-297652-ut6e1ysz	13	25	as	as	RB
cord-297652-ut6e1ysz	13	26	well	well	RB
cord-297652-ut6e1ysz	13	27	as	as	IN
cord-297652-ut6e1ysz	13	28	governments	government	NNS
cord-297652-ut6e1ysz	13	29	and	and	CC
cord-297652-ut6e1ysz	13	30	philanthropic	philanthropic	JJ
cord-297652-ut6e1ysz	13	31	associations	association	NNS
cord-297652-ut6e1ysz	13	32	(	(	-LRB-
cord-297652-ut6e1ysz	13	33	e.g.	e.g.	RB
cord-297652-ut6e1ysz	13	34	,	,	,
cord-297652-ut6e1ysz	13	35	The	the	DT
cord-297652-ut6e1ysz	13	36	Council	Council	NNP
cord-297652-ut6e1ysz	13	37	on	on	IN
cord-297652-ut6e1ysz	13	38	Foundations	Foundations	NNPS
cord-297652-ut6e1ysz	13	39	[	[	-LRB-
cord-297652-ut6e1ysz	13	40	3	3	CD
cord-297652-ut6e1ysz	13	41	]	]	-RRB-
cord-297652-ut6e1ysz	13	42	)	)	-RRB-
cord-297652-ut6e1ysz	13	43	.	.	.
cord-297652-ut6e1ysz	14	1	In	in	IN
cord-297652-ut6e1ysz	14	2	this	this	DT
cord-297652-ut6e1ysz	14	3	Opinion	opinion	NN
cord-297652-ut6e1ysz	14	4	,	,	,
cord-297652-ut6e1ysz	14	5	we	-PRON-	PRP
cord-297652-ut6e1ysz	14	6	give	give	VBP
cord-297652-ut6e1ysz	14	7	a	a	DT
cord-297652-ut6e1ysz	14	8	brief	brief	JJ
cord-297652-ut6e1ysz	14	9	overview	overview	NN
cord-297652-ut6e1ysz	14	10	of	of	IN
cord-297652-ut6e1ysz	14	11	some	some	DT
cord-297652-ut6e1ysz	14	12	current	current	JJ
cord-297652-ut6e1ysz	14	13	and	and	CC
cord-297652-ut6e1ysz	14	14	future	future	JJ
cord-297652-ut6e1ysz	14	15	clinical	clinical	JJ
cord-297652-ut6e1ysz	14	16	trials	trial	NNS
cord-297652-ut6e1ysz	14	17	,	,	,
cord-297652-ut6e1ysz	14	18	as	as	IN
cord-297652-ut6e1ysz	14	19	they	-PRON-	PRP
cord-297652-ut6e1ysz	14	20	can	can	MD
cord-297652-ut6e1ysz	14	21	be	be	VB
cord-297652-ut6e1ysz	14	22	found	find	VBN
cord-297652-ut6e1ysz	14	23	in	in	IN
cord-297652-ut6e1ysz	14	24	the	the	DT
cord-297652-ut6e1ysz	14	25	U.S.	U.S.	NNP
cord-297652-ut6e1ysz	14	26	National	National	NNP
cord-297652-ut6e1ysz	14	27	Library	Library	NNP
cord-297652-ut6e1ysz	14	28	of	of	IN
cord-297652-ut6e1ysz	14	29	Medicine	Medicine	NNP
cord-297652-ut6e1ysz	14	30	of	of	IN
cord-297652-ut6e1ysz	14	31	the	the	DT
cord-297652-ut6e1ysz	14	32	National	National	NNP
cord-297652-ut6e1ysz	14	33	Institutes	Institutes	NNPS
cord-297652-ut6e1ysz	14	34	of	of	IN
cord-297652-ut6e1ysz	14	35	Health	Health	NNP
cord-297652-ut6e1ysz	14	36	(	(	-LRB-
cord-297652-ut6e1ysz	14	37	Bethesda	Bethesda	NNP
cord-297652-ut6e1ysz	14	38	,	,	,
cord-297652-ut6e1ysz	14	39	MD	MD	NNP
cord-297652-ut6e1ysz	14	40	,	,	,
cord-297652-ut6e1ysz	14	41	USA	USA	NNP
cord-297652-ut6e1ysz	14	42	)	)	-RRB-
cord-297652-ut6e1ysz	14	43	[	[	-LRB-
cord-297652-ut6e1ysz	14	44	4	4	CD
cord-297652-ut6e1ysz	14	45	]	]	-RRB-
cord-297652-ut6e1ysz	14	46	.	.	.
cord-297652-ut6e1ysz	15	1	As	as	IN
cord-297652-ut6e1ysz	15	2	of	of	IN
cord-297652-ut6e1ysz	15	3	March	March	NNP
cord-297652-ut6e1ysz	15	4	28	28	CD
cord-297652-ut6e1ysz	15	5	,	,	,
cord-297652-ut6e1ysz	15	6	202	202	CD
cord-297652-ut6e1ysz	15	7	clinical	clinical	JJ
cord-297652-ut6e1ysz	15	8	trials	trial	NNS
cord-297652-ut6e1ysz	15	9	could	could	MD
cord-297652-ut6e1ysz	15	10	be	be	VB
cord-297652-ut6e1ysz	15	11	retrieved	retrieve	VBN
cord-297652-ut6e1ysz	15	12	with	with	IN
cord-297652-ut6e1ysz	15	13	the	the	DT
cord-297652-ut6e1ysz	15	14	search	search	NN
cord-297652-ut6e1ysz	15	15	term	term	NN
cord-297652-ut6e1ysz	15	16	"	"	''
cord-297652-ut6e1ysz	15	17	COVID-	covid-	NN
cord-297652-ut6e1ysz	15	18	19	19	CD
cord-297652-ut6e1ysz	15	19	More	More	JJR
cord-297652-ut6e1ysz	15	20	than	than	IN
cord-297652-ut6e1ysz	15	21	100	100	CD
cord-297652-ut6e1ysz	15	22	studies	study	NNS
cord-297652-ut6e1ysz	15	23	involving	involve	VBG
cord-297652-ut6e1ysz	15	24	other	other	JJ
cord-297652-ut6e1ysz	15	25	small	small	JJ
cord-297652-ut6e1ysz	15	26	molecules	molecule	NNS
cord-297652-ut6e1ysz	15	27	.	.	.
cord-297652-ut6e1ysz	16	1	A	a	DT
cord-297652-ut6e1ysz	16	2	quick	quick	JJ
cord-297652-ut6e1ysz	16	3	reading	reading	NN
cord-297652-ut6e1ysz	16	4	of	of	IN
cord-297652-ut6e1ysz	16	5	these	these	DT
cord-297652-ut6e1ysz	16	6	projects	project	NNS
cord-297652-ut6e1ysz	16	7	[	[	-LRB-
cord-297652-ut6e1ysz	16	8	4	4	CD
cord-297652-ut6e1ysz	16	9	]	]	-RRB-
cord-297652-ut6e1ysz	16	10	allows	allow	VBZ
cord-297652-ut6e1ysz	16	11	one	one	PRP
cord-297652-ut6e1ysz	16	12	to	to	TO
cord-297652-ut6e1ysz	16	13	sort	sort	VB
cord-297652-ut6e1ysz	16	14	out	out	RP
cord-297652-ut6e1ysz	16	15	the	the	DT
cord-297652-ut6e1ysz	16	16	monoclonal	monoclonal	JJ
cord-297652-ut6e1ysz	16	17	antibodies	antibody	NNS
cord-297652-ut6e1ysz	16	18	,	,	,
cord-297652-ut6e1ysz	16	19	antiviral	antiviral	JJ
cord-297652-ut6e1ysz	16	20	drugs	drug	NNS
cord-297652-ut6e1ysz	16	21	,	,	,
cord-297652-ut6e1ysz	16	22	and	and	CC
cord-297652-ut6e1ysz	16	23	other	other	JJ
cord-297652-ut6e1ysz	16	24	small	small	JJ
cord-297652-ut6e1ysz	16	25	molecules	molecule	NNS
cord-297652-ut6e1ysz	16	26	that	that	WDT
cord-297652-ut6e1ysz	16	27	are	be	VBP
cord-297652-ut6e1ysz	16	28	most	most	RBS
cord-297652-ut6e1ysz	16	29	cited	cite	VBN
cord-297652-ut6e1ysz	16	30	in	in	IN
cord-297652-ut6e1ysz	16	31	the	the	DT
cord-297652-ut6e1ysz	16	32	trials	trial	NNS
cord-297652-ut6e1ysz	16	33	.	.	.
cord-297652-ut6e1ysz	17	1	The	the	DT
cord-297652-ut6e1ysz	17	2	list	list	NN
cord-297652-ut6e1ysz	17	3	can	can	MD
cord-297652-ut6e1ysz	17	4	be	be	VB
cord-297652-ut6e1ysz	17	5	found	find	VBN
cord-297652-ut6e1ysz	17	6	in	in	IN
cord-297652-ut6e1ysz	17	7	Table	Table	NNP
cord-297652-ut6e1ysz	17	8	1	1	CD
cord-297652-ut6e1ysz	17	9	.	.	.
cord-297652-ut6e1ysz	17	10	 	 	_SP
cord-297652-ut6e1ysz	18	1	On	on	IN
cord-297652-ut6e1ysz	18	2	March	March	NNP
cord-297652-ut6e1ysz	18	3	13	13	CD
cord-297652-ut6e1ysz	18	4	,	,	,
cord-297652-ut6e1ysz	18	5	the	the	DT
cord-297652-ut6e1ysz	18	6	United	United	NNP
cord-297652-ut6e1ysz	18	7	Nations	Nations	NNP
cord-297652-ut6e1ysz	18	8	Foundation	Foundation	NNP
cord-297652-ut6e1ysz	18	9	,	,	,
cord-297652-ut6e1ysz	18	10	the	the	DT
cord-297652-ut6e1ysz	18	11	Swiss	Swiss	NNP
cord-297652-ut6e1ysz	18	12	Philanthropy	Philanthropy	NNP
cord-297652-ut6e1ysz	18	13	Foundation	Foundation	NNP
cord-297652-ut6e1ysz	18	14	,	,	,
cord-297652-ut6e1ysz	18	15	and	and	CC
cord-297652-ut6e1ysz	18	16	the	the	DT
cord-297652-ut6e1ysz	18	17	World	World	NNP
cord-297652-ut6e1ysz	18	18	Health	Health	NNP
cord-297652-ut6e1ysz	18	19	Organization	Organization	NNP
cord-297652-ut6e1ysz	18	20	(	(	-LRB-
cord-297652-ut6e1ysz	18	21	WHO	who	WP
cord-297652-ut6e1ysz	18	22	)	)	-RRB-
cord-297652-ut6e1ysz	18	23	have	have	VBP
cord-297652-ut6e1ysz	18	24	created	create	VBN
cord-297652-ut6e1ysz	18	25	the	the	DT
cord-297652-ut6e1ysz	18	26	SOLIDARITY	SOLIDARITY	NNP
cord-297652-ut6e1ysz	18	27	Response	Response	NNP
cord-297652-ut6e1ysz	18	28	Fund	Fund	NNP
cord-297652-ut6e1ysz	18	29	in	in	IN
cord-297652-ut6e1ysz	18	30	order	order	NN
cord-297652-ut6e1ysz	18	31	to	to	TO
cord-297652-ut6e1ysz	18	32	raise	raise	VB
cord-297652-ut6e1ysz	18	33	money	money	NN
cord-297652-ut6e1ysz	18	34	to	to	TO
cord-297652-ut6e1ysz	18	35	support	support	VB
cord-297652-ut6e1ysz	18	36	studies	study	NNS
cord-297652-ut6e1ysz	18	37	on	on	IN
cord-297652-ut6e1ysz	18	38	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	18	39	[	[	-LRB-
cord-297652-ut6e1ysz	18	40	5	5	CD
cord-297652-ut6e1ysz	18	41	]	]	-RRB-
cord-297652-ut6e1ysz	18	42	.	.	.
cord-297652-ut6e1ysz	19	1	On	on	IN
cord-297652-ut6e1ysz	19	2	March	March	NNP
cord-297652-ut6e1ysz	19	3	18	18	CD
cord-297652-ut6e1ysz	19	4	,	,	,
cord-297652-ut6e1ysz	19	5	WHO	who	WP
cord-297652-ut6e1ysz	19	6	indicated	indicate	VBD
cord-297652-ut6e1ysz	19	7	that	that	IN
cord-297652-ut6e1ysz	19	8	the	the	DT
cord-297652-ut6e1ysz	19	9	first	first	JJ
cord-297652-ut6e1ysz	19	10	trial	trial	NN
cord-297652-ut6e1ysz	19	11	supported	support	VBN
cord-297652-ut6e1ysz	19	12	by	by	IN
cord-297652-ut6e1ysz	19	13	the	the	DT
cord-297652-ut6e1ysz	19	14	Fund	Fund	NNP
cord-297652-ut6e1ysz	19	15	would	would	MD
cord-297652-ut6e1ysz	19	16	be	be	VB
cord-297652-ut6e1ysz	19	17	an	an	DT
cord-297652-ut6e1ysz	19	18	adaptative	adaptative	JJ
cord-297652-ut6e1ysz	19	19	study	study	NN
cord-297652-ut6e1ysz	19	20	performed	perform	VBN
cord-297652-ut6e1ysz	19	21	in	in	IN
cord-297652-ut6e1ysz	19	22	ten	ten	CD
cord-297652-ut6e1ysz	19	23	countries	country	NNS
cord-297652-ut6e1ysz	19	24	,	,	,
cord-297652-ut6e1ysz	19	25	namely	namely	RB
cord-297652-ut6e1ysz	19	26	Argentina	Argentina	NNP
cord-297652-ut6e1ysz	19	27	,	,	,
cord-297652-ut6e1ysz	19	28	Bahrain	Bahrain	NNP
cord-297652-ut6e1ysz	19	29	,	,	,
cord-297652-ut6e1ysz	19	30	Canada	Canada	NNP
cord-297652-ut6e1ysz	19	31	,	,	,
cord-297652-ut6e1ysz	19	32	France	France	NNP
cord-297652-ut6e1ysz	19	33	,	,	,
cord-297652-ut6e1ysz	19	34	Iran	Iran	NNP
cord-297652-ut6e1ysz	19	35	,	,	,
cord-297652-ut6e1ysz	19	36	Norway	Norway	NNP
cord-297652-ut6e1ysz	19	37	,	,	,
cord-297652-ut6e1ysz	19	38	South	South	NNP
cord-297652-ut6e1ysz	19	39	Africa	Africa	NNP
cord-297652-ut6e1ysz	19	40	,	,	,
cord-297652-ut6e1ysz	19	41	Spain	Spain	NNP
cord-297652-ut6e1ysz	19	42	,	,	,
cord-297652-ut6e1ysz	19	43	Switzerland	Switzerland	NNP
cord-297652-ut6e1ysz	19	44	,	,	,
cord-297652-ut6e1ysz	19	45	Thailand	Thailand	NNP
cord-297652-ut6e1ysz	19	46	.	.	.
cord-297652-ut6e1ysz	20	1	India	India	NNP
cord-297652-ut6e1ysz	20	2	joined	join	VBD
cord-297652-ut6e1ysz	20	3	the	the	DT
cord-297652-ut6e1ysz	20	4	trial	trial	NN
cord-297652-ut6e1ysz	20	5	on	on	IN
cord-297652-ut6e1ysz	20	6	March	March	NNP
cord-297652-ut6e1ysz	20	7	27	27	CD
cord-297652-ut6e1ysz	20	8	.	.	.
cord-297652-ut6e1ysz	21	1	On	on	IN
cord-297652-ut6e1ysz	21	2	March	March	NNP
cord-297652-ut6e1ysz	21	3	22	22	CD
cord-297652-ut6e1ysz	21	4	,	,	,
cord-297652-ut6e1ysz	21	5	the	the	DT
cord-297652-ut6e1ysz	21	6	French	french	JJ
cord-297652-ut6e1ysz	21	7	Institut	Institut	NNP
cord-297652-ut6e1ysz	21	8	National	National	NNP
cord-297652-ut6e1ysz	21	9	de	de	NNP
cord-297652-ut6e1ysz	21	10	la	la	FW
cord-297652-ut6e1ysz	21	11	Santé	Santé	NNP
cord-297652-ut6e1ysz	21	12	Et	Et	NNP
cord-297652-ut6e1ysz	21	13	de	de	FW
cord-297652-ut6e1ysz	21	14	la	la	FW
cord-297652-ut6e1ysz	21	15	Recherche	Recherche	NNP
cord-297652-ut6e1ysz	21	16	Médicale	Médicale	NNP
cord-297652-ut6e1ysz	21	17	(	(	-LRB-
cord-297652-ut6e1ysz	21	18	INSERM	INSERM	NNP
cord-297652-ut6e1ysz	21	19	)	)	-RRB-
cord-297652-ut6e1ysz	21	20	announced	announce	VBD
cord-297652-ut6e1ysz	21	21	a	a	DT
cord-297652-ut6e1ysz	21	22	European	european	JJ
cord-297652-ut6e1ysz	21	23	counterpart	counterpart	NN
cord-297652-ut6e1ysz	21	24	,	,	,
cord-297652-ut6e1ysz	21	25	named	name	VBN
cord-297652-ut6e1ysz	21	26	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	21	27	,	,	,
cord-297652-ut6e1ysz	21	28	and	and	CC
cord-297652-ut6e1ysz	21	29	aimed	aim	VBN
cord-297652-ut6e1ysz	21	30	at	at	IN
cord-297652-ut6e1ysz	21	31	a	a	DT
cord-297652-ut6e1ysz	21	32	study	study	NN
cord-297652-ut6e1ysz	21	33	of	of	IN
cord-297652-ut6e1ysz	21	34	four	four	CD
cord-297652-ut6e1ysz	21	35	treatments	treatment	NNS
cord-297652-ut6e1ysz	21	36	on	on	IN
cord-297652-ut6e1ysz	21	37	3100	3100	CD
cord-297652-ut6e1ysz	21	38	patients	patient	NNS
cord-297652-ut6e1ysz	21	39	in	in	IN
cord-297652-ut6e1ysz	21	40	seven	seven	CD
cord-297652-ut6e1ysz	21	41	countries	country	NNS
cord-297652-ut6e1ysz	21	42	,	,	,
cord-297652-ut6e1ysz	21	43	namely	namely	RB
cord-297652-ut6e1ysz	21	44	France	France	NNP
cord-297652-ut6e1ysz	21	45	,	,	,
cord-297652-ut6e1ysz	21	46	Spain	Spain	NNP
cord-297652-ut6e1ysz	21	47	,	,	,
cord-297652-ut6e1ysz	21	48	the	the	DT
cord-297652-ut6e1ysz	21	49	United	United	NNP
cord-297652-ut6e1ysz	21	50	Kingdom	Kingdom	NNP
cord-297652-ut6e1ysz	21	51	,	,	,
cord-297652-ut6e1ysz	21	52	Germany	Germany	NNP
cord-297652-ut6e1ysz	21	53	,	,	,
cord-297652-ut6e1ysz	21	54	Luxembourg	Luxembourg	NNP
cord-297652-ut6e1ysz	21	55	,	,	,
cord-297652-ut6e1ysz	21	56	the	the	DT
cord-297652-ut6e1ysz	21	57	Netherlands	Netherlands	NNP
cord-297652-ut6e1ysz	21	58	,	,	,
cord-297652-ut6e1ysz	21	59	and	and	CC
cord-297652-ut6e1ysz	21	60	Belgium	Belgium	NNP
cord-297652-ut6e1ysz	21	61	[	[	-LRB-
cord-297652-ut6e1ysz	21	62	6	6	CD
cord-297652-ut6e1ysz	21	63	]	]	-RRB-
cord-297652-ut6e1ysz	21	64	.	.	.
cord-297652-ut6e1ysz	22	1	The	the	DT
cord-297652-ut6e1ysz	22	2	four	four	CD
cord-297652-ut6e1ysz	22	3	treatments	treatment	NNS
cord-297652-ut6e1ysz	22	4	to	to	TO
cord-297652-ut6e1ysz	22	5	be	be	VB
cord-297652-ut6e1ysz	22	6	analyzed	analyze	VBN
cord-297652-ut6e1ysz	22	7	are	be	VBP
cord-297652-ut6e1ysz	22	8	:	:	:
cord-297652-ut6e1ysz	22	9	The	the	DT
cord-297652-ut6e1ysz	22	10	combination	combination	NN
cord-297652-ut6e1ysz	22	11	lopinavir	lopinavir	NNS
cord-297652-ut6e1ysz	22	12	/	/	SYM
cord-297652-ut6e1ysz	22	13	ritonavir	ritonavir	NNS
cord-297652-ut6e1ysz	22	14	;	;	:
cord-297652-ut6e1ysz	22	15	•	•	NNP
cord-297652-ut6e1ysz	23	1	The	the	DT
cord-297652-ut6e1ysz	23	2	combination	combination	NN
cord-297652-ut6e1ysz	23	3	lopinavir	lopinavir	NNS
cord-297652-ut6e1ysz	23	4	/	/	SYM
cord-297652-ut6e1ysz	23	5	ritonavir	ritonavir	NNS
cord-297652-ut6e1ysz	23	6	with	with	IN
cord-297652-ut6e1ysz	23	7	the	the	DT
cord-297652-ut6e1ysz	23	8	addition	addition	NN
cord-297652-ut6e1ysz	23	9	of	of	IN
cord-297652-ut6e1ysz	23	10	interferon	interferon	NNP
cord-297652-ut6e1ysz	23	11	β-1a	β-1a	NNP
cord-297652-ut6e1ysz	23	12	;	;	:
cord-297652-ut6e1ysz	23	13	•	•	NNP
cord-297652-ut6e1ysz	23	14	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-297652-ut6e1ysz	23	15	,	,	,
cord-297652-ut6e1ysz	23	16	eventually	eventually	RB
cord-297652-ut6e1ysz	23	17	associated	associate	VBN
cord-297652-ut6e1ysz	23	18	with	with	IN
cord-297652-ut6e1ysz	23	19	an	an	DT
cord-297652-ut6e1ysz	23	20	antibiotic	antibiotic	NN
cord-297652-ut6e1ysz	23	21	(	(	-LRB-
cord-297652-ut6e1ysz	23	22	azithromycin	azithromycin	NN
cord-297652-ut6e1ysz	23	23	)	)	-RRB-
cord-297652-ut6e1ysz	23	24	in	in	IN
cord-297652-ut6e1ysz	23	25	add	add	NN
cord-297652-ut6e1ysz	23	26	-	-	HYPH
cord-297652-ut6e1ysz	23	27	on	on	RP
cord-297652-ut6e1ysz	23	28	studies	study	NNS
cord-297652-ut6e1ysz	23	29	.	.	.
cord-297652-ut6e1ysz	24	1	The	the	DT
cord-297652-ut6e1ysz	24	2	study	study	NN
cord-297652-ut6e1ysz	24	3	is	be	VBZ
cord-297652-ut6e1ysz	24	4	entitled	entitle	VBN
cord-297652-ut6e1ysz	24	5	"	"	``
cord-297652-ut6e1ysz	24	6	Trial	Trial	NNP
cord-297652-ut6e1ysz	24	7	of	of	IN
cord-297652-ut6e1ysz	24	8	Treatments	Treatments	NNPS
cord-297652-ut6e1ysz	24	9	for	for	IN
cord-297652-ut6e1ysz	24	10	COVID-19	covid-19	CD
cord-297652-ut6e1ysz	24	11	in	in	IN
cord-297652-ut6e1ysz	24	12	Hospitalized	Hospitalized	NNP
cord-297652-ut6e1ysz	24	13	Adults	Adults	NNPS
cord-297652-ut6e1ysz	24	14	(	(	-LRB-
cord-297652-ut6e1ysz	24	15	DisCoVeRy	DisCoVeRy	NNP
cord-297652-ut6e1ysz	24	16	)	)	-RRB-
cord-297652-ut6e1ysz	24	17	"	"	''
cord-297652-ut6e1ysz	24	18	(	(	-LRB-
cord-297652-ut6e1ysz	24	19	NCT04315948	NCT04315948	NNP
cord-297652-ut6e1ysz	24	20	)	)	-RRB-
cord-297652-ut6e1ysz	24	21	[	[	-LRB-
cord-297652-ut6e1ysz	24	22	4	4	CD
cord-297652-ut6e1ysz	24	23	]	]	-RRB-
cord-297652-ut6e1ysz	24	24	.	.	.
cord-297652-ut6e1ysz	25	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	25	2	started	start	VBD
cord-297652-ut6e1ysz	25	3	in	in	IN
cord-297652-ut6e1ysz	25	4	three	three	CD
cord-297652-ut6e1ysz	25	5	French	french	JJ
cord-297652-ut6e1ysz	25	6	hospitals	hospital	NNS
cord-297652-ut6e1ysz	25	7	:	:	:
cord-297652-ut6e1ysz	25	8	Centre	Centre	NNP
cord-297652-ut6e1ysz	25	9	Hospitalier	Hospitalier	NNP
cord-297652-ut6e1ysz	25	10	Régional	Régional	NNP
cord-297652-ut6e1ysz	25	11	Universitaire	Universitaire	NNP
cord-297652-ut6e1ysz	25	12	de	de	FW
cord-297652-ut6e1ysz	25	13	Lille	Lille	NNP
cord-297652-ut6e1ysz	25	14	(	(	-LRB-
cord-297652-ut6e1ysz	25	15	Lille	Lille	NNP
cord-297652-ut6e1ysz	25	16	,	,	,
cord-297652-ut6e1ysz	25	17	France	France	NNP
cord-297652-ut6e1ysz	25	18	)	)	-RRB-
cord-297652-ut6e1ysz	25	19	,	,	,
cord-297652-ut6e1ysz	25	20	Centre	Centre	NNP
cord-297652-ut6e1ysz	25	21	Hospitalier	Hospitalier	NNP
cord-297652-ut6e1ysz	25	22	Universitaire	Universitaire	NNP
cord-297652-ut6e1ysz	25	23	de	de	IN
cord-297652-ut6e1ysz	25	24	Nantes	Nantes	NNP
cord-297652-ut6e1ysz	25	25	(	(	-LRB-
cord-297652-ut6e1ysz	25	26	Nantes	Nantes	NNP
cord-297652-ut6e1ysz	25	27	,	,	,
cord-297652-ut6e1ysz	25	28	France	France	NNP
cord-297652-ut6e1ysz	25	29	)	)	-RRB-
cord-297652-ut6e1ysz	25	30	,	,	,
cord-297652-ut6e1ysz	25	31	and	and	CC
cord-297652-ut6e1ysz	25	32	Assistance	Assistance	NNP
cord-297652-ut6e1ysz	25	33	Publique	Publique	NNP
cord-297652-ut6e1ysz	25	34	Hôpitaux	Hôpitaux	NNP
cord-297652-ut6e1ysz	25	35	de	de	NNP
cord-297652-ut6e1ysz	25	36	Paris	Paris	NNP
cord-297652-ut6e1ysz	26	1	-Bichat	-bichat	WDT
cord-297652-ut6e1ysz	26	2	Claude	Claude	NNP
cord-297652-ut6e1ysz	26	3	Bernard	Bernard	NNP
cord-297652-ut6e1ysz	26	4	(	(	-LRB-
cord-297652-ut6e1ysz	26	5	Paris	Paris	NNP
cord-297652-ut6e1ysz	26	6	,	,	,
cord-297652-ut6e1ysz	26	7	France	France	NNP
cord-297652-ut6e1ysz	26	8	)	)	-RRB-
cord-297652-ut6e1ysz	26	9	.	.	.
cord-297652-ut6e1ysz	27	1	The	the	DT
cord-297652-ut6e1ysz	27	2	structure	structure	NN
cord-297652-ut6e1ysz	27	3	and	and	CC
cord-297652-ut6e1ysz	27	4	some	some	DT
cord-297652-ut6e1ysz	27	5	characteristics	characteristic	NNS
cord-297652-ut6e1ysz	27	6	of	of	IN
cord-297652-ut6e1ysz	27	7	the	the	DT
cord-297652-ut6e1ysz	27	8	four	four	CD
cord-297652-ut6e1ysz	27	9	small	small	JJ
cord-297652-ut6e1ysz	27	10	molecules	molecule	NNS
cord-297652-ut6e1ysz	27	11	involved	involve	VBN
cord-297652-ut6e1ysz	27	12	in	in	IN
cord-297652-ut6e1ysz	27	13	that	that	DT
cord-297652-ut6e1ysz	27	14	clinical	clinical	JJ
cord-297652-ut6e1ysz	27	15	trial	trial	NN
cord-297652-ut6e1ysz	27	16	are	be	VBP
cord-297652-ut6e1ysz	27	17	collected	collect	VBN
cord-297652-ut6e1ysz	27	18	in	in	IN
cord-297652-ut6e1ysz	27	19	Figure	figure	NN
cord-297652-ut6e1ysz	27	20	1	1	CD
cord-297652-ut6e1ysz	27	21	.	.	.
cord-297652-ut6e1ysz	28	1	The	the	DT
cord-297652-ut6e1ysz	28	2	formula	formula	NN
cord-297652-ut6e1ysz	28	3	of	of	IN
cord-297652-ut6e1ysz	28	4	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	28	5	is	be	VBZ
cord-297652-ut6e1ysz	28	6	added	add	VBN
cord-297652-ut6e1ysz	28	7	for	for	IN
cord-297652-ut6e1ysz	28	8	comparison	comparison	NN
cord-297652-ut6e1ysz	28	9	.	.	.
cord-297652-ut6e1ysz	29	1	Lille	Lille	NNP
cord-297652-ut6e1ysz	29	2	(	(	-LRB-
cord-297652-ut6e1ysz	29	3	Lille	Lille	NNP
cord-297652-ut6e1ysz	29	4	,	,	,
cord-297652-ut6e1ysz	29	5	France	France	NNP
cord-297652-ut6e1ysz	29	6	)	)	-RRB-
cord-297652-ut6e1ysz	29	7	,	,	,
cord-297652-ut6e1ysz	29	8	Centre	Centre	NNP
cord-297652-ut6e1ysz	29	9	Hospitalier	Hospitalier	NNP
cord-297652-ut6e1ysz	29	10	Universitaire	Universitaire	NNP
cord-297652-ut6e1ysz	29	11	de	de	IN
cord-297652-ut6e1ysz	29	12	Nantes	Nantes	NNP
cord-297652-ut6e1ysz	29	13	(	(	-LRB-
cord-297652-ut6e1ysz	29	14	Nantes	Nantes	NNP
cord-297652-ut6e1ysz	29	15	,	,	,
cord-297652-ut6e1ysz	29	16	France	France	NNP
cord-297652-ut6e1ysz	29	17	)	)	-RRB-
cord-297652-ut6e1ysz	29	18	,	,	,
cord-297652-ut6e1ysz	29	19	and	and	CC
cord-297652-ut6e1ysz	29	20	Assistance	Assistance	NNP
cord-297652-ut6e1ysz	29	21	Publique	Publique	NNP
cord-297652-ut6e1ysz	29	22	Hôpitaux	Hôpitaux	NNP
cord-297652-ut6e1ysz	29	23	de	de	NNP
cord-297652-ut6e1ysz	29	24	Paris	Paris	NNP
cord-297652-ut6e1ysz	30	1	-Bichat	-bichat	WDT
cord-297652-ut6e1ysz	30	2	Claude	Claude	NNP
cord-297652-ut6e1ysz	30	3	Bernard	Bernard	NNP
cord-297652-ut6e1ysz	30	4	(	(	-LRB-
cord-297652-ut6e1ysz	30	5	Paris	Paris	NNP
cord-297652-ut6e1ysz	30	6	,	,	,
cord-297652-ut6e1ysz	30	7	France	France	NNP
cord-297652-ut6e1ysz	30	8	)	)	-RRB-
cord-297652-ut6e1ysz	30	9	.	.	.
cord-297652-ut6e1ysz	31	1	The	the	DT
cord-297652-ut6e1ysz	31	2	structure	structure	NN
cord-297652-ut6e1ysz	31	3	and	and	CC
cord-297652-ut6e1ysz	31	4	some	some	DT
cord-297652-ut6e1ysz	31	5	characteristics	characteristic	NNS
cord-297652-ut6e1ysz	31	6	of	of	IN
cord-297652-ut6e1ysz	31	7	the	the	DT
cord-297652-ut6e1ysz	31	8	four	four	CD
cord-297652-ut6e1ysz	31	9	small	small	JJ
cord-297652-ut6e1ysz	31	10	molecules	molecule	NNS
cord-297652-ut6e1ysz	31	11	involved	involve	VBN
cord-297652-ut6e1ysz	31	12	in	in	IN
cord-297652-ut6e1ysz	31	13	that	that	DT
cord-297652-ut6e1ysz	31	14	clinical	clinical	JJ
cord-297652-ut6e1ysz	31	15	trial	trial	NN
cord-297652-ut6e1ysz	31	16	are	be	VBP
cord-297652-ut6e1ysz	31	17	collected	collect	VBN
cord-297652-ut6e1ysz	31	18	in	in	IN
cord-297652-ut6e1ysz	31	19	Figure	figure	NN
cord-297652-ut6e1ysz	31	20	1	1	CD
cord-297652-ut6e1ysz	31	21	.	.	.
cord-297652-ut6e1ysz	32	1	The	the	DT
cord-297652-ut6e1ysz	32	2	formula	formula	NN
cord-297652-ut6e1ysz	32	3	of	of	IN
cord-297652-ut6e1ysz	32	4	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	32	5	is	be	VBZ
cord-297652-ut6e1ysz	32	6	added	add	VBN
cord-297652-ut6e1ysz	32	7	for	for	IN
cord-297652-ut6e1ysz	32	8	comparison	comparison	NN
cord-297652-ut6e1ysz	32	9	.	.	.
cord-297652-ut6e1ysz	32	10	 	 	_SP
cord-297652-ut6e1ysz	33	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	33	2	has	have	VBZ
cord-297652-ut6e1ysz	33	3	been	be	VBN
cord-297652-ut6e1ysz	33	4	announced	announce	VBN
cord-297652-ut6e1ysz	33	5	that	that	IN
cord-297652-ut6e1ysz	33	6	the	the	DT
cord-297652-ut6e1ysz	33	7	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	33	8	project	project	NN
cord-297652-ut6e1ysz	33	9	is	be	VBZ
cord-297652-ut6e1ysz	33	10	an	an	DT
cord-297652-ut6e1ysz	33	11	adaptive	adaptive	JJ
cord-297652-ut6e1ysz	33	12	study	study	NN
cord-297652-ut6e1ysz	33	13	.	.	.
cord-297652-ut6e1ysz	34	1	That	that	DT
cord-297652-ut6e1ysz	34	2	means	mean	VBZ
cord-297652-ut6e1ysz	34	3	that	that	IN
cord-297652-ut6e1ysz	34	4	some	some	DT
cord-297652-ut6e1ysz	34	5	treatments	treatment	NNS
cord-297652-ut6e1ysz	34	6	can	can	MD
cord-297652-ut6e1ysz	34	7	be	be	VB
cord-297652-ut6e1ysz	34	8	abandoned	abandon	VBN
cord-297652-ut6e1ysz	34	9	during	during	IN
cord-297652-ut6e1ysz	34	10	the	the	DT
cord-297652-ut6e1ysz	34	11	study	study	NN
cord-297652-ut6e1ysz	34	12	if	if	IN
cord-297652-ut6e1ysz	34	13	results	result	NNS
cord-297652-ut6e1ysz	34	14	are	be	VBP
cord-297652-ut6e1ysz	34	15	not	not	RB
cord-297652-ut6e1ysz	34	16	encouraging	encouraging	JJ
cord-297652-ut6e1ysz	34	17	,	,	,
cord-297652-ut6e1ysz	34	18	whereas	whereas	IN
cord-297652-ut6e1ysz	34	19	new	new	JJ
cord-297652-ut6e1ysz	34	20	treatments	treatment	NNS
cord-297652-ut6e1ysz	34	21	could	could	MD
cord-297652-ut6e1ysz	34	22	be	be	VB
cord-297652-ut6e1ysz	34	23	added	add	VBN
cord-297652-ut6e1ysz	34	24	.	.	.
cord-297652-ut6e1ysz	35	1	Some	some	DT
cord-297652-ut6e1ysz	35	2	noticeable	noticeable	JJ
cord-297652-ut6e1ysz	35	3	characteristics	characteristic	NNS
cord-297652-ut6e1ysz	35	4	of	of	IN
cord-297652-ut6e1ysz	35	5	each	each	DT
cord-297652-ut6e1ysz	35	6	of	of	IN
cord-297652-ut6e1ysz	35	7	the	the	DT
cord-297652-ut6e1ysz	35	8	four	four	CD
cord-297652-ut6e1ysz	35	9	actual	actual	JJ
cord-297652-ut6e1ysz	35	10	treatments	treatment	NNS
cord-297652-ut6e1ysz	35	11	are	be	VBP
cord-297652-ut6e1ysz	35	12	given	give	VBN
cord-297652-ut6e1ysz	35	13	in	in	IN
cord-297652-ut6e1ysz	35	14	Table	Table	NNP
cord-297652-ut6e1ysz	35	15	2	2	CD
cord-297652-ut6e1ysz	35	16	.	.	.
cord-297652-ut6e1ysz	36	1	Remdesivir	Remdesivir	NNP
cord-297652-ut6e1ysz	36	2	is	be	VBZ
cord-297652-ut6e1ysz	36	3	an	an	DT
cord-297652-ut6e1ysz	36	4	investigational	investigational	JJ
cord-297652-ut6e1ysz	36	5	drug	drug	NN
cord-297652-ut6e1ysz	36	6	developed	develop	VBN
cord-297652-ut6e1ysz	36	7	by	by	IN
cord-297652-ut6e1ysz	36	8	Gilead	Gilead	NNP
cord-297652-ut6e1ysz	36	9	Sciences	Sciences	NNPS
cord-297652-ut6e1ysz	36	10	.	.	.
cord-297652-ut6e1ysz	37	1	Before	before	IN
cord-297652-ut6e1ysz	37	2	the	the	DT
cord-297652-ut6e1ysz	37	3	outbreak	outbreak	NN
cord-297652-ut6e1ysz	37	4	of	of	IN
cord-297652-ut6e1ysz	37	5	SARS	SARS	NNP
cord-297652-ut6e1ysz	37	6	-	-	HYPH
cord-297652-ut6e1ysz	37	7	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	37	8	,	,	,
cord-297652-ut6e1ysz	37	9	it	-PRON-	PRP
cord-297652-ut6e1ysz	37	10	has	have	VBZ
cord-297652-ut6e1ysz	37	11	been	be	VBN
cord-297652-ut6e1ysz	37	12	the	the	DT
cord-297652-ut6e1ysz	37	13	subject	subject	NN
cord-297652-ut6e1ysz	37	14	of	of	IN
cord-297652-ut6e1ysz	37	15	only	only	RB
cord-297652-ut6e1ysz	37	16	one	one	CD
cord-297652-ut6e1ysz	37	17	clinical	clinical	JJ
cord-297652-ut6e1ysz	37	18	trial	trial	NN
cord-297652-ut6e1ysz	37	19	,	,	,
cord-297652-ut6e1ysz	37	20	following	follow	VBG
cord-297652-ut6e1ysz	37	21	the	the	DT
cord-297652-ut6e1ysz	37	22	U.S.	U.S.	NNP
cord-297652-ut6e1ysz	37	23	National	National	NNP
cord-297652-ut6e1ysz	37	24	Library	Library	NNP
cord-297652-ut6e1ysz	37	25	of	of	IN
cord-297652-ut6e1ysz	37	26	Medicine	Medicine	NNP
cord-297652-ut6e1ysz	37	27	of	of	IN
cord-297652-ut6e1ysz	37	28	the	the	DT
cord-297652-ut6e1ysz	37	29	National	National	NNP
cord-297652-ut6e1ysz	37	30	Institutes	Institutes	NNPS
cord-297652-ut6e1ysz	37	31	of	of	IN
cord-297652-ut6e1ysz	37	32	Health	Health	NNP
cord-297652-ut6e1ysz	37	33	[	[	-LRB-
cord-297652-ut6e1ysz	37	34	4	4	CD
cord-297652-ut6e1ysz	37	35	]	]	-RRB-
cord-297652-ut6e1ysz	37	36	.	.	.
cord-297652-ut6e1ysz	38	1	That	that	DT
cord-297652-ut6e1ysz	38	2	study	study	NN
cord-297652-ut6e1ysz	38	3	(	(	-LRB-
cord-297652-ut6e1ysz	38	4	NCT03719586	NCT03719586	NNP
cord-297652-ut6e1ysz	38	5	)	)	-RRB-
cord-297652-ut6e1ysz	38	6	was	be	VBD
cord-297652-ut6e1ysz	38	7	entitled	entitle	VBN
cord-297652-ut6e1ysz	38	8	"	"	``
cord-297652-ut6e1ysz	38	9	Investigational	Investigational	NNP
cord-297652-ut6e1ysz	38	10	Therapeutics	Therapeutics	NNPS
cord-297652-ut6e1ysz	38	11	for	for	IN
cord-297652-ut6e1ysz	38	12	the	the	DT
cord-297652-ut6e1ysz	38	13	Treatment	Treatment	NNP
cord-297652-ut6e1ysz	38	14	of	of	IN
cord-297652-ut6e1ysz	38	15	People	People	NNPS
cord-297652-ut6e1ysz	38	16	with	with	IN
cord-297652-ut6e1ysz	38	17	Ebola	Ebola	NNP
cord-297652-ut6e1ysz	38	18	Virus	Virus	NNP
cord-297652-ut6e1ysz	38	19	Disease	Disease	NNP
cord-297652-ut6e1ysz	38	20	"	"	''
cord-297652-ut6e1ysz	38	21	and	and	CC
cord-297652-ut6e1ysz	38	22	started	start	VBD
cord-297652-ut6e1ysz	38	23	on	on	IN
cord-297652-ut6e1ysz	38	24	November	November	NNP
cord-297652-ut6e1ysz	38	25	21	21	CD
cord-297652-ut6e1ysz	38	26	,	,	,
cord-297652-ut6e1ysz	38	27	2018	2018	CD
cord-297652-ut6e1ysz	38	28	.	.	.
cord-297652-ut6e1ysz	39	1	Three	three	CD
cord-297652-ut6e1ysz	39	2	monoclonal	monoclonal	JJ
cord-297652-ut6e1ysz	39	3	antibodies	antibody	NNS
cord-297652-ut6e1ysz	39	4	(	(	-LRB-
cord-297652-ut6e1ysz	39	5	ZMapp	ZMapp	NNP
cord-297652-ut6e1ysz	39	6	for	for	IN
cord-297652-ut6e1ysz	39	7	the	the	DT
cord-297652-ut6e1ysz	39	8	control	control	NN
cord-297652-ut6e1ysz	39	9	group	group	NN
cord-297652-ut6e1ysz	39	10	,	,	,
cord-297652-ut6e1ysz	39	11	REGN	REGN	NNP
cord-297652-ut6e1ysz	39	12	-	-	HYPH
cord-297652-ut6e1ysz	39	13	EB3	EB3	NNP
cord-297652-ut6e1ysz	39	14	,	,	,
cord-297652-ut6e1ysz	39	15	Mab114	Mab114	NNP
cord-297652-ut6e1ysz	39	16	)	)	-RRB-
cord-297652-ut6e1ysz	39	17	and	and	CC
cord-297652-ut6e1ysz	39	18	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	39	19	were	be	VBD
cord-297652-ut6e1ysz	39	20	separately	separately	RB
cord-297652-ut6e1ysz	39	21	administered	administer	VBN
cord-297652-ut6e1ysz	39	22	to	to	IN
cord-297652-ut6e1ysz	39	23	a	a	DT
cord-297652-ut6e1ysz	39	24	total	total	NN
cord-297652-ut6e1ysz	39	25	of	of	IN
cord-297652-ut6e1ysz	39	26	673	673	CD
cord-297652-ut6e1ysz	39	27	participants	participant	NNS
cord-297652-ut6e1ysz	39	28	.	.	.
cord-297652-ut6e1ysz	40	1	An	an	DT
cord-297652-ut6e1ysz	40	2	initial	initial	JJ
cord-297652-ut6e1ysz	40	3	dose	dose	NN
cord-297652-ut6e1ysz	40	4	of	of	IN
cord-297652-ut6e1ysz	40	5	200	200	CD
cord-297652-ut6e1ysz	40	6	mg	mg	NN
cord-297652-ut6e1ysz	40	7	of	of	IN
cord-297652-ut6e1ysz	40	8	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	40	9	was	be	VBD
cord-297652-ut6e1ysz	40	10	administered	administer	VBN
cord-297652-ut6e1ysz	40	11	on	on	IN
cord-297652-ut6e1ysz	40	12	day	day	NN
cord-297652-ut6e1ysz	40	13	1	1	CD
cord-297652-ut6e1ysz	40	14	,	,	,
cord-297652-ut6e1ysz	40	15	followed	follow	VBN
cord-297652-ut6e1ysz	40	16	by	by	IN
cord-297652-ut6e1ysz	40	17	a	a	DT
cord-297652-ut6e1ysz	40	18	daily	daily	JJ
cord-297652-ut6e1ysz	40	19	maintenance	maintenance	NN
cord-297652-ut6e1ysz	40	20	dose	dose	NN
cord-297652-ut6e1ysz	40	21	of	of	IN
cord-297652-ut6e1ysz	40	22	100	100	CD
cord-297652-ut6e1ysz	40	23	mg	mg	NN
cord-297652-ut6e1ysz	40	24	for	for	IN
cord-297652-ut6e1ysz	40	25	9	9	CD
cord-297652-ut6e1ysz	40	26	-	-	SYM
cord-297652-ut6e1ysz	40	27	13	13	CD
cord-297652-ut6e1ysz	40	28	days	day	NNS
cord-297652-ut6e1ysz	40	29	.	.	.
cord-297652-ut6e1ysz	41	1	Results	result	NNS
cord-297652-ut6e1ysz	41	2	were	be	VBD
cord-297652-ut6e1ysz	41	3	disappointing	disappointing	JJ
cord-297652-ut6e1ysz	41	4	.	.	.
cord-297652-ut6e1ysz	42	1	After	after	IN
cord-297652-ut6e1ysz	42	2	28	28	CD
cord-297652-ut6e1ysz	42	3	days	day	NNS
cord-297652-ut6e1ysz	42	4	,	,	,
cord-297652-ut6e1ysz	42	5	the	the	DT
cord-297652-ut6e1ysz	42	6	highest	high	JJS
cord-297652-ut6e1ysz	42	7	number	number	NN
cord-297652-ut6e1ysz	42	8	of	of	IN
cord-297652-ut6e1ysz	42	9	deaths	death	NNS
cord-297652-ut6e1ysz	42	10	(	(	-LRB-
cord-297652-ut6e1ysz	42	11	53.1	53.1	CD
cord-297652-ut6e1ysz	42	12	%	%	NN
cord-297652-ut6e1ysz	42	13	)	)	-RRB-
cord-297652-ut6e1ysz	42	14	was	be	VBD
cord-297652-ut6e1ysz	42	15	 	 	_SP
cord-297652-ut6e1ysz	43	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	43	2	has	have	VBZ
cord-297652-ut6e1ysz	43	3	been	be	VBN
cord-297652-ut6e1ysz	43	4	announced	announce	VBN
cord-297652-ut6e1ysz	43	5	that	that	IN
cord-297652-ut6e1ysz	43	6	the	the	DT
cord-297652-ut6e1ysz	43	7	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	43	8	project	project	NN
cord-297652-ut6e1ysz	43	9	is	be	VBZ
cord-297652-ut6e1ysz	43	10	an	an	DT
cord-297652-ut6e1ysz	43	11	adaptive	adaptive	JJ
cord-297652-ut6e1ysz	43	12	study	study	NN
cord-297652-ut6e1ysz	43	13	.	.	.
cord-297652-ut6e1ysz	44	1	That	that	DT
cord-297652-ut6e1ysz	44	2	means	mean	VBZ
cord-297652-ut6e1ysz	44	3	that	that	IN
cord-297652-ut6e1ysz	44	4	some	some	DT
cord-297652-ut6e1ysz	44	5	treatments	treatment	NNS
cord-297652-ut6e1ysz	44	6	can	can	MD
cord-297652-ut6e1ysz	44	7	be	be	VB
cord-297652-ut6e1ysz	44	8	abandoned	abandon	VBN
cord-297652-ut6e1ysz	44	9	during	during	IN
cord-297652-ut6e1ysz	44	10	the	the	DT
cord-297652-ut6e1ysz	44	11	study	study	NN
cord-297652-ut6e1ysz	44	12	if	if	IN
cord-297652-ut6e1ysz	44	13	results	result	NNS
cord-297652-ut6e1ysz	44	14	are	be	VBP
cord-297652-ut6e1ysz	44	15	not	not	RB
cord-297652-ut6e1ysz	44	16	encouraging	encouraging	JJ
cord-297652-ut6e1ysz	44	17	,	,	,
cord-297652-ut6e1ysz	44	18	whereas	whereas	IN
cord-297652-ut6e1ysz	44	19	new	new	JJ
cord-297652-ut6e1ysz	44	20	treatments	treatment	NNS
cord-297652-ut6e1ysz	44	21	could	could	MD
cord-297652-ut6e1ysz	44	22	be	be	VB
cord-297652-ut6e1ysz	44	23	added	add	VBN
cord-297652-ut6e1ysz	44	24	.	.	.
cord-297652-ut6e1ysz	45	1	Some	some	DT
cord-297652-ut6e1ysz	45	2	noticeable	noticeable	JJ
cord-297652-ut6e1ysz	45	3	characteristics	characteristic	NNS
cord-297652-ut6e1ysz	45	4	of	of	IN
cord-297652-ut6e1ysz	45	5	each	each	DT
cord-297652-ut6e1ysz	45	6	of	of	IN
cord-297652-ut6e1ysz	45	7	the	the	DT
cord-297652-ut6e1ysz	45	8	four	four	CD
cord-297652-ut6e1ysz	45	9	actual	actual	JJ
cord-297652-ut6e1ysz	45	10	treatments	treatment	NNS
cord-297652-ut6e1ysz	45	11	are	be	VBP
cord-297652-ut6e1ysz	45	12	given	give	VBN
cord-297652-ut6e1ysz	45	13	in	in	IN
cord-297652-ut6e1ysz	45	14	Table	Table	NNP
cord-297652-ut6e1ysz	45	15	2	2	CD
cord-297652-ut6e1ysz	45	16	.	.	.
cord-297652-ut6e1ysz	46	1	Remdesivir	Remdesivir	NNP
cord-297652-ut6e1ysz	46	2	is	be	VBZ
cord-297652-ut6e1ysz	46	3	an	an	DT
cord-297652-ut6e1ysz	46	4	investigational	investigational	JJ
cord-297652-ut6e1ysz	46	5	drug	drug	NN
cord-297652-ut6e1ysz	46	6	developed	develop	VBN
cord-297652-ut6e1ysz	46	7	by	by	IN
cord-297652-ut6e1ysz	46	8	Gilead	Gilead	NNP
cord-297652-ut6e1ysz	46	9	Sciences	Sciences	NNPS
cord-297652-ut6e1ysz	46	10	.	.	.
cord-297652-ut6e1ysz	47	1	Before	before	IN
cord-297652-ut6e1ysz	47	2	the	the	DT
cord-297652-ut6e1ysz	47	3	outbreak	outbreak	NN
cord-297652-ut6e1ysz	47	4	of	of	IN
cord-297652-ut6e1ysz	47	5	SARS	SARS	NNP
cord-297652-ut6e1ysz	47	6	-	-	HYPH
cord-297652-ut6e1ysz	47	7	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	47	8	,	,	,
cord-297652-ut6e1ysz	47	9	it	-PRON-	PRP
cord-297652-ut6e1ysz	47	10	has	have	VBZ
cord-297652-ut6e1ysz	47	11	been	be	VBN
cord-297652-ut6e1ysz	47	12	the	the	DT
cord-297652-ut6e1ysz	47	13	subject	subject	NN
cord-297652-ut6e1ysz	47	14	of	of	IN
cord-297652-ut6e1ysz	47	15	only	only	RB
cord-297652-ut6e1ysz	47	16	one	one	CD
cord-297652-ut6e1ysz	47	17	clinical	clinical	JJ
cord-297652-ut6e1ysz	47	18	trial	trial	NN
cord-297652-ut6e1ysz	47	19	,	,	,
cord-297652-ut6e1ysz	47	20	following	follow	VBG
cord-297652-ut6e1ysz	47	21	the	the	DT
cord-297652-ut6e1ysz	47	22	U.S.	U.S.	NNP
cord-297652-ut6e1ysz	47	23	National	National	NNP
cord-297652-ut6e1ysz	47	24	Library	Library	NNP
cord-297652-ut6e1ysz	47	25	of	of	IN
cord-297652-ut6e1ysz	47	26	Medicine	Medicine	NNP
cord-297652-ut6e1ysz	47	27	of	of	IN
cord-297652-ut6e1ysz	47	28	the	the	DT
cord-297652-ut6e1ysz	47	29	National	National	NNP
cord-297652-ut6e1ysz	47	30	Institutes	Institutes	NNPS
cord-297652-ut6e1ysz	47	31	of	of	IN
cord-297652-ut6e1ysz	47	32	Health	Health	NNP
cord-297652-ut6e1ysz	47	33	[	[	-LRB-
cord-297652-ut6e1ysz	47	34	4	4	CD
cord-297652-ut6e1ysz	47	35	]	]	-RRB-
cord-297652-ut6e1ysz	47	36	.	.	.
cord-297652-ut6e1ysz	48	1	That	that	DT
cord-297652-ut6e1ysz	48	2	study	study	NN
cord-297652-ut6e1ysz	48	3	(	(	-LRB-
cord-297652-ut6e1ysz	48	4	NCT03719586	NCT03719586	NNP
cord-297652-ut6e1ysz	48	5	)	)	-RRB-
cord-297652-ut6e1ysz	48	6	was	be	VBD
cord-297652-ut6e1ysz	48	7	entitled	entitle	VBN
cord-297652-ut6e1ysz	48	8	"	"	``
cord-297652-ut6e1ysz	48	9	Investigational	Investigational	NNP
cord-297652-ut6e1ysz	48	10	Therapeutics	Therapeutics	NNPS
cord-297652-ut6e1ysz	48	11	for	for	IN
cord-297652-ut6e1ysz	48	12	the	the	DT
cord-297652-ut6e1ysz	48	13	Treatment	Treatment	NNP
cord-297652-ut6e1ysz	48	14	of	of	IN
cord-297652-ut6e1ysz	48	15	People	People	NNPS
cord-297652-ut6e1ysz	48	16	with	with	IN
cord-297652-ut6e1ysz	48	17	Ebola	Ebola	NNP
cord-297652-ut6e1ysz	48	18	Virus	Virus	NNP
cord-297652-ut6e1ysz	48	19	Disease	Disease	NNP
cord-297652-ut6e1ysz	48	20	"	"	''
cord-297652-ut6e1ysz	48	21	and	and	CC
cord-297652-ut6e1ysz	48	22	started	start	VBD
cord-297652-ut6e1ysz	48	23	on	on	IN
cord-297652-ut6e1ysz	48	24	November	November	NNP
cord-297652-ut6e1ysz	48	25	21	21	CD
cord-297652-ut6e1ysz	48	26	,	,	,
cord-297652-ut6e1ysz	48	27	2018	2018	CD
cord-297652-ut6e1ysz	48	28	.	.	.
cord-297652-ut6e1ysz	49	1	Three	three	CD
cord-297652-ut6e1ysz	49	2	monoclonal	monoclonal	JJ
cord-297652-ut6e1ysz	49	3	antibodies	antibody	NNS
cord-297652-ut6e1ysz	49	4	(	(	-LRB-
cord-297652-ut6e1ysz	49	5	ZMapp	ZMapp	NNP
cord-297652-ut6e1ysz	49	6	for	for	IN
cord-297652-ut6e1ysz	49	7	the	the	DT
cord-297652-ut6e1ysz	49	8	control	control	NN
cord-297652-ut6e1ysz	49	9	group	group	NN
cord-297652-ut6e1ysz	49	10	,	,	,
cord-297652-ut6e1ysz	49	11	REGN	REGN	NNP
cord-297652-ut6e1ysz	49	12	-	-	HYPH
cord-297652-ut6e1ysz	49	13	EB3	EB3	NNP
cord-297652-ut6e1ysz	49	14	,	,	,
cord-297652-ut6e1ysz	49	15	Mab114	Mab114	NNP
cord-297652-ut6e1ysz	49	16	)	)	-RRB-
cord-297652-ut6e1ysz	49	17	and	and	CC
cord-297652-ut6e1ysz	49	18	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	49	19	were	be	VBD
cord-297652-ut6e1ysz	49	20	separately	separately	RB
cord-297652-ut6e1ysz	49	21	administered	administer	VBN
cord-297652-ut6e1ysz	49	22	to	to	IN
cord-297652-ut6e1ysz	49	23	a	a	DT
cord-297652-ut6e1ysz	49	24	total	total	NN
cord-297652-ut6e1ysz	49	25	of	of	IN
cord-297652-ut6e1ysz	49	26	673	673	CD
cord-297652-ut6e1ysz	49	27	participants	participant	NNS
cord-297652-ut6e1ysz	49	28	.	.	.
cord-297652-ut6e1ysz	50	1	An	an	DT
cord-297652-ut6e1ysz	50	2	initial	initial	JJ
cord-297652-ut6e1ysz	50	3	dose	dose	NN
cord-297652-ut6e1ysz	50	4	of	of	IN
cord-297652-ut6e1ysz	50	5	200	200	CD
cord-297652-ut6e1ysz	50	6	mg	mg	NN
cord-297652-ut6e1ysz	50	7	of	of	IN
cord-297652-ut6e1ysz	50	8	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	50	9	was	be	VBD
cord-297652-ut6e1ysz	50	10	administered	administer	VBN
cord-297652-ut6e1ysz	50	11	on	on	IN
cord-297652-ut6e1ysz	50	12	day	day	NN
cord-297652-ut6e1ysz	50	13	1	1	CD
cord-297652-ut6e1ysz	50	14	,	,	,
cord-297652-ut6e1ysz	50	15	followed	follow	VBN
cord-297652-ut6e1ysz	50	16	by	by	IN
cord-297652-ut6e1ysz	50	17	a	a	DT
cord-297652-ut6e1ysz	50	18	daily	daily	JJ
cord-297652-ut6e1ysz	50	19	maintenance	maintenance	NN
cord-297652-ut6e1ysz	50	20	dose	dose	NN
cord-297652-ut6e1ysz	50	21	of	of	IN
cord-297652-ut6e1ysz	50	22	100	100	CD
cord-297652-ut6e1ysz	50	23	mg	mg	NN
cord-297652-ut6e1ysz	50	24	for	for	IN
cord-297652-ut6e1ysz	50	25	9	9	CD
cord-297652-ut6e1ysz	50	26	-	-	SYM
cord-297652-ut6e1ysz	50	27	13	13	CD
cord-297652-ut6e1ysz	50	28	days	day	NNS
cord-297652-ut6e1ysz	50	29	.	.	.
cord-297652-ut6e1ysz	51	1	Results	result	NNS
cord-297652-ut6e1ysz	51	2	were	be	VBD
cord-297652-ut6e1ysz	51	3	disappointing	disappointing	JJ
cord-297652-ut6e1ysz	51	4	.	.	.
cord-297652-ut6e1ysz	52	1	After	after	IN
cord-297652-ut6e1ysz	52	2	28	28	CD
cord-297652-ut6e1ysz	52	3	days	day	NNS
cord-297652-ut6e1ysz	52	4	,	,	,
cord-297652-ut6e1ysz	52	5	the	the	DT
cord-297652-ut6e1ysz	52	6	highest	high	JJS
cord-297652-ut6e1ysz	52	7	number	number	NN
cord-297652-ut6e1ysz	52	8	of	of	IN
cord-297652-ut6e1ysz	52	9	deaths	death	NNS
cord-297652-ut6e1ysz	52	10	(	(	-LRB-
cord-297652-ut6e1ysz	52	11	53.1	53.1	CD
cord-297652-ut6e1ysz	52	12	%	%	NN
cord-297652-ut6e1ysz	52	13	)	)	-RRB-
cord-297652-ut6e1ysz	52	14	was	be	VBD
cord-297652-ut6e1ysz	52	15	observed	observe	VBN
cord-297652-ut6e1ysz	52	16	in	in	IN
cord-297652-ut6e1ysz	52	17	the	the	DT
cord-297652-ut6e1ysz	52	18	group	group	NN
cord-297652-ut6e1ysz	52	19	treated	treat	VBN
cord-297652-ut6e1ysz	52	20	with	with	IN
cord-297652-ut6e1ysz	52	21	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	52	22	,	,	,
cord-297652-ut6e1ysz	52	23	a	a	DT
cord-297652-ut6e1ysz	52	24	bit	bit	NN
cord-297652-ut6e1ysz	52	25	more	more	JJR
cord-297652-ut6e1ysz	52	26	than	than	IN
cord-297652-ut6e1ysz	52	27	in	in	IN
cord-297652-ut6e1ysz	52	28	the	the	DT
cord-297652-ut6e1ysz	52	29	control	control	NN
cord-297652-ut6e1ysz	52	30	group	group	NN
cord-297652-ut6e1ysz	52	31	(	(	-LRB-
cord-297652-ut6e1ysz	52	32	49.7	49.7	CD
cord-297652-ut6e1ysz	52	33	%	%	NN
cord-297652-ut6e1ysz	52	34	)	)	-RRB-
cord-297652-ut6e1ysz	52	35	.	.	.
cord-297652-ut6e1ysz	53	1	More	more	RBR
cord-297652-ut6e1ysz	53	2	encouraging	encouraging	JJ
cord-297652-ut6e1ysz	53	3	results	result	NNS
cord-297652-ut6e1ysz	53	4	were	be	VBD
cord-297652-ut6e1ysz	53	5	obtained	obtain	VBN
cord-297652-ut6e1ysz	53	6	in	in	IN
cord-297652-ut6e1ysz	53	7	the	the	DT
cord-297652-ut6e1ysz	53	8	two	two	CD
cord-297652-ut6e1ysz	53	9	other	other	JJ
cord-297652-ut6e1ysz	53	10	groups	group	NNS
cord-297652-ut6e1ysz	53	11	(	(	-LRB-
cord-297652-ut6e1ysz	53	12	REGN	REGN	NNP
cord-297652-ut6e1ysz	53	13	-	-	HYPH
cord-297652-ut6e1ysz	53	14	EB3	EB3	NNP
cord-297652-ut6e1ysz	53	15	:	:	:
cord-297652-ut6e1ysz	53	16	33.5	33.5	CD
cord-297652-ut6e1ysz	53	17	%	%	NN
cord-297652-ut6e1ysz	53	18	;	;	.
cord-297652-ut6e1ysz	54	1	Mab114	Mab114	NNS
cord-297652-ut6e1ysz	54	2	:	:	:
cord-297652-ut6e1ysz	54	3	35.1	35.1	CD
cord-297652-ut6e1ysz	54	4	%	%	NN
cord-297652-ut6e1ysz	54	5	)	)	-RRB-
cord-297652-ut6e1ysz	54	6	[	[	-LRB-
cord-297652-ut6e1ysz	54	7	7	7	CD
cord-297652-ut6e1ysz	54	8	]	]	-RRB-
cord-297652-ut6e1ysz	54	9	.	.	.
cord-297652-ut6e1ysz	55	1	In	in	IN
cord-297652-ut6e1ysz	55	2	contrast	contrast	NN
cord-297652-ut6e1ysz	55	3	,	,	,
cord-297652-ut6e1ysz	55	4	in	in	IN
cord-297652-ut6e1ysz	55	5	the	the	DT
cord-297652-ut6e1ysz	55	6	cases	case	NNS
cord-297652-ut6e1ysz	55	7	of	of	IN
cord-297652-ut6e1ysz	55	8	SARS	SARS	NNP
cord-297652-ut6e1ysz	55	9	-	-	HYPH
cord-297652-ut6e1ysz	55	10	CoV	CoV	NNP
cord-297652-ut6e1ysz	55	11	and	and	CC
cord-297652-ut6e1ysz	55	12	MERS	MERS	NNP
cord-297652-ut6e1ysz	55	13	-	-	HYPH
cord-297652-ut6e1ysz	55	14	CoV	CoV	NNP
cord-297652-ut6e1ysz	55	15	,	,	,
cord-297652-ut6e1ysz	55	16	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	55	17	exhibited	exhibit	VBD
cord-297652-ut6e1ysz	55	18	an	an	DT
cord-297652-ut6e1ysz	55	19	excellent	excellent	JJ
cord-297652-ut6e1ysz	55	20	activity	activity	NN
cord-297652-ut6e1ysz	55	21	,	,	,
cord-297652-ut6e1ysz	55	22	in	in	IN
cord-297652-ut6e1ysz	55	23	vitro	vitro	FW
cord-297652-ut6e1ysz	55	24	,	,	,
cord-297652-ut6e1ysz	55	25	in	in	IN
cord-297652-ut6e1ysz	55	26	the	the	DT
cord-297652-ut6e1ysz	55	27	submicromolar	submicromolar	NN
cord-297652-ut6e1ysz	55	28	range	range	NN
cord-297652-ut6e1ysz	55	29	with	with	IN
cord-297652-ut6e1ysz	55	30	EC	EC	NNP
cord-297652-ut6e1ysz	55	31	50	50	CD
cord-297652-ut6e1ysz	55	32	values	value	NNS
cord-297652-ut6e1ysz	55	33	of	of	IN
cord-297652-ut6e1ysz	55	34	0.07	0.07	CD
cord-297652-ut6e1ysz	55	35	µM	µM	NFP
cord-297652-ut6e1ysz	55	36	for	for	IN
cord-297652-ut6e1ysz	55	37	both	both	DT
cord-297652-ut6e1ysz	55	38	coronaviruses	coronaviruse	NNS
cord-297652-ut6e1ysz	55	39	[	[	-LRB-
cord-297652-ut6e1ysz	55	40	8	8	CD
cord-297652-ut6e1ysz	55	41	]	]	-RRB-
cord-297652-ut6e1ysz	55	42	.	.	.
cord-297652-ut6e1ysz	56	1	Results	result	NNS
cord-297652-ut6e1ysz	56	2	were	be	VBD
cord-297652-ut6e1ysz	56	3	confirmed	confirm	VBN
cord-297652-ut6e1ysz	56	4	in	in	IN
cord-297652-ut6e1ysz	56	5	vivo	vivo	NN
cord-297652-ut6e1ysz	56	6	in	in	IN
cord-297652-ut6e1ysz	56	7	the	the	DT
cord-297652-ut6e1ysz	56	8	case	case	NN
cord-297652-ut6e1ysz	56	9	of	of	IN
cord-297652-ut6e1ysz	56	10	an	an	DT
cord-297652-ut6e1ysz	56	11	infection	infection	NN
cord-297652-ut6e1ysz	56	12	by	by	IN
cord-297652-ut6e1ysz	56	13	MERS	MERS	NNP
cord-297652-ut6e1ysz	56	14	-	-	HYPH
cord-297652-ut6e1ysz	56	15	CoV	CoV	NNP
cord-297652-ut6e1ysz	56	16	in	in	IN
cord-297652-ut6e1ysz	56	17	mice	mouse	NNS
cord-297652-ut6e1ysz	56	18	[	[	-LRB-
cord-297652-ut6e1ysz	56	19	9	9	CD
cord-297652-ut6e1ysz	56	20	]	]	-RRB-
cord-297652-ut6e1ysz	56	21	and	and	CC
cord-297652-ut6e1ysz	56	22	rhesus	rhesus	NN
cord-297652-ut6e1ysz	56	23	macaque	macaque	NN
cord-297652-ut6e1ysz	56	24	models	model	NNS
cord-297652-ut6e1ysz	56	25	[	[	-LRB-
cord-297652-ut6e1ysz	56	26	10	10	CD
cord-297652-ut6e1ysz	56	27	]	]	-RRB-
cord-297652-ut6e1ysz	56	28	.	.	.
cord-297652-ut6e1ysz	57	1	However	however	RB
cord-297652-ut6e1ysz	57	2	,	,	,
cord-297652-ut6e1ysz	57	3	Pharmaceuticals	Pharmaceuticals	NNP
cord-297652-ut6e1ysz	57	4	2020	2020	CD
cord-297652-ut6e1ysz	57	5	,	,	,
cord-297652-ut6e1ysz	57	6	13	13	CD
cord-297652-ut6e1ysz	57	7	,	,	,
cord-297652-ut6e1ysz	57	8	65	65	CD
cord-297652-ut6e1ysz	57	9	4	4	CD
cord-297652-ut6e1ysz	57	10	of	of	IN
cord-297652-ut6e1ysz	57	11	8	8	CD
cord-297652-ut6e1ysz	57	12	the	the	DT
cord-297652-ut6e1ysz	57	13	conclusion	conclusion	NN
cord-297652-ut6e1ysz	57	14	of	of	IN
cord-297652-ut6e1ysz	57	15	Sheahan	Sheahan	NNP
cord-297652-ut6e1ysz	57	16	[	[	-LRB-
cord-297652-ut6e1ysz	57	17	9	9	CD
cord-297652-ut6e1ysz	57	18	]	]	-RRB-
cord-297652-ut6e1ysz	57	19	regarding	regard	VBG
cord-297652-ut6e1ysz	57	20	SARS	SARS	NNP
cord-297652-ut6e1ysz	57	21	-	-	HYPH
cord-297652-ut6e1ysz	57	22	CoV	CoV	NNP
cord-297652-ut6e1ysz	57	23	in	in	IN
cord-297652-ut6e1ysz	57	24	a	a	DT
cord-297652-ut6e1ysz	57	25	mouse	mouse	NN
cord-297652-ut6e1ysz	57	26	model	model	NN
cord-297652-ut6e1ysz	57	27	warned	warn	VBD
cord-297652-ut6e1ysz	57	28	that	that	IN
cord-297652-ut6e1ysz	57	29	"	"	``
cord-297652-ut6e1ysz	57	30	These	these	DT
cord-297652-ut6e1ysz	57	31	data	datum	NNS
cord-297652-ut6e1ysz	57	32	suggest	suggest	VBP
cord-297652-ut6e1ysz	57	33	that	that	IN
cord-297652-ut6e1ysz	57	34	reductions	reduction	NNS
cord-297652-ut6e1ysz	57	35	in	in	IN
cord-297652-ut6e1ysz	57	36	viral	viral	JJ
cord-297652-ut6e1ysz	57	37	load	load	NN
cord-297652-ut6e1ysz	57	38	after	after	IN
cord-297652-ut6e1ysz	57	39	peak	peak	NN
cord-297652-ut6e1ysz	57	40	lung	lung	NN
cord-297652-ut6e1ysz	57	41	titers	titer	NNS
cord-297652-ut6e1ysz	57	42	were	be	VBD
cord-297652-ut6e1ysz	57	43	achieved	achieve	VBN
cord-297652-ut6e1ysz	57	44	were	be	VBD
cord-297652-ut6e1ysz	57	45	insufficient	insufficient	JJ
cord-297652-ut6e1ysz	57	46	to	to	TO
cord-297652-ut6e1ysz	57	47	improve	improve	VB
cord-297652-ut6e1ysz	57	48	outcomes	outcome	NNS
cord-297652-ut6e1ysz	57	49	after	after	IN
cord-297652-ut6e1ysz	57	50	the	the	DT
cord-297652-ut6e1ysz	57	51	immunopathological	immunopathological	JJ
cord-297652-ut6e1ysz	57	52	phase	phase	NN
cord-297652-ut6e1ysz	57	53	of	of	IN
cord-297652-ut6e1ysz	57	54	disease	disease	NN
cord-297652-ut6e1ysz	57	55	had	have	VBD
cord-297652-ut6e1ysz	57	56	been	be	VBN
cord-297652-ut6e1ysz	57	57	initiated	initiate	VBN
cord-297652-ut6e1ysz	57	58	.	.	.
cord-297652-ut6e1ysz	58	1	Thus	thus	RB
cord-297652-ut6e1ysz	58	2	,	,	,
cord-297652-ut6e1ysz	58	3	in	in	IN
cord-297652-ut6e1ysz	58	4	the	the	DT
cord-297652-ut6e1ysz	58	5	mouse	mouse	NN
cord-297652-ut6e1ysz	58	6	,	,	,
cord-297652-ut6e1ysz	58	7	if	if	IN
cord-297652-ut6e1ysz	58	8	given	give	VBN
cord-297652-ut6e1ysz	58	9	prior	prior	RB
cord-297652-ut6e1ysz	58	10	to	to	IN
cord-297652-ut6e1ysz	58	11	the	the	DT
cord-297652-ut6e1ysz	58	12	peak	peak	NN
cord-297652-ut6e1ysz	58	13	of	of	IN
cord-297652-ut6e1ysz	58	14	SARS	SARS	NNP
cord-297652-ut6e1ysz	58	15	-	-	HYPH
cord-297652-ut6e1ysz	58	16	CoV	CoV	NNP
cord-297652-ut6e1ysz	58	17	replication	replication	NN
cord-297652-ut6e1ysz	58	18	and	and	CC
cord-297652-ut6e1ysz	58	19	peak	peak	NN
cord-297652-ut6e1ysz	58	20	damage	damage	NN
cord-297652-ut6e1ysz	58	21	to	to	IN
cord-297652-ut6e1ysz	58	22	the	the	DT
cord-297652-ut6e1ysz	58	23	airway	airway	NN
cord-297652-ut6e1ysz	58	24	epithelium	epithelium	NN
cord-297652-ut6e1ysz	58	25	,	,	,
cord-297652-ut6e1ysz	58	26	GS-5734	GS-5734	NNP
cord-297652-ut6e1ysz	58	27	(	(	-LRB-
cord-297652-ut6e1ysz	58	28	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	58	29	)	)	-RRB-
cord-297652-ut6e1ysz	58	30	can	can	MD
cord-297652-ut6e1ysz	58	31	improve	improve	VB
cord-297652-ut6e1ysz	58	32	pulmonary	pulmonary	JJ
cord-297652-ut6e1ysz	58	33	function	function	NN
cord-297652-ut6e1ysz	58	34	,	,	,
cord-297652-ut6e1ysz	58	35	reduce	reduce	VB
cord-297652-ut6e1ysz	58	36	viral	viral	JJ
cord-297652-ut6e1ysz	58	37	loads	load	NNS
cord-297652-ut6e1ysz	58	38	and	and	CC
cord-297652-ut6e1ysz	58	39	diminish	diminish	VB
cord-297652-ut6e1ysz	58	40	disease	disease	NN
cord-297652-ut6e1ysz	58	41	.	.	.
cord-297652-ut6e1ysz	58	42	"	"	''
cord-297652-ut6e1ysz	59	1	An	an	DT
cord-297652-ut6e1ysz	59	2	EC	EC	NNP
cord-297652-ut6e1ysz	59	3	50	50	CD
cord-297652-ut6e1ysz	59	4	value	value	NN
cord-297652-ut6e1ysz	59	5	of	of	IN
cord-297652-ut6e1ysz	59	6	1.76	1.76	CD
cord-297652-ut6e1ysz	59	7	µM	µm	CD
cord-297652-ut6e1ysz	59	8	for	for	IN
cord-297652-ut6e1ysz	59	9	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	59	10	against	against	IN
cord-297652-ut6e1ysz	59	11	SARS	SARS	NNP
cord-297652-ut6e1ysz	59	12	-	-	HYPH
cord-297652-ut6e1ysz	59	13	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	59	14	in	in	IN
cord-297652-ut6e1ysz	59	15	Vero	Vero	NNP
cord-297652-ut6e1ysz	59	16	E6	E6	NNP
cord-297652-ut6e1ysz	59	17	cells	cell	NNS
cord-297652-ut6e1ysz	59	18	has	have	VBZ
cord-297652-ut6e1ysz	59	19	been	be	VBN
cord-297652-ut6e1ysz	59	20	measured	measure	VBN
cord-297652-ut6e1ysz	59	21	by	by	IN
cord-297652-ut6e1ysz	59	22	Wang	Wang	NNP
cord-297652-ut6e1ysz	59	23	et	et	NNP
cord-297652-ut6e1ysz	59	24	al	al	NNP
cord-297652-ut6e1ysz	59	25	.	.	.
cord-297652-ut6e1ysz	60	1	[	[	-LRB-
cord-297652-ut6e1ysz	60	2	11	11	CD
cord-297652-ut6e1ysz	60	3	]	]	-RRB-
cord-297652-ut6e1ysz	60	4	.	.	.
cord-297652-ut6e1ysz	61	1	There	there	EX
cord-297652-ut6e1ysz	61	2	is	be	VBZ
cord-297652-ut6e1ysz	61	3	a	a	DT
cord-297652-ut6e1ysz	61	4	study	study	NN
cord-297652-ut6e1ysz	61	5	involving	involve	VBG
cord-297652-ut6e1ysz	61	6	only	only	RB
cord-297652-ut6e1ysz	61	7	one	one	CD
cord-297652-ut6e1ysz	61	8	human	human	NN
cord-297652-ut6e1ysz	61	9	:	:	:
cord-297652-ut6e1ysz	61	10	the	the	DT
cord-297652-ut6e1ysz	61	11	first	first	JJ
cord-297652-ut6e1ysz	61	12	patient	patient	NN
cord-297652-ut6e1ysz	61	13	suffering	suffer	VBG
cord-297652-ut6e1ysz	61	14	from	from	IN
cord-297652-ut6e1ysz	61	15	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	61	16	in	in	IN
cord-297652-ut6e1ysz	61	17	the	the	DT
cord-297652-ut6e1ysz	61	18	United	United	NNP
cord-297652-ut6e1ysz	61	19	States	States	NNP
cord-297652-ut6e1ysz	61	20	[	[	-LRB-
cord-297652-ut6e1ysz	61	21	12	12	CD
cord-297652-ut6e1ysz	61	22	]	]	-RRB-
cord-297652-ut6e1ysz	61	23	.	.	.
cord-297652-ut6e1ysz	62	1	He	-PRON-	PRP
cord-297652-ut6e1ysz	62	2	was	be	VBD
cord-297652-ut6e1ysz	62	3	hospitalized	hospitalize	VBN
cord-297652-ut6e1ysz	62	4	on	on	IN
cord-297652-ut6e1ysz	62	5	January	January	NNP
cord-297652-ut6e1ysz	62	6	19	19	CD
cord-297652-ut6e1ysz	62	7	in	in	IN
cord-297652-ut6e1ysz	62	8	the	the	DT
cord-297652-ut6e1ysz	62	9	State	State	NNP
cord-297652-ut6e1ysz	62	10	of	of	IN
cord-297652-ut6e1ysz	62	11	Washington	Washington	NNP
cord-297652-ut6e1ysz	62	12	.	.	.
cord-297652-ut6e1ysz	63	1	For	for	IN
cord-297652-ut6e1ysz	63	2	the	the	DT
cord-297652-ut6e1ysz	63	3	first	first	JJ
cord-297652-ut6e1ysz	63	4	6	6	CD
cord-297652-ut6e1ysz	63	5	days	day	NNS
cord-297652-ut6e1ysz	63	6	of	of	IN
cord-297652-ut6e1ysz	63	7	hospitalization	hospitalization	NN
cord-297652-ut6e1ysz	63	8	(	(	-LRB-
cord-297652-ut6e1ysz	63	9	days	day	NNS
cord-297652-ut6e1ysz	63	10	5	5	CD
cord-297652-ut6e1ysz	63	11	-	-	SYM
cord-297652-ut6e1ysz	63	12	10	10	CD
cord-297652-ut6e1ysz	63	13	of	of	IN
cord-297652-ut6e1ysz	63	14	the	the	DT
cord-297652-ut6e1ysz	63	15	illness	illness	NN
cord-297652-ut6e1ysz	63	16	)	)	-RRB-
cord-297652-ut6e1ysz	63	17	,	,	,
cord-297652-ut6e1ysz	63	18	he	-PRON-	PRP
cord-297652-ut6e1ysz	63	19	received	receive	VBD
cord-297652-ut6e1ysz	63	20	650	650	CD
cord-297652-ut6e1ysz	63	21	mg	mg	NN
cord-297652-ut6e1ysz	63	22	of	of	IN
cord-297652-ut6e1ysz	63	23	acetaminophen	acetaminophen	NN
cord-297652-ut6e1ysz	63	24	every	every	DT
cord-297652-ut6e1ysz	63	25	4	4	CD
cord-297652-ut6e1ysz	63	26	h	h	NN
cord-297652-ut6e1ysz	63	27	,	,	,
cord-297652-ut6e1ysz	63	28	600	600	CD
cord-297652-ut6e1ysz	63	29	mg	mg	NN
cord-297652-ut6e1ysz	63	30	of	of	IN
cord-297652-ut6e1ysz	63	31	ibuprofen	ibuprofen	NNP
cord-297652-ut6e1ysz	63	32	every	every	DT
cord-297652-ut6e1ysz	63	33	6	6	CD
cord-297652-ut6e1ysz	63	34	h	h	NN
cord-297652-ut6e1ysz	63	35	,	,	,
cord-297652-ut6e1ysz	63	36	600	600	CD
cord-297652-ut6e1ysz	63	37	mg	mg	NN
cord-297652-ut6e1ysz	63	38	of	of	IN
cord-297652-ut6e1ysz	63	39	guaifenesin	guaifenesin	NNP
cord-297652-ut6e1ysz	63	40	and	and	CC
cord-297652-ut6e1ysz	63	41	6	6	CD
cord-297652-ut6e1ysz	63	42	liters	liter	NNS
cord-297652-ut6e1ysz	63	43	of	of	IN
cord-297652-ut6e1ysz	63	44	normal	normal	JJ
cord-297652-ut6e1ysz	63	45	saline	saline	NN
cord-297652-ut6e1ysz	63	46	.	.	.
cord-297652-ut6e1ysz	64	1	On	on	IN
cord-297652-ut6e1ysz	64	2	day	day	NN
cord-297652-ut6e1ysz	64	3	6	6	CD
cord-297652-ut6e1ysz	64	4	of	of	IN
cord-297652-ut6e1ysz	64	5	hospitalization	hospitalization	NN
cord-297652-ut6e1ysz	64	6	,	,	,
cord-297652-ut6e1ysz	64	7	he	-PRON-	PRP
cord-297652-ut6e1ysz	64	8	was	be	VBD
cord-297652-ut6e1ysz	64	9	treated	treat	VBN
cord-297652-ut6e1ysz	64	10	with	with	IN
cord-297652-ut6e1ysz	64	11	vancomycin	vancomycin	NN
cord-297652-ut6e1ysz	64	12	(	(	-LRB-
cord-297652-ut6e1ysz	64	13	1750	1750	CD
cord-297652-ut6e1ysz	64	14	mg	mg	NN
cord-297652-ut6e1ysz	64	15	then	then	RB
cord-297652-ut6e1ysz	64	16	1	1	CD
cord-297652-ut6e1ysz	64	17	g	g	NN
cord-297652-ut6e1ysz	64	18	every	every	DT
cord-297652-ut6e1ysz	64	19	8	8	CD
cord-297652-ut6e1ysz	64	20	h	h	NN
cord-297652-ut6e1ysz	64	21	)	)	-RRB-
cord-297652-ut6e1ysz	64	22	and	and	CC
cord-297652-ut6e1ysz	64	23	cefepime	cefepime	NNP
cord-297652-ut6e1ysz	64	24	(	(	-LRB-
cord-297652-ut6e1ysz	64	25	every	every	DT
cord-297652-ut6e1ysz	64	26	8	8	CD
cord-297652-ut6e1ysz	64	27	h	h	NN
cord-297652-ut6e1ysz	64	28	)	)	-RRB-
cord-297652-ut6e1ysz	64	29	.	.	.
cord-297652-ut6e1ysz	65	1	The	the	DT
cord-297652-ut6e1ysz	65	2	next	next	JJ
cord-297652-ut6e1ysz	65	3	day	day	NN
cord-297652-ut6e1ysz	65	4	,	,	,
cord-297652-ut6e1ysz	65	5	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	65	6	was	be	VBD
cord-297652-ut6e1ysz	65	7	administered	administer	VBN
cord-297652-ut6e1ysz	65	8	for	for	IN
cord-297652-ut6e1ysz	65	9	compassionate	compassionate	JJ
cord-297652-ut6e1ysz	65	10	use	use	NN
cord-297652-ut6e1ysz	65	11	,	,	,
cord-297652-ut6e1ysz	65	12	whereas	whereas	IN
cord-297652-ut6e1ysz	65	13	the	the	DT
cord-297652-ut6e1ysz	65	14	antibiotics	antibiotic	NNS
cord-297652-ut6e1ysz	65	15	were	be	VBD
cord-297652-ut6e1ysz	65	16	discontinued	discontinue	VBN
cord-297652-ut6e1ysz	65	17	.	.	.
cord-297652-ut6e1ysz	66	1	The	the	DT
cord-297652-ut6e1ysz	66	2	authors	author	NNS
cord-297652-ut6e1ysz	66	3	concluded	conclude	VBD
cord-297652-ut6e1ysz	66	4	their	-PRON-	PRP$
cord-297652-ut6e1ysz	66	5	article	article	NN
cord-297652-ut6e1ysz	66	6	by	by	IN
cord-297652-ut6e1ysz	66	7	writing	write	VBG
cord-297652-ut6e1ysz	66	8	[	[	-LRB-
cord-297652-ut6e1ysz	66	9	12	12	CD
cord-297652-ut6e1ysz	66	10	]	]	-RRB-
cord-297652-ut6e1ysz	66	11	:	:	:
cord-297652-ut6e1ysz	66	12	"	"	``
cord-297652-ut6e1ysz	66	13	On	on	IN
cord-297652-ut6e1ysz	66	14	hospital	hospital	NN
cord-297652-ut6e1ysz	66	15	day	day	NN
cord-297652-ut6e1ysz	66	16	8	8	CD
cord-297652-ut6e1ysz	66	17	(	(	-LRB-
cord-297652-ut6e1ysz	66	18	illness	illness	NN
cord-297652-ut6e1ysz	66	19	day	day	NN
cord-297652-ut6e1ysz	66	20	12	12	CD
cord-297652-ut6e1ysz	66	21	)	)	-RRB-
cord-297652-ut6e1ysz	66	22	,	,	,
cord-297652-ut6e1ysz	66	23	the	the	DT
cord-297652-ut6e1ysz	66	24	patient	patient	NN
cord-297652-ut6e1ysz	66	25	's	's	POS
cord-297652-ut6e1ysz	66	26	clinical	clinical	JJ
cord-297652-ut6e1ysz	66	27	condition	condition	NN
cord-297652-ut6e1ysz	66	28	improved	improve	VBN
cord-297652-ut6e1ysz	66	29	.	.	.
cord-297652-ut6e1ysz	67	1	Supplemental	supplemental	JJ
cord-297652-ut6e1ysz	67	2	oxygen	oxygen	NN
cord-297652-ut6e1ysz	67	3	was	be	VBD
cord-297652-ut6e1ysz	67	4	discontinued	discontinue	VBN
cord-297652-ut6e1ysz	67	5	,	,	,
cord-297652-ut6e1ysz	67	6	and	and	CC
cord-297652-ut6e1ysz	67	7	his	-PRON-	PRP$
cord-297652-ut6e1ysz	67	8	oxygen	oxygen	NN
cord-297652-ut6e1ysz	67	9	saturation	saturation	NN
cord-297652-ut6e1ysz	67	10	values	value	NNS
cord-297652-ut6e1ysz	67	11	improved	improve	VBD
cord-297652-ut6e1ysz	67	12	to	to	IN
cord-297652-ut6e1ysz	67	13	94	94	CD
cord-297652-ut6e1ysz	67	14	%	%	NN
cord-297652-ut6e1ysz	67	15	to	to	TO
cord-297652-ut6e1ysz	67	16	96	96	CD
cord-297652-ut6e1ysz	67	17	%	%	NN
cord-297652-ut6e1ysz	67	18	while	while	IN
cord-297652-ut6e1ysz	67	19	he	-PRON-	PRP
cord-297652-ut6e1ysz	67	20	was	be	VBD
cord-297652-ut6e1ysz	67	21	breathing	breathe	VBG
cord-297652-ut6e1ysz	67	22	ambient	ambient	JJ
cord-297652-ut6e1ysz	67	23	air	air	NN
cord-297652-ut6e1ysz	67	24	.	.	.
cord-297652-ut6e1ysz	68	1	The	the	DT
cord-297652-ut6e1ysz	68	2	previous	previous	JJ
cord-297652-ut6e1ysz	68	3	bilateral	bilateral	JJ
cord-297652-ut6e1ysz	68	4	lower	low	JJR
cord-297652-ut6e1ysz	68	5	-	-	HYPH
cord-297652-ut6e1ysz	68	6	lobe	lobe	NN
cord-297652-ut6e1ysz	68	7	rales	rale	NNS
cord-297652-ut6e1ysz	68	8	were	be	VBD
cord-297652-ut6e1ysz	68	9	no	no	RB
cord-297652-ut6e1ysz	68	10	longer	long	RBR
cord-297652-ut6e1ysz	68	11	present	present	JJ
cord-297652-ut6e1ysz	68	12	.	.	.
cord-297652-ut6e1ysz	69	1	His	-PRON-	PRP$
cord-297652-ut6e1ysz	69	2	appetite	appetite	NN
cord-297652-ut6e1ysz	69	3	improved	improve	VBD
cord-297652-ut6e1ysz	69	4	,	,	,
cord-297652-ut6e1ysz	69	5	and	and	CC
cord-297652-ut6e1ysz	69	6	he	-PRON-	PRP
cord-297652-ut6e1ysz	69	7	was	be	VBD
cord-297652-ut6e1ysz	69	8	asymptomatic	asymptomatic	JJ
cord-297652-ut6e1ysz	69	9	aside	aside	RB
cord-297652-ut6e1ysz	69	10	from	from	IN
cord-297652-ut6e1ysz	69	11	intermittent	intermittent	JJ
cord-297652-ut6e1ysz	69	12	dry	dry	JJ
cord-297652-ut6e1ysz	69	13	cough	cough	NN
cord-297652-ut6e1ysz	69	14	and	and	CC
cord-297652-ut6e1ysz	69	15	rhinorrhea	rhinorrhea	NN
cord-297652-ut6e1ysz	69	16	.	.	.
cord-297652-ut6e1ysz	70	1	As	as	IN
cord-297652-ut6e1ysz	70	2	of	of	IN
cord-297652-ut6e1ysz	70	3	January	January	NNP
cord-297652-ut6e1ysz	70	4	30	30	CD
cord-297652-ut6e1ysz	70	5	,	,	,
cord-297652-ut6e1ysz	70	6	2020	2020	CD
cord-297652-ut6e1ysz	70	7	,	,	,
cord-297652-ut6e1ysz	70	8	the	the	DT
cord-297652-ut6e1ysz	70	9	patient	patient	NN
cord-297652-ut6e1ysz	70	10	remains	remain	VBZ
cord-297652-ut6e1ysz	70	11	hospitalized	hospitalize	VBN
cord-297652-ut6e1ysz	70	12	.	.	.
cord-297652-ut6e1ysz	71	1	He	-PRON-	PRP
cord-297652-ut6e1ysz	71	2	is	be	VBZ
cord-297652-ut6e1ysz	71	3	afebrile	afebrile	JJ
cord-297652-ut6e1ysz	71	4	,	,	,
cord-297652-ut6e1ysz	71	5	and	and	CC
cord-297652-ut6e1ysz	71	6	all	all	DT
cord-297652-ut6e1ysz	71	7	symptoms	symptom	NNS
cord-297652-ut6e1ysz	71	8	have	have	VBP
cord-297652-ut6e1ysz	71	9	resolved	resolve	VBN
cord-297652-ut6e1ysz	71	10	with	with	IN
cord-297652-ut6e1ysz	71	11	the	the	DT
cord-297652-ut6e1ysz	71	12	exception	exception	NN
cord-297652-ut6e1ysz	71	13	of	of	IN
cord-297652-ut6e1ysz	71	14	his	-PRON-	PRP$
cord-297652-ut6e1ysz	71	15	cough	cough	NN
cord-297652-ut6e1ysz	71	16	,	,	,
cord-297652-ut6e1ysz	71	17	which	which	WDT
cord-297652-ut6e1ysz	71	18	is	be	VBZ
cord-297652-ut6e1ysz	71	19	decreasing	decrease	VBG
cord-297652-ut6e1ysz	71	20	in	in	IN
cord-297652-ut6e1ysz	71	21	severity	severity	NN
cord-297652-ut6e1ysz	71	22	.	.	.
cord-297652-ut6e1ysz	71	23	.	.	.
cord-297652-ut6e1ysz	71	24	.	.	.
cord-297652-ut6e1ysz	71	25	.	.	.
cord-297652-ut6e1ysz	72	1	Although	although	IN
cord-297652-ut6e1ysz	72	2	a	a	DT
cord-297652-ut6e1ysz	72	3	decision	decision	NN
cord-297652-ut6e1ysz	72	4	to	to	TO
cord-297652-ut6e1ysz	72	5	administer	administer	VB
cord-297652-ut6e1ysz	72	6	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	72	7	for	for	IN
cord-297652-ut6e1ysz	72	8	compassionate	compassionate	JJ
cord-297652-ut6e1ysz	72	9	use	use	NN
cord-297652-ut6e1ysz	72	10	was	be	VBD
cord-297652-ut6e1ysz	72	11	based	base	VBN
cord-297652-ut6e1ysz	72	12	on	on	IN
cord-297652-ut6e1ysz	72	13	the	the	DT
cord-297652-ut6e1ysz	72	14	case	case	NN
cord-297652-ut6e1ysz	72	15	patient	patient	NN
cord-297652-ut6e1ysz	72	16	's	's	POS
cord-297652-ut6e1ysz	72	17	worsening	worsen	VBG
cord-297652-ut6e1ysz	72	18	clinical	clinical	JJ
cord-297652-ut6e1ysz	72	19	status	status	NN
cord-297652-ut6e1ysz	72	20	,	,	,
cord-297652-ut6e1ysz	72	21	randomized	randomized	JJ
cord-297652-ut6e1ysz	72	22	controlled	control	VBN
cord-297652-ut6e1ysz	72	23	trials	trial	NNS
cord-297652-ut6e1ysz	72	24	are	be	VBP
cord-297652-ut6e1ysz	72	25	needed	need	VBN
cord-297652-ut6e1ysz	72	26	to	to	TO
cord-297652-ut6e1ysz	72	27	determine	determine	VB
cord-297652-ut6e1ysz	72	28	the	the	DT
cord-297652-ut6e1ysz	72	29	safety	safety	NN
cord-297652-ut6e1ysz	72	30	and	and	CC
cord-297652-ut6e1ysz	72	31	efficacy	efficacy	NN
cord-297652-ut6e1ysz	72	32	of	of	IN
cord-297652-ut6e1ysz	72	33	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	72	34	and	and	CC
cord-297652-ut6e1ysz	72	35	any	any	DT
cord-297652-ut6e1ysz	72	36	other	other	JJ
cord-297652-ut6e1ysz	72	37	investigational	investigational	JJ
cord-297652-ut6e1ysz	72	38	agents	agent	NNS
cord-297652-ut6e1ysz	72	39	for	for	IN
cord-297652-ut6e1ysz	72	40	treatment	treatment	NN
cord-297652-ut6e1ysz	72	41	of	of	IN
cord-297652-ut6e1ysz	72	42	patients	patient	NNS
cord-297652-ut6e1ysz	72	43	with	with	IN
cord-297652-ut6e1ysz	72	44	2019-nCoV	2019-ncov	CD
cord-297652-ut6e1ysz	72	45	infection	infection	NN
cord-297652-ut6e1ysz	72	46	.	.	.
cord-297652-ut6e1ysz	72	47	"	"	''
cord-297652-ut6e1ysz	72	48	.	.	.
cord-297652-ut6e1ysz	73	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	73	2	is	be	VBZ
cord-297652-ut6e1ysz	73	3	actually	actually	RB
cord-297652-ut6e1ysz	73	4	too	too	RB
cord-297652-ut6e1ysz	73	5	early	early	JJ
cord-297652-ut6e1ysz	73	6	to	to	TO
cord-297652-ut6e1ysz	73	7	calculate	calculate	VB
cord-297652-ut6e1ysz	73	8	the	the	DT
cord-297652-ut6e1ysz	73	9	price	price	NN
cord-297652-ut6e1ysz	73	10	of	of	IN
cord-297652-ut6e1ysz	73	11	an	an	DT
cord-297652-ut6e1ysz	73	12	eventual	eventual	JJ
cord-297652-ut6e1ysz	73	13	treatment	treatment	NN
cord-297652-ut6e1ysz	73	14	of	of	IN
cord-297652-ut6e1ysz	73	15	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	73	16	with	with	IN
cord-297652-ut6e1ysz	73	17	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	73	18	,	,	,
cord-297652-ut6e1ysz	73	19	but	but	CC
cord-297652-ut6e1ysz	73	20	some	some	DT
cord-297652-ut6e1ysz	73	21	thoughts	thought	NNS
cord-297652-ut6e1ysz	73	22	can	can	MD
cord-297652-ut6e1ysz	73	23	be	be	VB
cord-297652-ut6e1ysz	73	24	explored	explore	VBN
cord-297652-ut6e1ysz	73	25	.	.	.
cord-297652-ut6e1ysz	74	1	The	the	DT
cord-297652-ut6e1ysz	74	2	dosage	dosage	NN
cord-297652-ut6e1ysz	74	3	that	that	WDT
cord-297652-ut6e1ysz	74	4	will	will	MD
cord-297652-ut6e1ysz	74	5	be	be	VB
cord-297652-ut6e1ysz	74	6	evaluated	evaluate	VBN
cord-297652-ut6e1ysz	74	7	in	in	IN
cord-297652-ut6e1ysz	74	8	the	the	DT
cord-297652-ut6e1ysz	74	9	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	74	10	project	project	NN
cord-297652-ut6e1ysz	74	11	(	(	-LRB-
cord-297652-ut6e1ysz	74	12	NCT04315948	NCT04315948	NNP
cord-297652-ut6e1ysz	74	13	[	[	-LRB-
cord-297652-ut6e1ysz	74	14	4,13	4,13	CD
cord-297652-ut6e1ysz	74	15	]	]	-RRB-
cord-297652-ut6e1ysz	74	16	)	)	-RRB-
cord-297652-ut6e1ysz	74	17	is	be	VBZ
cord-297652-ut6e1ysz	74	18	200	200	CD
cord-297652-ut6e1ysz	74	19	mg	mg	NNP
cord-297652-ut6e1ysz	74	20	IV	IV	NNP
cord-297652-ut6e1ysz	74	21	initially	initially	RB
cord-297652-ut6e1ysz	74	22	,	,	,
cord-297652-ut6e1ysz	74	23	then	then	RB
cord-297652-ut6e1ysz	74	24	100	100	CD
cord-297652-ut6e1ysz	74	25	mg	mg	NNP
cord-297652-ut6e1ysz	74	26	OD	OD	NNP
cord-297652-ut6e1ysz	74	27	for	for	IN
cord-297652-ut6e1ysz	74	28	2	2	CD
cord-297652-ut6e1ysz	74	29	-	-	SYM
cord-297652-ut6e1ysz	74	30	10	10	CD
cord-297652-ut6e1ysz	74	31	days	day	NNS
cord-297652-ut6e1ysz	74	32	.	.	.
cord-297652-ut6e1ysz	75	1	The	the	DT
cord-297652-ut6e1ysz	75	2	product	product	NN
cord-297652-ut6e1ysz	75	3	,	,	,
cord-297652-ut6e1ysz	75	4	as	as	IN
cord-297652-ut6e1ysz	75	5	a	a	DT
cord-297652-ut6e1ysz	75	6	research	research	NN
cord-297652-ut6e1ysz	75	7	derivative	derivative	NN
cord-297652-ut6e1ysz	75	8	,	,	,
cord-297652-ut6e1ysz	75	9	is	be	VBZ
cord-297652-ut6e1ysz	75	10	actually	actually	RB
cord-297652-ut6e1ysz	75	11	sold	sell	VBN
cord-297652-ut6e1ysz	75	12	at	at	IN
cord-297652-ut6e1ysz	75	13	854	854	CD
cord-297652-ut6e1ysz	75	14	USD	usd	NN
cord-297652-ut6e1ysz	75	15	for	for	IN
cord-297652-ut6e1ysz	75	16	10	10	CD
cord-297652-ut6e1ysz	75	17	mg	mg	NNS
cord-297652-ut6e1ysz	75	18	by	by	IN
cord-297652-ut6e1ysz	75	19	MedChemExpress	MedChemExpress	NNP
cord-297652-ut6e1ysz	75	20	(	(	-LRB-
cord-297652-ut6e1ysz	75	21	Monmouth	Monmouth	NNP
cord-297652-ut6e1ysz	75	22	Junction	Junction	NNP
cord-297652-ut6e1ysz	75	23	,	,	,
cord-297652-ut6e1ysz	75	24	NJ	NJ	NNP
cord-297652-ut6e1ysz	75	25	,	,	,
cord-297652-ut6e1ysz	75	26	USA	USA	NNP
cord-297652-ut6e1ysz	75	27	;	;	:
cord-297652-ut6e1ysz	75	28	cat	cat	NN
cord-297652-ut6e1ysz	75	29	#	#	NN
cord-297652-ut6e1ysz	75	30	HY-104077	hy-104077	NN
cord-297652-ut6e1ysz	75	31	)	)	-RRB-
cord-297652-ut6e1ysz	76	1	[	[	-LRB-
cord-297652-ut6e1ysz	76	2	14	14	CD
cord-297652-ut6e1ysz	76	3	]	]	-RRB-
cord-297652-ut6e1ysz	76	4	and	and	CC
cord-297652-ut6e1ysz	77	1	330	330	CD
cord-297652-ut6e1ysz	77	2	USD	usd	NN
cord-297652-ut6e1ysz	77	3	for	for	IN
cord-297652-ut6e1ysz	77	4	1	1	CD
cord-297652-ut6e1ysz	77	5	mg	mg	NN
cord-297652-ut6e1ysz	77	6	by	by	IN
cord-297652-ut6e1ysz	77	7	BioVision	BioVision	NNP
cord-297652-ut6e1ysz	77	8	Inc	Inc	NNP
cord-297652-ut6e1ysz	77	9	(	(	-LRB-
cord-297652-ut6e1ysz	77	10	Milpitas	Milpitas	NNP
cord-297652-ut6e1ysz	77	11	,	,	,
cord-297652-ut6e1ysz	77	12	CA	CA	NNP
cord-297652-ut6e1ysz	77	13	,	,	,
cord-297652-ut6e1ysz	77	14	USA	USA	NNP
cord-297652-ut6e1ysz	77	15	;	;	:
cord-297652-ut6e1ysz	77	16	cat	cat	NN
cord-297652-ut6e1ysz	77	17	#	#	$
cord-297652-ut6e1ysz	77	18	B2997	b2997	NN
cord-297652-ut6e1ysz	77	19	-	-	HYPH
cord-297652-ut6e1ysz	77	20	1000	1000	CD
cord-297652-ut6e1ysz	77	21	)	)	-RRB-
cord-297652-ut6e1ysz	78	1	[	[	-LRB-
cord-297652-ut6e1ysz	78	2	15	15	CD
cord-297652-ut6e1ysz	78	3	]	]	-RRB-
cord-297652-ut6e1ysz	78	4	,	,	,
cord-297652-ut6e1ysz	78	5	it	-PRON-	PRP
cord-297652-ut6e1ysz	78	6	is	be	VBZ
cord-297652-ut6e1ysz	78	7	not	not	RB
cord-297652-ut6e1ysz	78	8	pessimistic	pessimistic	JJ
cord-297652-ut6e1ysz	78	9	to	to	TO
cord-297652-ut6e1ysz	78	10	suggest	suggest	VB
cord-297652-ut6e1ysz	78	11	a	a	DT
cord-297652-ut6e1ysz	78	12	retail	retail	JJ
cord-297652-ut6e1ysz	78	13	price	price	NN
cord-297652-ut6e1ysz	78	14	higher	high	JJR
cord-297652-ut6e1ysz	78	15	than	than	IN
cord-297652-ut6e1ysz	78	16	5000	5000	CD
cord-297652-ut6e1ysz	78	17	USD	usd	NN
cord-297652-ut6e1ysz	78	18	.	.	.
cord-297652-ut6e1ysz	79	1	The	the	DT
cord-297652-ut6e1ysz	79	2	commercial	commercial	JJ
cord-297652-ut6e1ysz	79	3	combination	combination	NN
cord-297652-ut6e1ysz	79	4	(	(	-LRB-
cord-297652-ut6e1ysz	79	5	Kelatra	Kelatra	NNP
cord-297652-ut6e1ysz	79	6	®	®	.
cord-297652-ut6e1ysz	79	7	)	)	-RRB-
cord-297652-ut6e1ysz	79	8	comprises	comprise	VBZ
cord-297652-ut6e1ysz	79	9	lopinavir	lopinavir	NNP
cord-297652-ut6e1ysz	79	10	and	and	CC
cord-297652-ut6e1ysz	79	11	ritonavir	ritonavir	NNS
cord-297652-ut6e1ysz	79	12	in	in	IN
cord-297652-ut6e1ysz	79	13	a	a	DT
cord-297652-ut6e1ysz	79	14	weight	weight	NN
cord-297652-ut6e1ysz	79	15	ratio	ratio	NN
cord-297652-ut6e1ysz	79	16	4:1	4:1	CD
cord-297652-ut6e1ysz	79	17	;	;	:
cord-297652-ut6e1ysz	79	18	it	-PRON-	PRP
cord-297652-ut6e1ysz	79	19	is	be	VBZ
cord-297652-ut6e1ysz	79	20	available	available	JJ
cord-297652-ut6e1ysz	79	21	for	for	IN
cord-297652-ut6e1ysz	79	22	the	the	DT
cord-297652-ut6e1ysz	79	23	treatment	treatment	NN
cord-297652-ut6e1ysz	79	24	of	of	IN
cord-297652-ut6e1ysz	79	25	HIV	HIV	NNP
cord-297652-ut6e1ysz	79	26	infection	infection	NN
cord-297652-ut6e1ysz	79	27	.	.	.
cord-297652-ut6e1ysz	80	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	80	2	has	have	VBZ
cord-297652-ut6e1ysz	80	3	been	be	VBN
cord-297652-ut6e1ysz	80	4	the	the	DT
cord-297652-ut6e1ysz	80	5	subject	subject	NN
cord-297652-ut6e1ysz	80	6	of	of	IN
cord-297652-ut6e1ysz	80	7	more	more	JJR
cord-297652-ut6e1ysz	80	8	than	than	IN
cord-297652-ut6e1ysz	80	9	400	400	CD
cord-297652-ut6e1ysz	80	10	registered	register	VBN
cord-297652-ut6e1ysz	80	11	clinical	clinical	JJ
cord-297652-ut6e1ysz	80	12	trials	trial	NNS
cord-297652-ut6e1ysz	80	13	[	[	-LRB-
cord-297652-ut6e1ysz	80	14	4	4	CD
cord-297652-ut6e1ysz	80	15	]	]	-RRB-
cord-297652-ut6e1ysz	80	16	.	.	.
cord-297652-ut6e1ysz	81	1	In	in	IN
cord-297652-ut6e1ysz	81	2	vitro	vitro	FW
cord-297652-ut6e1ysz	81	3	,	,	,
cord-297652-ut6e1ysz	81	4	the	the	DT
cord-297652-ut6e1ysz	81	5	combination	combination	NN
cord-297652-ut6e1ysz	81	6	is	be	VBZ
cord-297652-ut6e1ysz	81	7	more	more	JJR
cord-297652-ut6e1ysz	81	8	than	than	IN
cord-297652-ut6e1ysz	81	9	100-fold	100-fold	CD
cord-297652-ut6e1ysz	81	10	less	less	RBR
cord-297652-ut6e1ysz	81	11	effective	effective	JJ
cord-297652-ut6e1ysz	81	12	than	than	IN
cord-297652-ut6e1ysz	81	13	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	81	14	against	against	IN
cord-297652-ut6e1ysz	81	15	strains	strain	NNS
cord-297652-ut6e1ysz	81	16	of	of	IN
cord-297652-ut6e1ysz	81	17	SARS	SARS	NNP
cord-297652-ut6e1ysz	81	18	-	-	HYPH
cord-297652-ut6e1ysz	81	19	CoV	CoV	NNP
cord-297652-ut6e1ysz	81	20	(	(	-LRB-
cord-297652-ut6e1ysz	81	21	EC	EC	NNP
cord-297652-ut6e1ysz	81	22	50	50	CD
cord-297652-ut6e1ysz	81	23	=	=	SYM
cord-297652-ut6e1ysz	81	24	17.1	17.1	CD
cord-297652-ut6e1ysz	81	25	µM	µM	NFP
cord-297652-ut6e1ysz	81	26	[	[	-LRB-
cord-297652-ut6e1ysz	81	27	16	16	CD
cord-297652-ut6e1ysz	81	28	]	]	-RRB-
cord-297652-ut6e1ysz	81	29	)	)	-RRB-
cord-297652-ut6e1ysz	81	30	and	and	CC
cord-297652-ut6e1ysz	81	31	MERS	MERS	NNP
cord-297652-ut6e1ysz	81	32	-	-	HYPH
cord-297652-ut6e1ysz	81	33	CoV	CoV	NNP
cord-297652-ut6e1ysz	81	34	(	(	-LRB-
cord-297652-ut6e1ysz	81	35	EC	EC	NNP
cord-297652-ut6e1ysz	81	36	50	50	CD
cord-297652-ut6e1ysz	81	37	=	=	SYM
cord-297652-ut6e1ysz	81	38	8.0	8.0	CD
cord-297652-ut6e1ysz	81	39	µM	µM	NFP
cord-297652-ut6e1ysz	81	40	[	[	-LRB-
cord-297652-ut6e1ysz	81	41	16	16	CD
cord-297652-ut6e1ysz	81	42	]	]	-RRB-
cord-297652-ut6e1ysz	81	43	)	)	-RRB-
cord-297652-ut6e1ysz	81	44	.	.	.
cord-297652-ut6e1ysz	82	1	Other	other	JJ
cord-297652-ut6e1ysz	82	2	data	datum	NNS
cord-297652-ut6e1ysz	82	3	indicated	indicate	VBD
cord-297652-ut6e1ysz	82	4	some	some	DT
cord-297652-ut6e1ysz	82	5	success	success	NN
cord-297652-ut6e1ysz	82	6	regarding	regard	VBG
cord-297652-ut6e1ysz	82	7	the	the	DT
cord-297652-ut6e1ysz	82	8	use	use	NN
cord-297652-ut6e1ysz	82	9	of	of	IN
cord-297652-ut6e1ysz	82	10	the	the	DT
cord-297652-ut6e1ysz	82	11	combination	combination	NN
cord-297652-ut6e1ysz	82	12	in	in	IN
cord-297652-ut6e1ysz	82	13	marmosets	marmoset	NNS
cord-297652-ut6e1ysz	82	14	(	(	-LRB-
cord-297652-ut6e1ysz	82	15	MERS	MERS	NNP
cord-297652-ut6e1ysz	82	16	)	)	-RRB-
cord-297652-ut6e1ysz	82	17	[	[	-LRB-
cord-297652-ut6e1ysz	82	18	17	17	CD
cord-297652-ut6e1ysz	82	19	]	]	-RRB-
cord-297652-ut6e1ysz	82	20	and	and	CC
cord-297652-ut6e1ysz	82	21	in	in	IN
cord-297652-ut6e1ysz	82	22	infected	infected	JJ
cord-297652-ut6e1ysz	82	23	human	human	JJ
cord-297652-ut6e1ysz	82	24	patients	patient	NNS
cord-297652-ut6e1ysz	82	25	(	(	-LRB-
cord-297652-ut6e1ysz	82	26	SARS	SARS	NNP
cord-297652-ut6e1ysz	82	27	as	as	RB
cord-297652-ut6e1ysz	82	28	well	well	RB
cord-297652-ut6e1ysz	82	29	as	as	IN
cord-297652-ut6e1ysz	82	30	MERS	MERS	NNP
cord-297652-ut6e1ysz	82	31	)	)	-RRB-
cord-297652-ut6e1ysz	82	32	[	[	-LRB-
cord-297652-ut6e1ysz	82	33	18	18	CD
cord-297652-ut6e1ysz	82	34	]	]	-RRB-
cord-297652-ut6e1ysz	82	35	.	.	.
cord-297652-ut6e1ysz	83	1	However	however	RB
cord-297652-ut6e1ysz	83	2	,	,	,
cord-297652-ut6e1ysz	83	3	some	some	DT
cord-297652-ut6e1ysz	83	4	authors	author	NNS
cord-297652-ut6e1ysz	83	5	remain	remain	VBP
cord-297652-ut6e1ysz	83	6	skeptical	skeptical	JJ
cord-297652-ut6e1ysz	83	7	and	and	CC
cord-297652-ut6e1ysz	83	8	are	be	VBP
cord-297652-ut6e1ysz	83	9	not	not	RB
cord-297652-ut6e1ysz	83	10	confident	confident	JJ
cord-297652-ut6e1ysz	83	11	in	in	IN
cord-297652-ut6e1ysz	83	12	the	the	DT
cord-297652-ut6e1ysz	83	13	success	success	NN
cord-297652-ut6e1ysz	83	14	of	of	IN
cord-297652-ut6e1ysz	83	15	Kelatra	Kelatra	NNP
cord-297652-ut6e1ysz	84	1	®	®	VB
cord-297652-ut6e1ysz	84	2	for	for	IN
cord-297652-ut6e1ysz	84	3	treating	treat	VBG
cord-297652-ut6e1ysz	84	4	COVID-19	covid-19	ADD
cord-297652-ut6e1ysz	84	5	[	[	-LRB-
cord-297652-ut6e1ysz	84	6	19	19	CD
cord-297652-ut6e1ysz	84	7	]	]	-RRB-
cord-297652-ut6e1ysz	84	8	[	[	-LRB-
cord-297652-ut6e1ysz	84	9	20	20	CD
cord-297652-ut6e1ysz	84	10	]	]	-RRB-
cord-297652-ut6e1ysz	84	11	[	[	-LRB-
cord-297652-ut6e1ysz	84	12	21	21	CD
cord-297652-ut6e1ysz	84	13	]	]	-RRB-
cord-297652-ut6e1ysz	84	14	[	[	-LRB-
cord-297652-ut6e1ysz	84	15	22	22	CD
cord-297652-ut6e1ysz	84	16	]	]	-RRB-
cord-297652-ut6e1ysz	84	17	.	.	.
cord-297652-ut6e1ysz	85	1	In	in	IN
cord-297652-ut6e1ysz	85	2	the	the	DT
cord-297652-ut6e1ysz	85	3	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	85	4	project	project	NN
cord-297652-ut6e1ysz	85	5	(	(	-LRB-
cord-297652-ut6e1ysz	85	6	NCT04315948	NCT04315948	NNP
cord-297652-ut6e1ysz	85	7	[	[	-LRB-
cord-297652-ut6e1ysz	85	8	4,13	4,13	CD
cord-297652-ut6e1ysz	85	9	]	]	-RRB-
cord-297652-ut6e1ysz	85	10	)	)	-RRB-
cord-297652-ut6e1ysz	86	1	,	,	,
cord-297652-ut6e1ysz	86	2	the	the	DT
cord-297652-ut6e1ysz	86	3	suggested	suggested	JJ
cord-297652-ut6e1ysz	86	4	dose	dose	NN
cord-297652-ut6e1ysz	86	5	of	of	IN
cord-297652-ut6e1ysz	86	6	the	the	DT
cord-297652-ut6e1ysz	86	7	combination	combination	NN
cord-297652-ut6e1ysz	86	8	is	be	VBZ
cord-297652-ut6e1ysz	86	9	500	500	CD
cord-297652-ut6e1ysz	86	10	mg	mg	NN
cord-297652-ut6e1ysz	86	11	(	(	-LRB-
cord-297652-ut6e1ysz	87	1	400	400	CD
cord-297652-ut6e1ysz	87	2	mg	mg	NNP
cord-297652-ut6e1ysz	87	3	lopinavir	lopinavir	NNS
cord-297652-ut6e1ysz	87	4	+	+	CC
cord-297652-ut6e1ysz	88	1	100	100	CD
cord-297652-ut6e1ysz	88	2	mg	mg	NNP
cord-297652-ut6e1ysz	88	3	ritonavir	ritonavir	NNP
cord-297652-ut6e1ysz	88	4	)	)	-RRB-
cord-297652-ut6e1ysz	89	1	every	every	DT
cord-297652-ut6e1ysz	89	2	12	12	CD
cord-297652-ut6e1ysz	89	3	h	h	NN
cord-297652-ut6e1ysz	89	4	for	for	IN
cord-297652-ut6e1ysz	89	5	14	14	CD
cord-297652-ut6e1ysz	89	6	days	day	NNS
cord-297652-ut6e1ysz	89	7	.	.	.
cord-297652-ut6e1ysz	90	1	On	on	IN
cord-297652-ut6e1ysz	90	2	the	the	DT
cord-297652-ut6e1ysz	90	3	basis	basis	NN
cord-297652-ut6e1ysz	90	4	of	of	IN
cord-297652-ut6e1ysz	90	5	the	the	DT
cord-297652-ut6e1ysz	90	6	lowest	low	JJS
cord-297652-ut6e1ysz	90	7	retail	retail	JJ
cord-297652-ut6e1ysz	90	8	price	price	NN
cord-297652-ut6e1ysz	90	9	found	find	VBN
cord-297652-ut6e1ysz	90	10	on	on	IN
cord-297652-ut6e1ysz	90	11	the	the	DT
cord-297652-ut6e1ysz	90	12	website	website	NN
cord-297652-ut6e1ysz	90	13	PharmacyChercker.com	PharmacyChercker.com	NNP
cord-297652-ut6e1ysz	90	14	[	[	-LRB-
cord-297652-ut6e1ysz	90	15	23	23	CD
cord-297652-ut6e1ysz	90	16	]	]	-RRB-
cord-297652-ut6e1ysz	90	17	,	,	,
cord-297652-ut6e1ysz	90	18	the	the	DT
cord-297652-ut6e1ysz	90	19	cost	cost	NN
cord-297652-ut6e1ysz	90	20	of	of	IN
cord-297652-ut6e1ysz	90	21	the	the	DT
cord-297652-ut6e1ysz	90	22	treatment	treatment	NN
cord-297652-ut6e1ysz	90	23	,	,	,
cord-297652-ut6e1ysz	90	24	if	if	IN
cord-297652-ut6e1ysz	90	25	the	the	DT
cord-297652-ut6e1ysz	90	26	drug	drug	NN
cord-297652-ut6e1ysz	90	27	combination	combination	NN
cord-297652-ut6e1ysz	90	28	proves	prove	VBZ
cord-297652-ut6e1ysz	90	29	to	to	TO
cord-297652-ut6e1ysz	90	30	be	be	VB
cord-297652-ut6e1ysz	90	31	efficacious	efficacious	JJ
cord-297652-ut6e1ysz	90	32	in	in	IN
cord-297652-ut6e1ysz	90	33	humans	human	NNS
cord-297652-ut6e1ysz	90	34	,	,	,
cord-297652-ut6e1ysz	90	35	should	should	MD
cord-297652-ut6e1ysz	90	36	be	be	VB
cord-297652-ut6e1ysz	90	37	estimated	estimate	VBN
cord-297652-ut6e1ysz	90	38	at	at	IN
cord-297652-ut6e1ysz	90	39	61	61	CD
cord-297652-ut6e1ysz	90	40	USD	usd	NN
cord-297652-ut6e1ysz	90	41	for	for	IN
cord-297652-ut6e1ysz	90	42	the	the	DT
cord-297652-ut6e1ysz	90	43	generic	generic	JJ
cord-297652-ut6e1ysz	90	44	and	and	CC
cord-297652-ut6e1ysz	90	45	215	215	CD
cord-297652-ut6e1ysz	90	46	USD	usd	NN
cord-297652-ut6e1ysz	90	47	for	for	IN
cord-297652-ut6e1ysz	90	48	the	the	DT
cord-297652-ut6e1ysz	90	49	original	original	JJ
cord-297652-ut6e1ysz	90	50	brand	brand	NN
cord-297652-ut6e1ysz	90	51	.	.	.
cord-297652-ut6e1ysz	91	1	Interferon	Interferon	NNP
cord-297652-ut6e1ysz	91	2	β-1a	β-1a	NN
cord-297652-ut6e1ysz	91	3	is	be	VBZ
cord-297652-ut6e1ysz	91	4	an	an	DT
cord-297652-ut6e1ysz	91	5	efficient	efficient	JJ
cord-297652-ut6e1ysz	91	6	inhibitor	inhibitor	NN
cord-297652-ut6e1ysz	91	7	of	of	IN
cord-297652-ut6e1ysz	91	8	the	the	DT
cord-297652-ut6e1ysz	91	9	multiplication	multiplication	NN
cord-297652-ut6e1ysz	91	10	of	of	IN
cord-297652-ut6e1ysz	91	11	SARS	SARS	NNP
cord-297652-ut6e1ysz	91	12	-	-	HYPH
cord-297652-ut6e1ysz	91	13	CoV	CoV	NNP
cord-297652-ut6e1ysz	91	14	[	[	-LRB-
cord-297652-ut6e1ysz	91	15	24	24	CD
cord-297652-ut6e1ysz	91	16	,	,	,
cord-297652-ut6e1ysz	91	17	25	25	CD
cord-297652-ut6e1ysz	91	18	]	]	-RRB-
cord-297652-ut6e1ysz	91	19	and	and	CC
cord-297652-ut6e1ysz	91	20	MERS	MERS	NNP
cord-297652-ut6e1ysz	91	21	-	-	HYPH
cord-297652-ut6e1ysz	91	22	CoV	CoV	NNP
cord-297652-ut6e1ysz	91	23	[	[	-LRB-
cord-297652-ut6e1ysz	91	24	26	26	CD
cord-297652-ut6e1ysz	91	25	]	]	-RRB-
cord-297652-ut6e1ysz	91	26	in	in	IN
cord-297652-ut6e1ysz	91	27	cell	cell	NN
cord-297652-ut6e1ysz	91	28	cultures	culture	NNS
cord-297652-ut6e1ysz	91	29	.	.	.
cord-297652-ut6e1ysz	92	1	In	in	IN
cord-297652-ut6e1ysz	92	2	a	a	DT
cord-297652-ut6e1ysz	92	3	MERS	MERS	NNP
cord-297652-ut6e1ysz	92	4	-	-	HYPH
cord-297652-ut6e1ysz	92	5	CoV	CoV	NNP
cord-297652-ut6e1ysz	92	6	mouse	mouse	NN
cord-297652-ut6e1ysz	92	7	model	model	NN
cord-297652-ut6e1ysz	92	8	,	,	,
cord-297652-ut6e1ysz	92	9	the	the	DT
cord-297652-ut6e1ysz	92	10	combination	combination	NN
cord-297652-ut6e1ysz	92	11	lopinavir	lopinavir	NNP
cord-297652-ut6e1ysz	92	12	/	/	SYM
cord-297652-ut6e1ysz	92	13	ritonavir	ritonavir	NNP
cord-297652-ut6e1ysz	92	14	/	/	SYM
cord-297652-ut6e1ysz	92	15	interferon	interferon	NNP
cord-297652-ut6e1ysz	92	16	β-1a	β-1a	NNP
cord-297652-ut6e1ysz	92	17	,	,	,
cord-297652-ut6e1ysz	92	18	used	use	VBN
cord-297652-ut6e1ysz	92	19	as	as	IN
cord-297652-ut6e1ysz	92	20	prophylactic	prophylactic	JJ
cord-297652-ut6e1ysz	92	21	and	and	CC
cord-297652-ut6e1ysz	92	22	curative	curative	JJ
cord-297652-ut6e1ysz	92	23	treatments	treatment	NNS
cord-297652-ut6e1ysz	92	24	,	,	,
cord-297652-ut6e1ysz	92	25	revealed	reveal	VBD
cord-297652-ut6e1ysz	92	26	no	no	DT
cord-297652-ut6e1ysz	92	27	significant	significant	JJ
cord-297652-ut6e1ysz	92	28	decrease	decrease	NN
cord-297652-ut6e1ysz	92	29	in	in	IN
cord-297652-ut6e1ysz	92	30	the	the	DT
cord-297652-ut6e1ysz	92	31	viral	viral	JJ
cord-297652-ut6e1ysz	92	32	load	load	NN
cord-297652-ut6e1ysz	92	33	[	[	-LRB-
cord-297652-ut6e1ysz	92	34	9	9	CD
cord-297652-ut6e1ysz	92	35	]	]	-RRB-
cord-297652-ut6e1ysz	92	36	.	.	.
cord-297652-ut6e1ysz	93	1	In	in	IN
cord-297652-ut6e1ysz	93	2	a	a	DT
cord-297652-ut6e1ysz	93	3	marmoset	marmoset	JJ
cord-297652-ut6e1ysz	93	4	model	model	NN
cord-297652-ut6e1ysz	93	5	[	[	-LRB-
cord-297652-ut6e1ysz	93	6	17	17	CD
cord-297652-ut6e1ysz	93	7	]	]	-RRB-
cord-297652-ut6e1ysz	93	8	,	,	,
cord-297652-ut6e1ysz	93	9	the	the	DT
cord-297652-ut6e1ysz	93	10	combination	combination	NN
cord-297652-ut6e1ysz	93	11	lopinavir	lopinavir	NNP
cord-297652-ut6e1ysz	93	12	/	/	SYM
cord-297652-ut6e1ysz	93	13	ritonavir	ritonavir	NNP
cord-297652-ut6e1ysz	93	14	/	/	SYM
cord-297652-ut6e1ysz	93	15	interferon	interferon	NNP
cord-297652-ut6e1ysz	93	16	β-1b	β-1b	NNP
cord-297652-ut6e1ysz	93	17	(	(	-LRB-
cord-297652-ut6e1ysz	93	18	bacterial	bacterial	JJ
cord-297652-ut6e1ysz	93	19	origin	origin	NN
cord-297652-ut6e1ysz	93	20	,	,	,
cord-297652-ut6e1ysz	93	21	whereas	whereas	IN
cord-297652-ut6e1ysz	93	22	interferon	interferon	NNP
cord-297652-ut6e1ysz	93	23	β-1a	β-1a	NNP
cord-297652-ut6e1ysz	93	24	is	be	VBZ
cord-297652-ut6e1ysz	93	25	produced	produce	VBN
cord-297652-ut6e1ysz	93	26	by	by	IN
cord-297652-ut6e1ysz	93	27	Chinese	chinese	JJ
cord-297652-ut6e1ysz	93	28	hamster	hamster	NN
cord-297652-ut6e1ysz	93	29	ovary	ovary	NN
cord-297652-ut6e1ysz	93	30	cells	cell	NNS
cord-297652-ut6e1ysz	93	31	[	[	-LRB-
cord-297652-ut6e1ysz	93	32	27	27	CD
cord-297652-ut6e1ysz	93	33	]	]	-RRB-
cord-297652-ut6e1ysz	93	34	)	)	-RRB-
cord-297652-ut6e1ysz	93	35	opened	open	VBD
cord-297652-ut6e1ysz	93	36	some	some	DT
cord-297652-ut6e1ysz	93	37	hope	hope	NN
cord-297652-ut6e1ysz	93	38	for	for	IN
cord-297652-ut6e1ysz	93	39	curing	cure	VBG
cord-297652-ut6e1ysz	93	40	MERS	MERS	NNP
cord-297652-ut6e1ysz	93	41	-	-	HYPH
cord-297652-ut6e1ysz	93	42	CoV	cov	NN
cord-297652-ut6e1ysz	93	43	-	-	HYPH
cord-297652-ut6e1ysz	93	44	infected	infect	VBN
cord-297652-ut6e1ysz	93	45	animals	animal	NNS
cord-297652-ut6e1ysz	93	46	.	.	.
cord-297652-ut6e1ysz	94	1	The	the	DT
cord-297652-ut6e1ysz	94	2	results	result	NNS
cord-297652-ut6e1ysz	94	3	of	of	IN
cord-297652-ut6e1ysz	94	4	an	an	DT
cord-297652-ut6e1ysz	94	5	ongoing	ongoing	JJ
cord-297652-ut6e1ysz	94	6	clinical	clinical	JJ
cord-297652-ut6e1ysz	94	7	trial	trial	NN
cord-297652-ut6e1ysz	94	8	(	(	-LRB-
cord-297652-ut6e1ysz	94	9	NCT	NCT	NNP
cord-297652-ut6e1ysz	94	10	Pharmaceuticals	Pharmaceuticals	NNPS
cord-297652-ut6e1ysz	94	11	2020	2020	CD
cord-297652-ut6e1ysz	94	12	,	,	,
cord-297652-ut6e1ysz	94	13	13	13	CD
cord-297652-ut6e1ysz	94	14	,	,	,
cord-297652-ut6e1ysz	94	15	65	65	CD
cord-297652-ut6e1ysz	94	16	5	5	CD
cord-297652-ut6e1ysz	94	17	of	of	IN
cord-297652-ut6e1ysz	94	18	8	8	CD
cord-297652-ut6e1ysz	94	19	02845843	02845843	CD
cord-297652-ut6e1ysz	94	20	[	[	-LRB-
cord-297652-ut6e1ysz	94	21	4	4	CD
cord-297652-ut6e1ysz	94	22	]	]	-RRB-
cord-297652-ut6e1ysz	94	23	)	)	-RRB-
cord-297652-ut6e1ysz	94	24	,	,	,
cord-297652-ut6e1ysz	94	25	entitled	entitle	VBN
cord-297652-ut6e1ysz	94	26	"	"	``
cord-297652-ut6e1ysz	94	27	MERS	MERS	NNP
cord-297652-ut6e1ysz	94	28	-	-	HYPH
cord-297652-ut6e1ysz	94	29	CoV	cov	NN
cord-297652-ut6e1ysz	94	30	infection	infection	NN
cord-297652-ut6e1ysz	94	31	treated	treat	VBN
cord-297652-ut6e1ysz	94	32	with	with	IN
cord-297652-ut6e1ysz	94	33	a	a	DT
cord-297652-ut6e1ysz	94	34	combination	combination	NN
cord-297652-ut6e1ysz	94	35	of	of	IN
cord-297652-ut6e1ysz	94	36	lopinavir	lopinavir	NNS
cord-297652-ut6e1ysz	94	37	/	/	SYM
cord-297652-ut6e1ysz	94	38	ritonavir	ritonavir	NNS
cord-297652-ut6e1ysz	94	39	and	and	CC
cord-297652-ut6e1ysz	94	40	interferon	interferon	NN
cord-297652-ut6e1ysz	94	41	Beta-1b	Beta-1b	NNP
cord-297652-ut6e1ysz	94	42	"	"	''
cord-297652-ut6e1ysz	94	43	,	,	,
cord-297652-ut6e1ysz	94	44	are	be	VBP
cord-297652-ut6e1ysz	94	45	eagerly	eagerly	RB
cord-297652-ut6e1ysz	94	46	awaited	await	VBN
cord-297652-ut6e1ysz	94	47	,	,	,
cord-297652-ut6e1ysz	94	48	but	but	CC
cord-297652-ut6e1ysz	94	49	will	will	MD
cord-297652-ut6e1ysz	94	50	not	not	RB
cord-297652-ut6e1ysz	94	51	be	be	VB
cord-297652-ut6e1ysz	94	52	disclosed	disclose	VBN
cord-297652-ut6e1ysz	94	53	before	before	IN
cord-297652-ut6e1ysz	94	54	2021	2021	CD
cord-297652-ut6e1ysz	94	55	.	.	.
cord-297652-ut6e1ysz	95	1	The	the	DT
cord-297652-ut6e1ysz	95	2	study	study	NN
cord-297652-ut6e1ysz	95	3	suggested	suggest	VBD
cord-297652-ut6e1ysz	95	4	a	a	DT
cord-297652-ut6e1ysz	95	5	dose	dose	NN
cord-297652-ut6e1ysz	95	6	of	of	IN
cord-297652-ut6e1ysz	95	7	lopinavir	lopinavir	NNS
cord-297652-ut6e1ysz	95	8	/	/	SYM
cord-297652-ut6e1ysz	95	9	ritonavir	ritonavir	NNP
cord-297652-ut6e1ysz	95	10	(	(	-LRB-
cord-297652-ut6e1ysz	95	11	400/100	400/100	CD
cord-297652-ut6e1ysz	95	12	mg	mg	NNP
cord-297652-ut6e1ysz	95	13	)	)	-RRB-
cord-297652-ut6e1ysz	95	14	twice	twice	RB
cord-297652-ut6e1ysz	95	15	daily	daily	RB
cord-297652-ut6e1ysz	95	16	for	for	IN
cord-297652-ut6e1ysz	95	17	14	14	CD
cord-297652-ut6e1ysz	95	18	days	day	NNS
cord-297652-ut6e1ysz	95	19	,	,	,
cord-297652-ut6e1ysz	95	20	and	and	CC
cord-297652-ut6e1ysz	95	21	interferon	interferon	NN
cord-297652-ut6e1ysz	95	22	β-1b	β-1b	.
cord-297652-ut6e1ysz	96	1	0.25	0.25	CD
cord-297652-ut6e1ysz	96	2	mg	mg	NN
cord-297652-ut6e1ysz	96	3	subcutaneous	subcutaneous	JJ
cord-297652-ut6e1ysz	96	4	every	every	DT
cord-297652-ut6e1ysz	96	5	alternate	alternate	JJ
cord-297652-ut6e1ysz	96	6	day	day	NN
cord-297652-ut6e1ysz	96	7	for	for	IN
cord-297652-ut6e1ysz	96	8	14	14	CD
cord-297652-ut6e1ysz	96	9	days	day	NNS
cord-297652-ut6e1ysz	96	10	[	[	-LRB-
cord-297652-ut6e1ysz	96	11	4	4	CD
cord-297652-ut6e1ysz	96	12	]	]	-RRB-
cord-297652-ut6e1ysz	96	13	.	.	.
cord-297652-ut6e1ysz	97	1	Interferon	interferon	NN
cord-297652-ut6e1ysz	97	2	β-1a	β-1a	NN
cord-297652-ut6e1ysz	97	3	is	be	VBZ
cord-297652-ut6e1ysz	97	4	clinically	clinically	RB
cord-297652-ut6e1ysz	97	5	used	use	VBN
cord-297652-ut6e1ysz	97	6	for	for	IN
cord-297652-ut6e1ysz	97	7	the	the	DT
cord-297652-ut6e1ysz	97	8	treatment	treatment	NN
cord-297652-ut6e1ysz	97	9	of	of	IN
cord-297652-ut6e1ysz	97	10	relapsing	relapse	VBG
cord-297652-ut6e1ysz	97	11	multiple	multiple	JJ
cord-297652-ut6e1ysz	97	12	sclerosis	sclerosis	NN
cord-297652-ut6e1ysz	97	13	.	.	.
cord-297652-ut6e1ysz	98	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	98	2	was	be	VBD
cord-297652-ut6e1ysz	98	3	approved	approve	VBN
cord-297652-ut6e1ysz	98	4	by	by	IN
cord-297652-ut6e1ysz	98	5	the	the	DT
cord-297652-ut6e1ysz	98	6	FDA	FDA	NNP
cord-297652-ut6e1ysz	98	7	on	on	IN
cord-297652-ut6e1ysz	98	8	05/17/1996	05/17/1996	CD
cord-297652-ut6e1ysz	98	9	under	under	IN
cord-297652-ut6e1ysz	98	10	the	the	DT
cord-297652-ut6e1ysz	98	11	brand	brand	NN
cord-297652-ut6e1ysz	98	12	name	name	NN
cord-297652-ut6e1ysz	98	13	Avonex	Avonex	NNP
cord-297652-ut6e1ysz	98	14	®	®	,
cord-297652-ut6e1ysz	98	15	and	and	CC
cord-297652-ut6e1ysz	98	16	is	be	VBZ
cord-297652-ut6e1ysz	98	17	sold	sell	VBN
cord-297652-ut6e1ysz	98	18	by	by	IN
cord-297652-ut6e1ysz	98	19	Biogen	Biogen	NNP
cord-297652-ut6e1ysz	98	20	under	under	IN
cord-297652-ut6e1ysz	98	21	the	the	DT
cord-297652-ut6e1ysz	98	22	Orphan	Orphan	NNP
cord-297652-ut6e1ysz	98	23	Drug	Drug	NNP
cord-297652-ut6e1ysz	98	24	designation	designation	NN
cord-297652-ut6e1ysz	98	25	.	.	.
cord-297652-ut6e1ysz	99	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	99	2	is	be	VBZ
cord-297652-ut6e1ysz	99	3	also	also	RB
cord-297652-ut6e1ysz	99	4	known	know	VBN
cord-297652-ut6e1ysz	99	5	as	as	IN
cord-297652-ut6e1ysz	99	6	Rebif	Rebif	NNP
cord-297652-ut6e1ysz	100	1	®	®	VBG
cord-297652-ut6e1ysz	100	2	from	from	IN
cord-297652-ut6e1ysz	100	3	Serono	Serono	NNP
cord-297652-ut6e1ysz	100	4	Inc	Inc	NNP
cord-297652-ut6e1ysz	100	5	(	(	-LRB-
cord-297652-ut6e1ysz	100	6	FDA	FDA	NNP
cord-297652-ut6e1ysz	100	7	-	-	HYPH
cord-297652-ut6e1ysz	100	8	approved	approve	VBN
cord-297652-ut6e1ysz	100	9	on	on	IN
cord-297652-ut6e1ysz	100	10	03/07/2002	03/07/2002	CD
cord-297652-ut6e1ysz	100	11	)	)	-RRB-
cord-297652-ut6e1ysz	100	12	.	.	.
cord-297652-ut6e1ysz	101	1	In	in	IN
cord-297652-ut6e1ysz	101	2	the	the	DT
cord-297652-ut6e1ysz	101	3	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	101	4	project	project	NN
cord-297652-ut6e1ysz	101	5	,	,	,
cord-297652-ut6e1ysz	101	6	interferon	interferon	NNP
cord-297652-ut6e1ysz	101	7	β-1a	β-1a	NNP
cord-297652-ut6e1ysz	101	8	will	will	MD
cord-297652-ut6e1ysz	101	9	be	be	VB
cord-297652-ut6e1ysz	101	10	added	add	VBN
cord-297652-ut6e1ysz	101	11	to	to	IN
cord-297652-ut6e1ysz	101	12	the	the	DT
cord-297652-ut6e1ysz	101	13	treatment	treatment	NN
cord-297652-ut6e1ysz	101	14	lopinavir	lopinavir	NNS
cord-297652-ut6e1ysz	101	15	/	/	SYM
cord-297652-ut6e1ysz	101	16	ritonavir	ritonavir	NNP
cord-297652-ut6e1ysz	101	17	(	(	-LRB-
cord-297652-ut6e1ysz	101	18	see	see	VB
cord-297652-ut6e1ysz	101	19	Section	section	NN
cord-297652-ut6e1ysz	101	20	4.2	4.2	CD
cord-297652-ut6e1ysz	101	21	)	)	-RRB-
cord-297652-ut6e1ysz	101	22	and	and	CC
cord-297652-ut6e1ysz	101	23	administered	administer	VBD
cord-297652-ut6e1ysz	101	24	subcutaneously	subcutaneously	RB
cord-297652-ut6e1ysz	101	25	at	at	IN
cord-297652-ut6e1ysz	101	26	the	the	DT
cord-297652-ut6e1ysz	101	27	dose	dose	NN
cord-297652-ut6e1ysz	101	28	of	of	IN
cord-297652-ut6e1ysz	101	29	44	44	CD
cord-297652-ut6e1ysz	101	30	µg	µg	NNS
cord-297652-ut6e1ysz	101	31	for	for	IN
cord-297652-ut6e1ysz	101	32	a	a	DT
cord-297652-ut6e1ysz	101	33	total	total	NN
cord-297652-ut6e1ysz	101	34	of	of	IN
cord-297652-ut6e1ysz	101	35	three	three	CD
cord-297652-ut6e1ysz	101	36	doses	dose	NNS
cord-297652-ut6e1ysz	101	37	in	in	IN
cord-297652-ut6e1ysz	101	38	6	6	CD
cord-297652-ut6e1ysz	101	39	days	day	NNS
cord-297652-ut6e1ysz	101	40	.	.	.
cord-297652-ut6e1ysz	102	1	That	that	DT
cord-297652-ut6e1ysz	102	2	will	will	MD
cord-297652-ut6e1ysz	102	3	represent	represent	VB
cord-297652-ut6e1ysz	102	4	an	an	DT
cord-297652-ut6e1ysz	102	5	additional	additional	JJ
cord-297652-ut6e1ysz	102	6	cost	cost	NN
cord-297652-ut6e1ysz	102	7	of	of	IN
cord-297652-ut6e1ysz	102	8	almost	almost	RB
cord-297652-ut6e1ysz	102	9	2000	2000	CD
cord-297652-ut6e1ysz	102	10	USD	usd	NN
cord-297652-ut6e1ysz	102	11	for	for	IN
cord-297652-ut6e1ysz	102	12	Rebif	Rebif	NNP
cord-297652-ut6e1ysz	103	1	®	®	NNP
cord-297652-ut6e1ysz	103	2	,	,	,
cord-297652-ut6e1ysz	103	3	following	follow	VBG
cord-297652-ut6e1ysz	103	4	[	[	-LRB-
cord-297652-ut6e1ysz	103	5	23	23	CD
cord-297652-ut6e1ysz	103	6	]	]	-RRB-
cord-297652-ut6e1ysz	103	7	.	.	.
cord-297652-ut6e1ysz	104	1	There	there	EX
cord-297652-ut6e1ysz	104	2	is	be	VBZ
cord-297652-ut6e1ysz	104	3	a	a	DT
cord-297652-ut6e1ysz	104	4	huge	huge	JJ
cord-297652-ut6e1ysz	104	5	confusion	confusion	NN
cord-297652-ut6e1ysz	104	6	in	in	IN
cord-297652-ut6e1ysz	104	7	the	the	DT
cord-297652-ut6e1ysz	104	8	public	public	NN
cord-297652-ut6e1ysz	104	9	,	,	,
cord-297652-ut6e1ysz	104	10	as	as	RB
cord-297652-ut6e1ysz	104	11	well	well	RB
cord-297652-ut6e1ysz	104	12	as	as	IN
cord-297652-ut6e1ysz	104	13	among	among	IN
cord-297652-ut6e1ysz	104	14	politicians	politician	NNS
cord-297652-ut6e1ysz	104	15	and	and	CC
cord-297652-ut6e1ysz	104	16	even	even	RB
cord-297652-ut6e1ysz	104	17	some	some	DT
cord-297652-ut6e1ysz	104	18	scientists	scientist	NNS
cord-297652-ut6e1ysz	104	19	,	,	,
cord-297652-ut6e1ysz	104	20	about	about	IN
cord-297652-ut6e1ysz	104	21	those	those	DT
cord-297652-ut6e1ysz	104	22	two	two	CD
cord-297652-ut6e1ysz	104	23	molecules	molecule	NNS
cord-297652-ut6e1ysz	104	24	.	.	.
cord-297652-ut6e1ysz	105	1	That	that	DT
cord-297652-ut6e1ysz	105	2	confusion	confusion	NN
cord-297652-ut6e1ysz	105	3	ultimately	ultimately	RB
cord-297652-ut6e1ysz	105	4	led	lead	VBD
cord-297652-ut6e1ysz	105	5	to	to	IN
cord-297652-ut6e1ysz	105	6	people	people	NNS
cord-297652-ut6e1ysz	105	7	accidently	accidently	RB
cord-297652-ut6e1ysz	105	8	overdosing	overdose	VBG
cord-297652-ut6e1ysz	105	9	[	[	-LRB-
cord-297652-ut6e1ysz	105	10	28	28	CD
cord-297652-ut6e1ysz	105	11	]	]	-RRB-
cord-297652-ut6e1ysz	105	12	.	.	.
cord-297652-ut6e1ysz	106	1	Both	both	DT
cord-297652-ut6e1ysz	106	2	molecules	molecule	NNS
cord-297652-ut6e1ysz	106	3	can	can	MD
cord-297652-ut6e1ysz	106	4	be	be	VB
cord-297652-ut6e1ysz	106	5	classified	classify	VBN
cord-297652-ut6e1ysz	106	6	as	as	IN
cord-297652-ut6e1ysz	106	7	4-aminoquinolines	4-aminoquinolines	CD
cord-297652-ut6e1ysz	106	8	,	,	,
cord-297652-ut6e1ysz	106	9	and	and	CC
cord-297652-ut6e1ysz	106	10	both	both	DT
cord-297652-ut6e1ysz	106	11	have	have	VBP
cord-297652-ut6e1ysz	106	12	anti	anti	JJ
cord-297652-ut6e1ysz	106	13	-	-	JJ
cord-297652-ut6e1ysz	106	14	plasmodial	plasmodial	JJ
cord-297652-ut6e1ysz	106	15	activities	activity	NNS
cord-297652-ut6e1ysz	106	16	,	,	,
cord-297652-ut6e1ysz	106	17	but	but	CC
cord-297652-ut6e1ysz	106	18	they	-PRON-	PRP
cord-297652-ut6e1ysz	106	19	remain	remain	VBP
cord-297652-ut6e1ysz	106	20	two	two	CD
cord-297652-ut6e1ysz	106	21	different	different	JJ
cord-297652-ut6e1ysz	106	22	molecules	molecule	NNS
cord-297652-ut6e1ysz	106	23	with	with	IN
cord-297652-ut6e1ysz	106	24	some	some	DT
cord-297652-ut6e1ysz	106	25	different	different	JJ
cord-297652-ut6e1ysz	106	26	metabolites	metabolite	NNS
cord-297652-ut6e1ysz	106	27	.	.	.
cord-297652-ut6e1ysz	107	1	Chloroquine	Chloroquine	NNP
cord-297652-ut6e1ysz	107	2	has	have	VBZ
cord-297652-ut6e1ysz	107	3	been	be	VBN
cord-297652-ut6e1ysz	107	4	widely	widely	RB
cord-297652-ut6e1ysz	107	5	used	use	VBN
cord-297652-ut6e1ysz	107	6	since	since	IN
cord-297652-ut6e1ysz	107	7	the	the	DT
cord-297652-ut6e1ysz	107	8	1950s	1950	NNS
cord-297652-ut6e1ysz	107	9	for	for	IN
cord-297652-ut6e1ysz	107	10	prophylactic	prophylactic	JJ
cord-297652-ut6e1ysz	107	11	and	and	CC
cord-297652-ut6e1ysz	107	12	curative	curative	JJ
cord-297652-ut6e1ysz	107	13	treatments	treatment	NNS
cord-297652-ut6e1ysz	107	14	of	of	IN
cord-297652-ut6e1ysz	107	15	malaria	malaria	NN
cord-297652-ut6e1ysz	107	16	.	.	.
cord-297652-ut6e1ysz	108	1	Its	-PRON-	PRP$
cord-297652-ut6e1ysz	108	2	extensive	extensive	JJ
cord-297652-ut6e1ysz	108	3	use	use	NN
cord-297652-ut6e1ysz	108	4	has	have	VBZ
cord-297652-ut6e1ysz	108	5	led	lead	VBN
cord-297652-ut6e1ysz	108	6	to	to	IN
cord-297652-ut6e1ysz	108	7	the	the	DT
cord-297652-ut6e1ysz	108	8	emergence	emergence	NN
cord-297652-ut6e1ysz	108	9	of	of	IN
cord-297652-ut6e1ysz	108	10	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	108	11	-	-	HYPH
cord-297652-ut6e1ysz	108	12	resistant	resistant	JJ
cord-297652-ut6e1ysz	108	13	strains	strain	NNS
cord-297652-ut6e1ysz	108	14	of	of	IN
cord-297652-ut6e1ysz	108	15	Plasmodium	Plasmodium	NNP
cord-297652-ut6e1ysz	108	16	falciparum	falciparum	NN
cord-297652-ut6e1ysz	108	17	,	,	,
cord-297652-ut6e1ysz	108	18	the	the	DT
cord-297652-ut6e1ysz	108	19	parasite	parasite	NN
cord-297652-ut6e1ysz	108	20	responsible	responsible	JJ
cord-297652-ut6e1ysz	108	21	for	for	IN
cord-297652-ut6e1ysz	108	22	the	the	DT
cord-297652-ut6e1ysz	108	23	severest	severe	JJS
cord-297652-ut6e1ysz	108	24	form	form	NN
cord-297652-ut6e1ysz	108	25	of	of	IN
cord-297652-ut6e1ysz	108	26	malaria	malaria	NN
cord-297652-ut6e1ysz	108	27	.	.	.
cord-297652-ut6e1ysz	109	1	Such	such	JJ
cord-297652-ut6e1ysz	109	2	strains	strain	NNS
cord-297652-ut6e1ysz	109	3	are	be	VBP
cord-297652-ut6e1ysz	109	4	also	also	RB
cord-297652-ut6e1ysz	109	5	resistant	resistant	JJ
cord-297652-ut6e1ysz	109	6	to	to	IN
cord-297652-ut6e1ysz	109	7	the	the	DT
cord-297652-ut6e1ysz	109	8	structurally	structurally	RB
cord-297652-ut6e1ysz	109	9	related	relate	VBN
cord-297652-ut6e1ysz	109	10	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	109	11	.	.	.
cord-297652-ut6e1ysz	110	1	Regardless	regardless	RB
cord-297652-ut6e1ysz	110	2	,	,	,
cord-297652-ut6e1ysz	110	3	the	the	DT
cord-297652-ut6e1ysz	110	4	latter	latter	JJ
cord-297652-ut6e1ysz	110	5	is	be	VBZ
cord-297652-ut6e1ysz	110	6	sometimes	sometimes	RB
cord-297652-ut6e1ysz	110	7	preferred	prefer	VBN
cord-297652-ut6e1ysz	110	8	because	because	IN
cord-297652-ut6e1ysz	110	9	of	of	IN
cord-297652-ut6e1ysz	110	10	its	-PRON-	PRP$
cord-297652-ut6e1ysz	110	11	lower	low	JJR
cord-297652-ut6e1ysz	110	12	(	(	-LRB-
cord-297652-ut6e1ysz	110	13	retinal	retinal	JJ
cord-297652-ut6e1ysz	110	14	)	)	-RRB-
cord-297652-ut6e1ysz	110	15	toxicity	toxicity	NN
cord-297652-ut6e1ysz	110	16	[	[	-LRB-
cord-297652-ut6e1ysz	110	17	29	29	CD
cord-297652-ut6e1ysz	110	18	,	,	,
cord-297652-ut6e1ysz	110	19	30	30	CD
cord-297652-ut6e1ysz	110	20	]	]	-RRB-
cord-297652-ut6e1ysz	110	21	.	.	.
cord-297652-ut6e1ysz	111	1	Chloroquine	Chloroquine	NNP
cord-297652-ut6e1ysz	111	2	(	(	-LRB-
cord-297652-ut6e1ysz	111	3	Aralen	Aralen	NNP
cord-297652-ut6e1ysz	111	4	®	®	NNP
cord-297652-ut6e1ysz	111	5	)	)	-RRB-
cord-297652-ut6e1ysz	111	6	is	be	VBZ
cord-297652-ut6e1ysz	111	7	indicated	indicate	VBN
cord-297652-ut6e1ysz	111	8	for	for	IN
cord-297652-ut6e1ysz	111	9	the	the	DT
cord-297652-ut6e1ysz	111	10	treatment	treatment	NN
cord-297652-ut6e1ysz	111	11	of	of	IN
cord-297652-ut6e1ysz	111	12	malaria	malaria	NN
cord-297652-ut6e1ysz	111	13	and	and	CC
cord-297652-ut6e1ysz	111	14	extraintestinal	extraintestinal	NNP
cord-297652-ut6e1ysz	111	15	amebiasis	amebiasis	NNP
cord-297652-ut6e1ysz	111	16	.	.	.
cord-297652-ut6e1ysz	112	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-297652-ut6e1ysz	113	1	(	(	-LRB-
cord-297652-ut6e1ysz	113	2	Plaquenil	Plaquenil	NNP
cord-297652-ut6e1ysz	113	3	®	®	.
cord-297652-ut6e1ysz	113	4	)	)	-RRB-
cord-297652-ut6e1ysz	113	5	is	be	VBZ
cord-297652-ut6e1ysz	113	6	also	also	RB
cord-297652-ut6e1ysz	113	7	prescribed	prescribe	VBN
cord-297652-ut6e1ysz	113	8	for	for	IN
cord-297652-ut6e1ysz	113	9	the	the	DT
cord-297652-ut6e1ysz	113	10	treatment	treatment	NN
cord-297652-ut6e1ysz	113	11	of	of	IN
cord-297652-ut6e1ysz	113	12	malaria	malaria	NN
cord-297652-ut6e1ysz	113	13	.	.	.
cord-297652-ut6e1ysz	114	1	It	-PRON-	PRP
cord-297652-ut6e1ysz	114	2	is	be	VBZ
cord-297652-ut6e1ysz	114	3	also	also	RB
cord-297652-ut6e1ysz	114	4	used	use	VBN
cord-297652-ut6e1ysz	114	5	successfully	successfully	RB
cord-297652-ut6e1ysz	114	6	to	to	TO
cord-297652-ut6e1ysz	114	7	treat	treat	VB
cord-297652-ut6e1ysz	114	8	lupus	lupus	NN
cord-297652-ut6e1ysz	114	9	erythematosus	erythematosus	NN
cord-297652-ut6e1ysz	114	10	and	and	CC
cord-297652-ut6e1ysz	114	11	rheumatoid	rheumatoid	NN
cord-297652-ut6e1ysz	114	12	arthritis	arthritis	NN
cord-297652-ut6e1ysz	114	13	[	[	-LRB-
cord-297652-ut6e1ysz	114	14	27	27	CD
cord-297652-ut6e1ysz	114	15	]	]	-RRB-
cord-297652-ut6e1ysz	114	16	.	.	.
cord-297652-ut6e1ysz	115	1	In	in	IN
cord-297652-ut6e1ysz	115	2	addition	addition	NN
cord-297652-ut6e1ysz	115	3	,	,	,
cord-297652-ut6e1ysz	115	4	it	-PRON-	PRP
cord-297652-ut6e1ysz	115	5	should	should	MD
cord-297652-ut6e1ysz	115	6	be	be	VB
cord-297652-ut6e1ysz	115	7	noted	note	VBN
cord-297652-ut6e1ysz	115	8	that	that	IN
cord-297652-ut6e1ysz	115	9	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	115	10	,	,	,
cord-297652-ut6e1ysz	115	11	essentially	essentially	RB
cord-297652-ut6e1ysz	115	12	,	,	,
cord-297652-ut6e1ysz	115	13	and	and	CC
cord-297652-ut6e1ysz	115	14	hydroxychloroquine	hydroxychloroquine	UH
cord-297652-ut6e1ysz	115	15	,	,	,
cord-297652-ut6e1ysz	115	16	to	to	IN
cord-297652-ut6e1ysz	115	17	a	a	DT
cord-297652-ut6e1ysz	115	18	lesser	less	JJR
cord-297652-ut6e1ysz	115	19	extent	extent	NN
cord-297652-ut6e1ysz	115	20	,	,	,
cord-297652-ut6e1ysz	115	21	have	have	VBP
cord-297652-ut6e1ysz	115	22	been	be	VBN
cord-297652-ut6e1ysz	115	23	clinically	clinically	RB
cord-297652-ut6e1ysz	115	24	tested	test	VBN
cord-297652-ut6e1ysz	115	25	for	for	IN
cord-297652-ut6e1ysz	115	26	their	-PRON-	PRP$
cord-297652-ut6e1ysz	115	27	anti	anti	JJ
cord-297652-ut6e1ysz	115	28	-	-	JJ
cord-297652-ut6e1ysz	115	29	HIV	hiv	JJ
cord-297652-ut6e1ysz	115	30	activity	activity	NN
cord-297652-ut6e1ysz	115	31	[	[	-LRB-
cord-297652-ut6e1ysz	115	32	4	4	CD
cord-297652-ut6e1ysz	115	33	,	,	,
cord-297652-ut6e1ysz	115	34	31	31	CD
cord-297652-ut6e1ysz	115	35	]	]	-RRB-
cord-297652-ut6e1ysz	115	36	.	.	.
cord-297652-ut6e1ysz	116	1	As	as	RB
cord-297652-ut6e1ysz	116	2	recently	recently	RB
cord-297652-ut6e1ysz	116	3	as	as	IN
cord-297652-ut6e1ysz	116	4	2006	2006	CD
cord-297652-ut6e1ysz	116	5	,	,	,
cord-297652-ut6e1ysz	116	6	the	the	DT
cord-297652-ut6e1ysz	116	7	anti	anti	JJ
cord-297652-ut6e1ysz	116	8	-	-	JJ
cord-297652-ut6e1ysz	116	9	coronavirus	coronavirus	JJ
cord-297652-ut6e1ysz	116	10	properties	property	NNS
cord-297652-ut6e1ysz	116	11	of	of	IN
cord-297652-ut6e1ysz	116	12	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	116	13	and	and	CC
cord-297652-ut6e1ysz	116	14	chloroquine	chloroquine	NNP
cord-297652-ut6e1ysz	116	15	were	be	VBD
cord-297652-ut6e1ysz	116	16	reported	report	VBN
cord-297652-ut6e1ysz	116	17	by	by	IN
cord-297652-ut6e1ysz	116	18	Biot	Biot	NNP
cord-297652-ut6e1ysz	116	19	et	et	NNP
cord-297652-ut6e1ysz	116	20	al	al	NNP
cord-297652-ut6e1ysz	116	21	.	.	.
cord-297652-ut6e1ysz	117	1	[	[	-LRB-
cord-297652-ut6e1ysz	117	2	32	32	CD
cord-297652-ut6e1ysz	117	3	]	]	-RRB-
cord-297652-ut6e1ysz	117	4	.	.	.
cord-297652-ut6e1ysz	118	1	Those	those	DT
cord-297652-ut6e1ysz	118	2	authors	author	NNS
cord-297652-ut6e1ysz	118	3	observed	observe	VBD
cord-297652-ut6e1ysz	118	4	that	that	IN
cord-297652-ut6e1ysz	118	5	,	,	,
cord-297652-ut6e1ysz	118	6	in	in	IN
cord-297652-ut6e1ysz	118	7	vitro	vitro	FW
cord-297652-ut6e1ysz	118	8	,	,	,
cord-297652-ut6e1ysz	118	9	both	both	DT
cord-297652-ut6e1ysz	118	10	molecules	molecule	NNS
cord-297652-ut6e1ysz	118	11	were	be	VBD
cord-297652-ut6e1ysz	118	12	active	active	JJ
cord-297652-ut6e1ysz	118	13	against	against	IN
cord-297652-ut6e1ysz	118	14	SARS	SARS	NNP
cord-297652-ut6e1ysz	118	15	-	-	HYPH
cord-297652-ut6e1ysz	118	16	CoV	CoV	NNP
cord-297652-ut6e1ysz	118	17	with	with	IN
cord-297652-ut6e1ysz	118	18	EC	EC	NNP
cord-297652-ut6e1ysz	118	19	50	50	CD
cord-297652-ut6e1ysz	118	20	values	value	NNS
cord-297652-ut6e1ysz	118	21	of	of	IN
cord-297652-ut6e1ysz	118	22	34	34	CD
cord-297652-ut6e1ysz	118	23	and	and	CC
cord-297652-ut6e1ysz	118	24	6.5	6.5	CD
cord-297652-ut6e1ysz	118	25	µM	µm	XX
cord-297652-ut6e1ysz	118	26	,	,	,
cord-297652-ut6e1ysz	118	27	for	for	IN
cord-297652-ut6e1ysz	118	28	hydroxyquinoline	hydroxyquinoline	NNP
cord-297652-ut6e1ysz	118	29	(	(	-LRB-
cord-297652-ut6e1ysz	118	30	4	4	CD
cord-297652-ut6e1ysz	118	31	)	)	-RRB-
cord-297652-ut6e1ysz	118	32	and	and	CC
cord-297652-ut6e1ysz	118	33	chloroquine	chloroquine	NNP
cord-297652-ut6e1ysz	118	34	(	(	-LRB-
cord-297652-ut6e1ysz	118	35	5	5	CD
cord-297652-ut6e1ysz	118	36	)	)	-RRB-
cord-297652-ut6e1ysz	118	37	,	,	,
cord-297652-ut6e1ysz	118	38	respectively	respectively	RB
cord-297652-ut6e1ysz	118	39	.	.	.
cord-297652-ut6e1ysz	119	1	The	the	DT
cord-297652-ut6e1ysz	119	2	difference	difference	NN
cord-297652-ut6e1ysz	119	3	is	be	VBZ
cord-297652-ut6e1ysz	119	4	less	less	RBR
cord-297652-ut6e1ysz	119	5	marked	mark	VBN
cord-297652-ut6e1ysz	119	6	in	in	IN
cord-297652-ut6e1ysz	119	7	the	the	DT
cord-297652-ut6e1ysz	119	8	study	study	NN
cord-297652-ut6e1ysz	119	9	of	of	IN
cord-297652-ut6e1ysz	119	10	Dyall	Dyall	NNP
cord-297652-ut6e1ysz	119	11	et	et	FW
cord-297652-ut6e1ysz	119	12	al	al	NNP
cord-297652-ut6e1ysz	119	13	.	.	.
cord-297652-ut6e1ysz	120	1	[	[	-LRB-
cord-297652-ut6e1ysz	120	2	33	33	CD
cord-297652-ut6e1ysz	120	3	]	]	-RRB-
cord-297652-ut6e1ysz	120	4	who	who	WP
cord-297652-ut6e1ysz	120	5	reported	report	VBD
cord-297652-ut6e1ysz	120	6	EC	EC	NNP
cord-297652-ut6e1ysz	120	7	50	50	CD
cord-297652-ut6e1ysz	120	8	values	value	NNS
cord-297652-ut6e1ysz	120	9	of	of	IN
cord-297652-ut6e1ysz	120	10	7.97	7.97	CD
cord-297652-ut6e1ysz	120	11	µM	µm	XX
cord-297652-ut6e1ysz	120	12	(	(	-LRB-
cord-297652-ut6e1ysz	120	13	4	4	CD
cord-297652-ut6e1ysz	120	14	)	)	-RRB-
cord-297652-ut6e1ysz	120	15	and	and	CC
cord-297652-ut6e1ysz	120	16	6.54	6.54	CD
cord-297652-ut6e1ysz	120	17	µM	µm	XX
cord-297652-ut6e1ysz	120	18	(	(	-LRB-
cord-297652-ut6e1ysz	120	19	5	5	CD
cord-297652-ut6e1ysz	120	20	)	)	-RRB-
cord-297652-ut6e1ysz	120	21	against	against	IN
cord-297652-ut6e1ysz	120	22	SARS	SARS	NNP
cord-297652-ut6e1ysz	120	23	-	-	HYPH
cord-297652-ut6e1ysz	120	24	CoV	CoV	NNP
cord-297652-ut6e1ysz	120	25	and	and	CC
cord-297652-ut6e1ysz	120	26	8.28	8.28	CD
cord-297652-ut6e1ysz	120	27	µM	µm	NN
cord-297652-ut6e1ysz	120	28	(	(	-LRB-
cord-297652-ut6e1ysz	120	29	4	4	CD
cord-297652-ut6e1ysz	120	30	)	)	-RRB-
cord-297652-ut6e1ysz	120	31	and	and	CC
cord-297652-ut6e1ysz	120	32	6.28	6.28	CD
cord-297652-ut6e1ysz	120	33	µM	µm	NN
cord-297652-ut6e1ysz	120	34	(	(	-LRB-
cord-297652-ut6e1ysz	120	35	5	5	CD
cord-297652-ut6e1ysz	120	36	)	)	-RRB-
cord-297652-ut6e1ysz	120	37	against	against	IN
cord-297652-ut6e1ysz	120	38	MERS-	MERS-	NNP
cord-297652-ut6e1ysz	121	1	CoV.	CoV.	NNP
cord-297652-ut6e1ysz	122	1	The	the	DT
cord-297652-ut6e1ysz	122	2	trend	trend	NN
cord-297652-ut6e1ysz	122	3	is	be	VBZ
cord-297652-ut6e1ysz	122	4	reversed	reverse	VBN
cord-297652-ut6e1ysz	122	5	when	when	WRB
cord-297652-ut6e1ysz	122	6	dealing	deal	VBG
cord-297652-ut6e1ysz	122	7	with	with	IN
cord-297652-ut6e1ysz	122	8	SARS	SARS	NNP
cord-297652-ut6e1ysz	122	9	-	-	HYPH
cord-297652-ut6e1ysz	122	10	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	122	11	,	,	,
cord-297652-ut6e1ysz	122	12	as	as	IN
cord-297652-ut6e1ysz	122	13	values	value	NNS
cord-297652-ut6e1ysz	122	14	related	relate	VBN
cord-297652-ut6e1ysz	122	15	by	by	IN
cord-297652-ut6e1ysz	122	16	Yao	Yao	NNP
cord-297652-ut6e1ysz	122	17	et	et	FW
cord-297652-ut6e1ysz	122	18	al	al	NNP
cord-297652-ut6e1ysz	122	19	.	.	.
cord-297652-ut6e1ysz	123	1	[	[	-LRB-
cord-297652-ut6e1ysz	123	2	34	34	CD
cord-297652-ut6e1ysz	123	3	]	]	-RRB-
cord-297652-ut6e1ysz	123	4	were	be	VBD
cord-297652-ut6e1ysz	123	5	0.72	0.72	CD
cord-297652-ut6e1ysz	123	6	µM	µm	NN
cord-297652-ut6e1ysz	123	7	(	(	-LRB-
cord-297652-ut6e1ysz	123	8	4	4	CD
cord-297652-ut6e1ysz	123	9	)	)	-RRB-
cord-297652-ut6e1ysz	123	10	and	and	CC
cord-297652-ut6e1ysz	123	11	5.47	5.47	CD
cord-297652-ut6e1ysz	123	12	µM	µm	NN
cord-297652-ut6e1ysz	123	13	(	(	-LRB-
cord-297652-ut6e1ysz	123	14	5	5	CD
cord-297652-ut6e1ysz	123	15	)	)	-RRB-
cord-297652-ut6e1ysz	123	16	.	.	.
cord-297652-ut6e1ysz	124	1	A	a	DT
cord-297652-ut6e1ysz	124	2	comparable	comparable	JJ
cord-297652-ut6e1ysz	124	3	efficacy	efficacy	NN
cord-297652-ut6e1ysz	124	4	of	of	IN
cord-297652-ut6e1ysz	124	5	6.9	6.9	CD
cord-297652-ut6e1ysz	124	6	µM	µm	NN
cord-297652-ut6e1ysz	124	7	was	be	VBD
cord-297652-ut6e1ysz	124	8	measured	measure	VBN
cord-297652-ut6e1ysz	124	9	by	by	IN
cord-297652-ut6e1ysz	124	10	Wang	Wang	NNP
cord-297652-ut6e1ysz	124	11	et	et	NNP
cord-297652-ut6e1ysz	124	12	al	al	NNP
cord-297652-ut6e1ysz	124	13	.	.	.
cord-297652-ut6e1ysz	125	1	[	[	-LRB-
cord-297652-ut6e1ysz	125	2	11	11	CD
cord-297652-ut6e1ysz	125	3	]	]	-RRB-
cord-297652-ut6e1ysz	125	4	for	for	IN
cord-297652-ut6e1ysz	125	5	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	125	6	(	(	-LRB-
cord-297652-ut6e1ysz	125	7	5	5	CD
cord-297652-ut6e1ysz	125	8	)	)	-RRB-
cord-297652-ut6e1ysz	125	9	.	.	.
cord-297652-ut6e1ysz	126	1	On	on	IN
cord-297652-ut6e1ysz	126	2	February	February	NNP
cord-297652-ut6e1ysz	126	3	19	19	CD
cord-297652-ut6e1ysz	126	4	,	,	,
cord-297652-ut6e1ysz	126	5	Gao	Gao	NNP
cord-297652-ut6e1ysz	126	6	et	et	NNP
cord-297652-ut6e1ysz	126	7	al	al	NNP
cord-297652-ut6e1ysz	126	8	.	.	.
cord-297652-ut6e1ysz	127	1	[	[	-LRB-
cord-297652-ut6e1ysz	127	2	35	35	CD
cord-297652-ut6e1ysz	127	3	]	]	-RRB-
cord-297652-ut6e1ysz	127	4	recorded	record	VBN
cord-297652-ut6e1ysz	127	5	,	,	,
cord-297652-ut6e1ysz	127	6	in	in	IN
cord-297652-ut6e1ysz	127	7	China	China	NNP
cord-297652-ut6e1ysz	127	8	,	,	,
cord-297652-ut6e1ysz	127	9	15	15	CD
cord-297652-ut6e1ysz	127	10	clinical	clinical	JJ
cord-297652-ut6e1ysz	127	11	trials	trial	NNS
cord-297652-ut6e1ysz	127	12	involving	involve	VBG
cord-297652-ut6e1ysz	127	13	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	127	14	.	.	.
cord-297652-ut6e1ysz	128	1	On	on	IN
cord-297652-ut6e1ysz	128	2	March	March	NNP
cord-297652-ut6e1ysz	128	3	28	28	CD
cord-297652-ut6e1ysz	128	4	,	,	,
cord-297652-ut6e1ysz	128	5	the	the	DT
cord-297652-ut6e1ysz	128	6	FDA	FDA	NNP
cord-297652-ut6e1ysz	128	7	issued	issue	VBD
cord-297652-ut6e1ysz	128	8	an	an	DT
cord-297652-ut6e1ysz	128	9	Emergency	Emergency	NNP
cord-297652-ut6e1ysz	128	10	Use	Use	NNP
cord-297652-ut6e1ysz	128	11	Authorization	Authorization	NNP
cord-297652-ut6e1ysz	128	12	for	for	IN
cord-297652-ut6e1ysz	128	13	use	use	NN
cord-297652-ut6e1ysz	128	14	of	of	IN
cord-297652-ut6e1ysz	128	15	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	128	16	and	and	CC
cord-297652-ut6e1ysz	128	17	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	128	18	for	for	IN
cord-297652-ut6e1ysz	128	19	patients	patient	NNS
cord-297652-ut6e1ysz	128	20	who	who	WP
cord-297652-ut6e1ysz	128	21	do	do	VBP
cord-297652-ut6e1ysz	128	22	not	not	RB
cord-297652-ut6e1ysz	128	23	have	have	VB
cord-297652-ut6e1ysz	128	24	access	access	NN
cord-297652-ut6e1ysz	128	25	to	to	IN
cord-297652-ut6e1ysz	128	26	the	the	DT
cord-297652-ut6e1ysz	128	27	drugs	drug	NNS
cord-297652-ut6e1ysz	128	28	via	via	IN
cord-297652-ut6e1ysz	128	29	clinical	clinical	JJ
cord-297652-ut6e1ysz	128	30	trials	trial	NNS
cord-297652-ut6e1ysz	128	31	[	[	-LRB-
cord-297652-ut6e1ysz	128	32	36	36	CD
cord-297652-ut6e1ysz	128	33	]	]	-RRB-
cord-297652-ut6e1ysz	128	34	.	.	.
cord-297652-ut6e1ysz	129	1	As	as	IN
cord-297652-ut6e1ysz	129	2	underlined	underline	VBN
cord-297652-ut6e1ysz	129	3	by	by	IN
cord-297652-ut6e1ysz	129	4	a	a	DT
cord-297652-ut6e1ysz	129	5	reviewer	reviewer	NN
cord-297652-ut6e1ysz	129	6	of	of	IN
cord-297652-ut6e1ysz	129	7	this	this	DT
cord-297652-ut6e1ysz	129	8	manuscript	manuscript	NN
cord-297652-ut6e1ysz	129	9	,	,	,
cord-297652-ut6e1ysz	129	10	this	this	DT
cord-297652-ut6e1ysz	129	11	essentially	essentially	RB
cord-297652-ut6e1ysz	129	12	means	mean	VBZ
cord-297652-ut6e1ysz	129	13	that	that	IN
cord-297652-ut6e1ysz	129	14	lots	lot	NNS
cord-297652-ut6e1ysz	129	15	of	of	IN
cord-297652-ut6e1ysz	129	16	anecdotal	anecdotal	JJ
cord-297652-ut6e1ysz	129	17	testimonies	testimony	NNS
cord-297652-ut6e1ysz	129	18	as	as	IN
cord-297652-ut6e1ysz	129	19	to	to	IN
cord-297652-ut6e1ysz	129	20	the	the	DT
cord-297652-ut6e1ysz	129	21	effects	effect	NNS
cord-297652-ut6e1ysz	129	22	of	of	IN
cord-297652-ut6e1ysz	129	23	these	these	DT
cord-297652-ut6e1ysz	129	24	two	two	CD
cord-297652-ut6e1ysz	129	25	drugs	drug	NNS
cord-297652-ut6e1ysz	129	26	will	will	MD
cord-297652-ut6e1ysz	129	27	be	be	VB
cord-297652-ut6e1ysz	129	28	released	release	VBN
cord-297652-ut6e1ysz	129	29	until	until	IN
cord-297652-ut6e1ysz	129	30	properly	properly	RB
cord-297652-ut6e1ysz	129	31	controlled	control	VBN
cord-297652-ut6e1ysz	129	32	clinical	clinical	JJ
cord-297652-ut6e1ysz	129	33	trials	trial	NNS
cord-297652-ut6e1ysz	129	34	are	be	VBP
cord-297652-ut6e1ysz	129	35	done	do	VBN
cord-297652-ut6e1ysz	129	36	.	.	.
cord-297652-ut6e1ysz	130	1	As	as	IN
cord-297652-ut6e1ysz	130	2	of	of	IN
cord-297652-ut6e1ysz	130	3	8	8	CD
cord-297652-ut6e1ysz	130	4	April	April	NNP
cord-297652-ut6e1ysz	130	5	,	,	,
cord-297652-ut6e1ysz	130	6	58	58	CD
cord-297652-ut6e1ysz	130	7	clinical	clinical	JJ
cord-297652-ut6e1ysz	130	8	trials	trial	NNS
cord-297652-ut6e1ysz	130	9	concern	concern	NN
cord-297652-ut6e1ysz	130	10	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	130	11	,	,	,
cord-297652-ut6e1ysz	130	12	compared	compare	VBN
cord-297652-ut6e1ysz	130	13	to	to	IN
cord-297652-ut6e1ysz	130	14	19	19	CD
cord-297652-ut6e1ysz	130	15	on	on	IN
cord-297652-ut6e1ysz	130	16	March	March	NNP
cord-297652-ut6e1ysz	130	17	28	28	CD
cord-297652-ut6e1ysz	130	18	[	[	-LRB-
cord-297652-ut6e1ysz	130	19	4	4	CD
cord-297652-ut6e1ysz	130	20	]	]	-RRB-
cord-297652-ut6e1ysz	130	21	.	.	.
cord-297652-ut6e1ysz	131	1	In	in	IN
cord-297652-ut6e1ysz	131	2	France	France	NNP
cord-297652-ut6e1ysz	131	3	,	,	,
cord-297652-ut6e1ysz	131	4	controversial	controversial	JJ
cord-297652-ut6e1ysz	131	5	results	result	NNS
cord-297652-ut6e1ysz	131	6	have	have	VBP
cord-297652-ut6e1ysz	131	7	been	be	VBN
cord-297652-ut6e1ysz	131	8	published	publish	VBN
cord-297652-ut6e1ysz	131	9	,	,	,
cord-297652-ut6e1ysz	131	10	in	in	IN
cord-297652-ut6e1ysz	131	11	March	March	NNP
cord-297652-ut6e1ysz	131	12	,	,	,
cord-297652-ut6e1ysz	131	13	on	on	IN
cord-297652-ut6e1ysz	131	14	a	a	DT
cord-297652-ut6e1ysz	131	15	treatment	treatment	NN
cord-297652-ut6e1ysz	131	16	associating	associate	VBG
cord-297652-ut6e1ysz	131	17	the	the	DT
cord-297652-ut6e1ysz	131	18	same	same	JJ
cord-297652-ut6e1ysz	131	19	dosing	dosing	NN
cord-297652-ut6e1ysz	131	20	regimen	regimen	NN
cord-297652-ut6e1ysz	131	21	of	of	IN
cord-297652-ut6e1ysz	131	22	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	131	23	and	and	CC
cord-297652-ut6e1ysz	131	24	azithromycin	azithromycin	NNP
cord-297652-ut6e1ysz	131	25	.	.	.
cord-297652-ut6e1ysz	132	1	The	the	DT
cord-297652-ut6e1ysz	132	2	treatment	treatment	NN
cord-297652-ut6e1ysz	132	3	was	be	VBD
cord-297652-ut6e1ysz	132	4	administered	administer	VBN
cord-297652-ut6e1ysz	132	5	to	to	IN
cord-297652-ut6e1ysz	132	6	small	small	JJ
cord-297652-ut6e1ysz	132	7	cohorts	cohort	NNS
cord-297652-ut6e1ysz	132	8	(	(	-LRB-
cord-297652-ut6e1ysz	132	9	less	less	JJR
cord-297652-ut6e1ysz	132	10	than	than	IN
cord-297652-ut6e1ysz	132	11	25	25	CD
cord-297652-ut6e1ysz	132	12	people	people	NNS
cord-297652-ut6e1ysz	132	13	)	)	-RRB-
cord-297652-ut6e1ysz	132	14	of	of	IN
cord-297652-ut6e1ysz	132	15	patients	patient	NNS
cord-297652-ut6e1ysz	132	16	hospitalized	hospitalize	VBN
cord-297652-ut6e1ysz	132	17	for	for	IN
cord-297652-ut6e1ysz	132	18	severe	severe	JJ
cord-297652-ut6e1ysz	132	19	COVID-19	covid-19	CD
cord-297652-ut6e1ysz	132	20	infection	infection	NN
cord-297652-ut6e1ysz	132	21	[	[	-LRB-
cord-297652-ut6e1ysz	132	22	37	37	CD
cord-297652-ut6e1ysz	132	23	,	,	,
cord-297652-ut6e1ysz	132	24	38	38	CD
cord-297652-ut6e1ysz	132	25	]	]	-RRB-
cord-297652-ut6e1ysz	132	26	.	.	.
cord-297652-ut6e1ysz	133	1	Due	due	IN
cord-297652-ut6e1ysz	133	2	to	to	IN
cord-297652-ut6e1ysz	133	3	such	such	JJ
cord-297652-ut6e1ysz	133	4	confusion	confusion	NN
cord-297652-ut6e1ysz	133	5	,	,	,
cord-297652-ut6e1ysz	133	6	in	in	IN
cord-297652-ut6e1ysz	133	7	France	France	NNP
cord-297652-ut6e1ysz	133	8	and	and	CC
cord-297652-ut6e1ysz	133	9	Belgium	Belgium	NNP
cord-297652-ut6e1ysz	133	10	(	(	-LRB-
cord-297652-ut6e1ysz	133	11	and	and	CC
cord-297652-ut6e1ysz	133	12	probably	probably	RB
cord-297652-ut6e1ysz	133	13	in	in	IN
cord-297652-ut6e1ysz	133	14	other	other	JJ
cord-297652-ut6e1ysz	133	15	countries	country	NNS
cord-297652-ut6e1ysz	133	16	)	)	-RRB-
cord-297652-ut6e1ysz	133	17	,	,	,
cord-297652-ut6e1ysz	133	18	politicians	politician	NNS
cord-297652-ut6e1ysz	133	19	,	,	,
cord-297652-ut6e1ysz	133	20	their	-PRON-	PRP$
cord-297652-ut6e1ysz	133	21	advisors	advisor	NNS
cord-297652-ut6e1ysz	133	22	,	,	,
cord-297652-ut6e1ysz	133	23	and	and	CC
cord-297652-ut6e1ysz	133	24	even	even	RB
cord-297652-ut6e1ysz	133	25	some	some	DT
cord-297652-ut6e1ysz	133	26	physicians	physician	NNS
cord-297652-ut6e1ysz	133	27	called	call	VBD
cord-297652-ut6e1ysz	133	28	for	for	IN
cord-297652-ut6e1ysz	133	29	caution	caution	NN
cord-297652-ut6e1ysz	133	30	.	.	.
cord-297652-ut6e1ysz	134	1	They	-PRON-	PRP
cord-297652-ut6e1ysz	134	2	suggested	suggest	VBD
cord-297652-ut6e1ysz	134	3	that	that	IN
cord-297652-ut6e1ysz	134	4	preliminary	preliminary	JJ
cord-297652-ut6e1ysz	134	5	reports	report	NNS
cord-297652-ut6e1ysz	134	6	describing	describe	VBG
cord-297652-ut6e1ysz	134	7	successful	successful	JJ
cord-297652-ut6e1ysz	134	8	outcomes	outcome	NNS
cord-297652-ut6e1ysz	134	9	in	in	IN
cord-297652-ut6e1ysz	134	10	the	the	DT
cord-297652-ut6e1ysz	134	11	use	use	NN
cord-297652-ut6e1ysz	134	12	of	of	IN
cord-297652-ut6e1ysz	134	13	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	134	14	or	or	CC
cord-297652-ut6e1ysz	134	15	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	134	16	in	in	IN
cord-297652-ut6e1ysz	134	17	hospitals	hospital	NNS
cord-297652-ut6e1ysz	134	18	must	must	MD
cord-297652-ut6e1ysz	134	19	be	be	VB
cord-297652-ut6e1ysz	134	20	carefully	carefully	RB
cord-297652-ut6e1ysz	134	21	considered	consider	VBN
cord-297652-ut6e1ysz	134	22	,	,	,
cord-297652-ut6e1ysz	134	23	either	either	CC
cord-297652-ut6e1ysz	134	24	because	because	IN
cord-297652-ut6e1ysz	134	25	those	those	DT
cord-297652-ut6e1ysz	134	26	two	two	CD
cord-297652-ut6e1ysz	134	27	molecules	molecule	NNS
cord-297652-ut6e1ysz	134	28	are	be	VBP
cord-297652-ut6e1ysz	134	29	plagued	plague	VBN
cord-297652-ut6e1ysz	134	30	by	by	IN
cord-297652-ut6e1ysz	134	31	side	side	NN
cord-297652-ut6e1ysz	134	32	-	-	HYPH
cord-297652-ut6e1ysz	134	33	effects	effect	NNS
cord-297652-ut6e1ysz	134	34	or	or	CC
cord-297652-ut6e1ysz	134	35	because	because	IN
cord-297652-ut6e1ysz	134	36	of	of	IN
cord-297652-ut6e1ysz	134	37	a	a	DT
cord-297652-ut6e1ysz	134	38	lack	lack	NN
cord-297652-ut6e1ysz	134	39	of	of	IN
cord-297652-ut6e1ysz	134	40	scientific	scientific	JJ
cord-297652-ut6e1ysz	134	41	rigor	rigor	NN
cord-297652-ut6e1ysz	134	42	in	in	IN
cord-297652-ut6e1ysz	134	43	the	the	DT
cord-297652-ut6e1ysz	134	44	studies	study	NNS
cord-297652-ut6e1ysz	134	45	.	.	.
cord-297652-ut6e1ysz	135	1	Contrastingly	contrastingly	RB
cord-297652-ut6e1ysz	135	2	,	,	,
cord-297652-ut6e1ysz	135	3	The	the	DT
cord-297652-ut6e1ysz	135	4	Bill	Bill	NNP
cord-297652-ut6e1ysz	135	5	and	and	CC
cord-297652-ut6e1ysz	135	6	Melinda	Melinda	NNP
cord-297652-ut6e1ysz	135	7	Gates	Gates	NNP
cord-297652-ut6e1ysz	135	8	foundation	foundation	NN
cord-297652-ut6e1ysz	135	9	announced	announce	VBD
cord-297652-ut6e1ysz	135	10	that	that	IN
cord-297652-ut6e1ysz	135	11	it	-PRON-	PRP
cord-297652-ut6e1ysz	135	12	had	have	VBD
cord-297652-ut6e1ysz	135	13	launched	launch	VBN
cord-297652-ut6e1ysz	135	14	and	and	CC
cord-297652-ut6e1ysz	135	15	financially	financially	RB
cord-297652-ut6e1ysz	135	16	supported	support	VBD
cord-297652-ut6e1ysz	135	17	two	two	CD
cord-297652-ut6e1ysz	135	18	trials	trial	NNS
cord-297652-ut6e1ysz	135	19	aiming	aim	VBG
cord-297652-ut6e1ysz	135	20	at	at	IN
cord-297652-ut6e1ysz	135	21	a	a	DT
cord-297652-ut6e1ysz	135	22	study	study	NN
cord-297652-ut6e1ysz	135	23	on	on	IN
cord-297652-ut6e1ysz	135	24	the	the	DT
cord-297652-ut6e1ysz	135	25	use	use	NN
cord-297652-ut6e1ysz	135	26	of	of	IN
cord-297652-ut6e1ysz	135	27	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	135	28	as	as	IN
cord-297652-ut6e1ysz	135	29	a	a	DT
cord-297652-ut6e1ysz	135	30	prophylactic	prophylactic	JJ
cord-297652-ut6e1ysz	135	31	agent	agent	NN
cord-297652-ut6e1ysz	135	32	for	for	IN
cord-297652-ut6e1ysz	135	33	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	135	34	[	[	-LRB-
cord-297652-ut6e1ysz	135	35	39	39	CD
cord-297652-ut6e1ysz	135	36	]	]	-RRB-
cord-297652-ut6e1ysz	135	37	.	.	.
cord-297652-ut6e1ysz	136	1	In	in	IN
cord-297652-ut6e1ysz	136	2	the	the	DT
cord-297652-ut6e1ysz	136	3	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	136	4	project	project	NN
cord-297652-ut6e1ysz	136	5	,	,	,
cord-297652-ut6e1ysz	136	6	the	the	DT
cord-297652-ut6e1ysz	136	7	suggested	suggest	VBN
cord-297652-ut6e1ysz	136	8	dosage	dosage	NN
cord-297652-ut6e1ysz	136	9	for	for	IN
cord-297652-ut6e1ysz	136	10	hydroxychloroquine	hydroxychloroquine	NNP
cord-297652-ut6e1ysz	136	11	is	be	VBZ
cord-297652-ut6e1ysz	136	12	400	400	CD
cord-297652-ut6e1ysz	136	13	mg	mg	NN
cord-297652-ut6e1ysz	136	14	for	for	IN
cord-297652-ut6e1ysz	136	15	the	the	DT
cord-297652-ut6e1ysz	136	16	initial	initial	JJ
cord-297652-ut6e1ysz	136	17	dose	dose	NN
cord-297652-ut6e1ysz	136	18	,	,	,
cord-297652-ut6e1ysz	136	19	followed	follow	VBN
cord-297652-ut6e1ysz	136	20	by	by	IN
cord-297652-ut6e1ysz	136	21	400	400	CD
cord-297652-ut6e1ysz	136	22	mg	mg	NN
cord-297652-ut6e1ysz	136	23	12	12	CD
cord-297652-ut6e1ysz	136	24	h	h	NNP
cord-297652-ut6e1ysz	136	25	later	later	RB
cord-297652-ut6e1ysz	137	1	and	and	CC
cord-297652-ut6e1ysz	137	2	then	then	RB
cord-297652-ut6e1ysz	137	3	200	200	CD
cord-297652-ut6e1ysz	137	4	mg	mg	NN
cord-297652-ut6e1ysz	137	5	BID	BID	VBN
cord-297652-ut6e1ysz	137	6	for	for	IN
cord-297652-ut6e1ysz	137	7	up	up	IN
cord-297652-ut6e1ysz	137	8	to	to	TO
cord-297652-ut6e1ysz	137	9	4	4	CD
cord-297652-ut6e1ysz	137	10	days	day	NNS
cord-297652-ut6e1ysz	137	11	.	.	.
cord-297652-ut6e1ysz	138	1	Using	use	VBG
cord-297652-ut6e1ysz	138	2	the	the	DT
cord-297652-ut6e1ysz	138	3	same	same	JJ
cord-297652-ut6e1ysz	138	4	metric	metric	NN
cord-297652-ut6e1ysz	138	5	[	[	-LRB-
cord-297652-ut6e1ysz	138	6	23	23	CD
cord-297652-ut6e1ysz	138	7	]	]	-RRB-
cord-297652-ut6e1ysz	138	8	to	to	TO
cord-297652-ut6e1ysz	138	9	evaluate	evaluate	VB
cord-297652-ut6e1ysz	138	10	the	the	DT
cord-297652-ut6e1ysz	138	11	cost	cost	NN
cord-297652-ut6e1ysz	138	12	of	of	IN
cord-297652-ut6e1ysz	138	13	the	the	DT
cord-297652-ut6e1ysz	138	14	treatment	treatment	NN
cord-297652-ut6e1ysz	138	15	,	,	,
cord-297652-ut6e1ysz	138	16	the	the	DT
cord-297652-ut6e1ysz	138	17	price	price	NN
cord-297652-ut6e1ysz	138	18	should	should	MD
cord-297652-ut6e1ysz	138	19	not	not	RB
cord-297652-ut6e1ysz	138	20	exceed	exceed	VB
cord-297652-ut6e1ysz	138	21	4.1	4.1	CD
cord-297652-ut6e1ysz	138	22	USD	usd	NN
cord-297652-ut6e1ysz	138	23	.	.	.
cord-297652-ut6e1ysz	139	1	Alternatively	alternatively	RB
cord-297652-ut6e1ysz	139	2	,	,	,
cord-297652-ut6e1ysz	139	3	a	a	DT
cord-297652-ut6e1ysz	139	4	higher	high	JJR
cord-297652-ut6e1ysz	139	5	dosage	dosage	NN
cord-297652-ut6e1ysz	139	6	is	be	VBZ
cord-297652-ut6e1ysz	139	7	proposed	propose	VBN
cord-297652-ut6e1ysz	139	8	for	for	IN
cord-297652-ut6e1ysz	139	9	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	139	10	:	:	:
cord-297652-ut6e1ysz	139	11	600	600	CD
cord-297652-ut6e1ysz	139	12	mg	mg	NN
cord-297652-ut6e1ysz	139	13	for	for	IN
cord-297652-ut6e1ysz	139	14	the	the	DT
cord-297652-ut6e1ysz	139	15	initial	initial	JJ
cord-297652-ut6e1ysz	139	16	dose	dose	NN
cord-297652-ut6e1ysz	139	17	,	,	,
cord-297652-ut6e1ysz	139	18	followed	follow	VBN
cord-297652-ut6e1ysz	139	19	by	by	IN
cord-297652-ut6e1ysz	139	20	600	600	CD
cord-297652-ut6e1ysz	139	21	mg	mg	CD
cord-297652-ut6e1ysz	139	22	12	12	CD
cord-297652-ut6e1ysz	139	23	h	h	NNP
cord-297652-ut6e1ysz	139	24	later	later	RB
cord-297652-ut6e1ysz	140	1	and	and	CC
cord-297652-ut6e1ysz	140	2	then	then	RB
cord-297652-ut6e1ysz	140	3	300	300	CD
cord-297652-ut6e1ysz	140	4	mg	mg	NN
cord-297652-ut6e1ysz	140	5	BID	BID	VBD
cord-297652-ut6e1ysz	140	6	for	for	IN
cord-297652-ut6e1ysz	140	7	up	up	IN
cord-297652-ut6e1ysz	140	8	to	to	TO
cord-297652-ut6e1ysz	140	9	4	4	CD
cord-297652-ut6e1ysz	140	10	days	day	NNS
cord-297652-ut6e1ysz	140	11	.	.	.
cord-297652-ut6e1ysz	141	1	Considering	consider	VBG
cord-297652-ut6e1ysz	141	2	the	the	DT
cord-297652-ut6e1ysz	141	3	commercial	commercial	JJ
cord-297652-ut6e1ysz	141	4	availability	availability	NN
cord-297652-ut6e1ysz	141	5	of	of	IN
cord-297652-ut6e1ysz	141	6	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	141	7	as	as	IN
cord-297652-ut6e1ysz	141	8	a	a	DT
cord-297652-ut6e1ysz	141	9	diphosphate	diphosphate	NN
cord-297652-ut6e1ysz	141	10	salt	salt	NN
cord-297652-ut6e1ysz	141	11	,	,	,
cord-297652-ut6e1ysz	141	12	the	the	DT
cord-297652-ut6e1ysz	141	13	retail	retail	JJ
cord-297652-ut6e1ysz	141	14	price	price	NN
cord-297652-ut6e1ysz	141	15	would	would	MD
cord-297652-ut6e1ysz	141	16	not	not	RB
cord-297652-ut6e1ysz	141	17	exceed	exceed	VB
cord-297652-ut6e1ysz	141	18	6.6	6.6	CD
cord-297652-ut6e1ysz	141	19	USD	usd	NN
cord-297652-ut6e1ysz	141	20	[	[	-LRB-
cord-297652-ut6e1ysz	141	21	23	23	CD
cord-297652-ut6e1ysz	141	22	]	]	-RRB-
cord-297652-ut6e1ysz	141	23	.	.	.
cord-297652-ut6e1ysz	142	1	The	the	DT
cord-297652-ut6e1ysz	142	2	first	first	JJ
cord-297652-ut6e1ysz	142	3	cases	case	NNS
cord-297652-ut6e1ysz	142	4	of	of	IN
cord-297652-ut6e1ysz	142	5	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	142	6	emerged	emerge	VBD
cord-297652-ut6e1ysz	142	7	in	in	IN
cord-297652-ut6e1ysz	142	8	Wuhan	Wuhan	NNP
cord-297652-ut6e1ysz	142	9	,	,	,
cord-297652-ut6e1ysz	142	10	China	China	NNP
cord-297652-ut6e1ysz	142	11	,	,	,
cord-297652-ut6e1ysz	142	12	in	in	IN
cord-297652-ut6e1ysz	142	13	late	late	JJ
cord-297652-ut6e1ysz	142	14	2019	2019	CD
cord-297652-ut6e1ysz	142	15	,	,	,
cord-297652-ut6e1ysz	142	16	and	and	CC
cord-297652-ut6e1ysz	142	17	to	to	IN
cord-297652-ut6e1ysz	142	18	date	date	NN
cord-297652-ut6e1ysz	142	19	there	there	EX
cord-297652-ut6e1ysz	142	20	is	be	VBZ
cord-297652-ut6e1ysz	142	21	no	no	DT
cord-297652-ut6e1ysz	142	22	approved	approve	VBN
cord-297652-ut6e1ysz	142	23	specific	specific	JJ
cord-297652-ut6e1ysz	142	24	drug	drug	NN
cord-297652-ut6e1ysz	142	25	to	to	TO
cord-297652-ut6e1ysz	142	26	cure	cure	VB
cord-297652-ut6e1ysz	142	27	patients	patient	NNS
cord-297652-ut6e1ysz	142	28	infected	infect	VBN
cord-297652-ut6e1ysz	142	29	by	by	IN
cord-297652-ut6e1ysz	142	30	SARS	SARS	NNP
cord-297652-ut6e1ysz	142	31	-	-	HYPH
cord-297652-ut6e1ysz	142	32	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	142	33	.	.	.
cord-297652-ut6e1ysz	143	1	Politicians	politician	NNS
cord-297652-ut6e1ysz	143	2	and	and	CC
cord-297652-ut6e1ysz	143	3	physicians	physician	NNS
cord-297652-ut6e1ysz	143	4	suggest	suggest	VBP
cord-297652-ut6e1ysz	143	5	that	that	IN
cord-297652-ut6e1ysz	143	6	we	-PRON-	PRP
cord-297652-ut6e1ysz	143	7	should	should	MD
cord-297652-ut6e1ysz	143	8	wait	wait	VB
cord-297652-ut6e1ysz	143	9	for	for	IN
cord-297652-ut6e1ysz	143	10	clinical	clinical	JJ
cord-297652-ut6e1ysz	143	11	trials	trial	NNS
cord-297652-ut6e1ysz	143	12	'	'	POS
cord-297652-ut6e1ysz	143	13	data	datum	NNS
cord-297652-ut6e1ysz	143	14	before	before	IN
cord-297652-ut6e1ysz	143	15	considering	consider	VBG
cord-297652-ut6e1ysz	143	16	an	an	DT
cord-297652-ut6e1ysz	143	17	eventual	eventual	JJ
cord-297652-ut6e1ysz	143	18	treatment	treatment	NN
cord-297652-ut6e1ysz	143	19	.	.	.
cord-297652-ut6e1ysz	144	1	In	in	IN
cord-297652-ut6e1ysz	144	2	Europe	Europe	NNP
cord-297652-ut6e1ysz	144	3	,	,	,
cord-297652-ut6e1ysz	144	4	the	the	DT
cord-297652-ut6e1ysz	144	5	Discovery	Discovery	NNP
cord-297652-ut6e1ysz	144	6	project	project	NN
cord-297652-ut6e1ysz	144	7	(	(	-LRB-
cord-297652-ut6e1ysz	144	8	NCT04315948	NCT04315948	NNP
cord-297652-ut6e1ysz	144	9	)	)	-RRB-
cord-297652-ut6e1ysz	144	10	has	have	VBZ
cord-297652-ut6e1ysz	144	11	a	a	DT
cord-297652-ut6e1ysz	144	12	study	study	NN
cord-297652-ut6e1ysz	144	13	start	start	VB
cord-297652-ut6e1ysz	144	14	date	date	NN
cord-297652-ut6e1ysz	144	15	of	of	IN
cord-297652-ut6e1ysz	144	16	March	March	NNP
cord-297652-ut6e1ysz	144	17	22	22	CD
cord-297652-ut6e1ysz	144	18	,	,	,
cord-297652-ut6e1ysz	144	19	2020	2020	CD
cord-297652-ut6e1ysz	144	20	and	and	CC
cord-297652-ut6e1ysz	144	21	will	will	MD
cord-297652-ut6e1ysz	144	22	enroll	enroll	VB
cord-297652-ut6e1ysz	144	23	3100	3100	CD
cord-297652-ut6e1ysz	144	24	patients	patient	NNS
cord-297652-ut6e1ysz	144	25	.	.	.
cord-297652-ut6e1ysz	145	1	The	the	DT
cord-297652-ut6e1ysz	145	2	first	first	JJ
cord-297652-ut6e1ysz	145	3	results	result	NNS
cord-297652-ut6e1ysz	145	4	should	should	MD
cord-297652-ut6e1ysz	145	5	be	be	VB
cord-297652-ut6e1ysz	145	6	available	available	JJ
cord-297652-ut6e1ysz	145	7	within	within	IN
cord-297652-ut6e1ysz	145	8	time	time	NN
cord-297652-ut6e1ysz	145	9	frames	frame	NNS
cord-297652-ut6e1ysz	145	10	of	of	IN
cord-297652-ut6e1ysz	145	11	15	15	CD
cord-297652-ut6e1ysz	145	12	and	and	CC
cord-297652-ut6e1ysz	145	13	29	29	CD
cord-297652-ut6e1ysz	145	14	days	day	NNS
cord-297652-ut6e1ysz	145	15	,	,	,
cord-297652-ut6e1ysz	145	16	but	but	CC
cord-297652-ut6e1ysz	145	17	no	no	DT
cord-297652-ut6e1ysz	145	18	publication	publication	NN
cord-297652-ut6e1ysz	145	19	date	date	NN
cord-297652-ut6e1ysz	145	20	has	have	VBZ
cord-297652-ut6e1ysz	145	21	been	be	VBN
cord-297652-ut6e1ysz	145	22	announced	announce	VBN
cord-297652-ut6e1ysz	145	23	.	.	.
cord-297652-ut6e1ysz	146	1	The	the	DT
cord-297652-ut6e1ysz	146	2	estimated	estimated	JJ
cord-297652-ut6e1ysz	146	3	study	study	NN
cord-297652-ut6e1ysz	146	4	completion	completion	NN
cord-297652-ut6e1ysz	146	5	date	date	NN
cord-297652-ut6e1ysz	146	6	has	have	VBZ
cord-297652-ut6e1ysz	146	7	been	be	VBN
cord-297652-ut6e1ysz	146	8	set	set	VBN
cord-297652-ut6e1ysz	146	9	in	in	IN
cord-297652-ut6e1ysz	146	10	March	March	NNP
cord-297652-ut6e1ysz	146	11	2023	2023	CD
cord-297652-ut6e1ysz	146	12	.	.	.
cord-297652-ut6e1ysz	147	1	As	as	IN
cord-297652-ut6e1ysz	147	2	of	of	IN
cord-297652-ut6e1ysz	147	3	April	April	NNP
cord-297652-ut6e1ysz	147	4	8	8	CD
cord-297652-ut6e1ysz	147	5	,	,	,
cord-297652-ut6e1ysz	147	6	there	there	EX
cord-297652-ut6e1ysz	147	7	are	be	VBP
cord-297652-ut6e1ysz	147	8	388	388	CD
cord-297652-ut6e1ysz	147	9	ongoing	ongoing	JJ
cord-297652-ut6e1ysz	147	10	studies	study	NNS
cord-297652-ut6e1ysz	147	11	on	on	IN
cord-297652-ut6e1ysz	147	12	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	147	13	that	that	WDT
cord-297652-ut6e1ysz	147	14	are	be	VBP
cord-297652-ut6e1ysz	147	15	recorded	record	VBN
cord-297652-ut6e1ysz	147	16	in	in	IN
cord-297652-ut6e1ysz	147	17	the	the	DT
cord-297652-ut6e1ysz	147	18	U.S.	U.S.	NNP
cord-297652-ut6e1ysz	147	19	National	National	NNP
cord-297652-ut6e1ysz	147	20	Library	Library	NNP
cord-297652-ut6e1ysz	147	21	of	of	IN
cord-297652-ut6e1ysz	147	22	Medicine	Medicine	NNP
cord-297652-ut6e1ysz	147	23	of	of	IN
cord-297652-ut6e1ysz	147	24	the	the	DT
cord-297652-ut6e1ysz	147	25	National	National	NNP
cord-297652-ut6e1ysz	147	26	Institutes	Institutes	NNPS
cord-297652-ut6e1ysz	147	27	of	of	IN
cord-297652-ut6e1ysz	147	28	Health	Health	NNP
cord-297652-ut6e1ysz	147	29	[	[	-LRB-
cord-297652-ut6e1ysz	147	30	4	4	CD
cord-297652-ut6e1ysz	147	31	]	]	-RRB-
cord-297652-ut6e1ysz	147	32	:	:	:
cord-297652-ut6e1ysz	147	33	a	a	DT
cord-297652-ut6e1ysz	147	34	breath	breath	NN
cord-297652-ut6e1ysz	147	35	of	of	IN
cord-297652-ut6e1ysz	147	36	hope	hope	NN
cord-297652-ut6e1ysz	147	37	.	.	.
cord-297652-ut6e1ysz	148	1	A	a	DT
cord-297652-ut6e1ysz	148	2	novel	novel	JJ
cord-297652-ut6e1ysz	148	3	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	148	4	from	from	IN
cord-297652-ut6e1ysz	148	5	patients	patient	NNS
cord-297652-ut6e1ysz	148	6	with	with	IN
cord-297652-ut6e1ysz	148	7	pneumonia	pneumonia	NN
cord-297652-ut6e1ysz	148	8	in	in	IN
cord-297652-ut6e1ysz	148	9	China	China	NNP
cord-297652-ut6e1ysz	149	1	The	the	DT
cord-297652-ut6e1ysz	149	2	species	specie	NNS
cord-297652-ut6e1ysz	149	3	Severe	severe	JJ
cord-297652-ut6e1ysz	149	4	acute	acute	JJ
cord-297652-ut6e1ysz	149	5	respiratory	respiratory	JJ
cord-297652-ut6e1ysz	149	6	syndrome	syndrome	NN
cord-297652-ut6e1ysz	149	7	related	relate	VBN
cord-297652-ut6e1ysz	149	8	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	149	9	:	:	:
cord-297652-ut6e1ysz	149	10	Classifying	classify	VBG
cord-297652-ut6e1ysz	149	11	2019-nCoV	2019-ncov	CD
cord-297652-ut6e1ysz	149	12	and	and	CC
cord-297652-ut6e1ysz	149	13	naming	name	VBG
cord-297652-ut6e1ysz	149	14	it	-PRON-	PRP
cord-297652-ut6e1ysz	149	15	SARS	SARS	NNP
cord-297652-ut6e1ysz	149	16	-	-	HYPH
cord-297652-ut6e1ysz	149	17	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	150	1	A	a	DT
cord-297652-ut6e1ysz	150	2	Call	call	NN
cord-297652-ut6e1ysz	150	3	to	to	IN
cord-297652-ut6e1ysz	150	4	Action	action	NN
cord-297652-ut6e1ysz	150	5	:	:	:
cord-297652-ut6e1ysz	151	1	Philanthropy	Philanthropy	NNP
cord-297652-ut6e1ysz	151	2	's	's	POS
cord-297652-ut6e1ysz	151	3	Commitment	Commitment	NNP
cord-297652-ut6e1ysz	151	4	during	during	IN
cord-297652-ut6e1ysz	151	5	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	151	6	Foundation	Foundation	NNP
cord-297652-ut6e1ysz	151	7	and	and	CC
cord-297652-ut6e1ysz	151	8	Partners	Partners	NNPS
cord-297652-ut6e1ysz	151	9	Launch	launch	VBP
cord-297652-ut6e1ysz	152	1	First	first	JJ
cord-297652-ut6e1ysz	152	2	-	-	HYPH
cord-297652-ut6e1ysz	152	3	of	of	IN
cord-297652-ut6e1ysz	152	4	-	-	HYPH
cord-297652-ut6e1ysz	152	5	its	-PRON-	PRP$
cord-297652-ut6e1ysz	152	6	-	-	HYPH
cord-297652-ut6e1ysz	152	7	kind	kind	NN
cord-297652-ut6e1ysz	152	8	COVID-19	COVID-19	NNP
cord-297652-ut6e1ysz	152	9	Solidarity	Solidarity	NNP
cord-297652-ut6e1ysz	152	10	Response	Response	NNP
cord-297652-ut6e1ysz	152	11	Fund	Fund	NNP
cord-297652-ut6e1ysz	153	1	A	a	DT
cord-297652-ut6e1ysz	153	2	randomized	randomized	JJ
cord-297652-ut6e1ysz	153	3	,	,	,
cord-297652-ut6e1ysz	153	4	controlled	control	VBN
cord-297652-ut6e1ysz	153	5	trial	trial	NN
cord-297652-ut6e1ysz	153	6	of	of	IN
cord-297652-ut6e1ysz	153	7	Ebola	Ebola	NNP
cord-297652-ut6e1ysz	153	8	virus	virus	NN
cord-297652-ut6e1ysz	153	9	disease	disease	NN
cord-297652-ut6e1ysz	153	10	therapeutics	therapeutics	NNP
cord-297652-ut6e1ysz	153	11	Broad	Broad	NNP
cord-297652-ut6e1ysz	153	12	-	-	HYPH
cord-297652-ut6e1ysz	153	13	spectrum	spectrum	NN
cord-297652-ut6e1ysz	153	14	antiviral	antiviral	JJ
cord-297652-ut6e1ysz	153	15	GS-5734	GS-5734	NNS
cord-297652-ut6e1ysz	153	16	inhibits	inhibit	VBZ
cord-297652-ut6e1ysz	153	17	both	both	DT
cord-297652-ut6e1ysz	153	18	epidemic	epidemic	NN
cord-297652-ut6e1ysz	153	19	and	and	CC
cord-297652-ut6e1ysz	153	20	zoonotic	zoonotic	JJ
cord-297652-ut6e1ysz	153	21	coronaviruses	coronaviruse	NNS
cord-297652-ut6e1ysz	154	1	Comparative	comparative	JJ
cord-297652-ut6e1ysz	154	2	therapeutic	therapeutic	JJ
cord-297652-ut6e1ysz	154	3	efficacy	efficacy	NN
cord-297652-ut6e1ysz	154	4	of	of	IN
cord-297652-ut6e1ysz	154	5	remdesivir	remdesivir	NNP
cord-297652-ut6e1ysz	154	6	and	and	CC
cord-297652-ut6e1ysz	154	7	combination	combination	NN
cord-297652-ut6e1ysz	154	8	lopinavir	lopinavir	NNS
cord-297652-ut6e1ysz	154	9	,	,	,
cord-297652-ut6e1ysz	154	10	ritonavir	ritonavir	NNP
cord-297652-ut6e1ysz	154	11	,	,	,
cord-297652-ut6e1ysz	154	12	and	and	CC
cord-297652-ut6e1ysz	154	13	interferon	interferon	NN
cord-297652-ut6e1ysz	154	14	beta	beta	NN
cord-297652-ut6e1ysz	154	15	against	against	IN
cord-297652-ut6e1ysz	154	16	MERS	MERS	NNP
cord-297652-ut6e1ysz	154	17	-	-	HYPH
cord-297652-ut6e1ysz	154	18	CoV	CoV	NNP
cord-297652-ut6e1ysz	154	19	Prophylactic	Prophylactic	NNP
cord-297652-ut6e1ysz	154	20	and	and	CC
cord-297652-ut6e1ysz	154	21	therapeutic	therapeutic	JJ
cord-297652-ut6e1ysz	154	22	Remdesivir	Remdesivir	NNP
cord-297652-ut6e1ysz	154	23	(	(	-LRB-
cord-297652-ut6e1ysz	154	24	GS-5734	GS-5734	NNP
cord-297652-ut6e1ysz	154	25	)	)	-RRB-
cord-297652-ut6e1ysz	154	26	treatment	treatment	NN
cord-297652-ut6e1ysz	154	27	in	in	IN
cord-297652-ut6e1ysz	154	28	the	the	DT
cord-297652-ut6e1ysz	154	29	rhesus	rhesus	NNP
cord-297652-ut6e1ysz	154	30	macaque	macaque	NN
cord-297652-ut6e1ysz	154	31	model	model	NN
cord-297652-ut6e1ysz	154	32	of	of	IN
cord-297652-ut6e1ysz	154	33	MERS	MERS	NNP
cord-297652-ut6e1ysz	154	34	-	-	HYPH
cord-297652-ut6e1ysz	154	35	CoV	CoV	NNP
cord-297652-ut6e1ysz	154	36	infection	infection	NN
cord-297652-ut6e1ysz	154	37	Remdesivir	Remdesivir	NNP
cord-297652-ut6e1ysz	154	38	and	and	CC
cord-297652-ut6e1ysz	154	39	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	154	40	effectively	effectively	RB
cord-297652-ut6e1ysz	154	41	inhibit	inhibit	VBP
cord-297652-ut6e1ysz	154	42	the	the	DT
cord-297652-ut6e1ysz	154	43	recently	recently	RB
cord-297652-ut6e1ysz	154	44	emerged	emerge	VBN
cord-297652-ut6e1ysz	154	45	novel	novel	JJ
cord-297652-ut6e1ysz	154	46	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	154	47	(	(	-LRB-
cord-297652-ut6e1ysz	154	48	2019-nCoV	2019-ncov	CD
cord-297652-ut6e1ysz	154	49	)	)	-RRB-
cord-297652-ut6e1ysz	154	50	in	in	IN
cord-297652-ut6e1ysz	154	51	vitro	vitro	FW
cord-297652-ut6e1ysz	154	52	First	First	NNP
cord-297652-ut6e1ysz	154	53	Case	Case	NNP
cord-297652-ut6e1ysz	154	54	of	of	IN
cord-297652-ut6e1ysz	154	55	2019	2019	CD
cord-297652-ut6e1ysz	154	56	Novel	Novel	NNP
cord-297652-ut6e1ysz	154	57	Coronavirus	Coronavirus	NNP
cord-297652-ut6e1ysz	154	58	in	in	IN
cord-297652-ut6e1ysz	154	59	the	the	DT
cord-297652-ut6e1ysz	154	60	United	United	NNP
cord-297652-ut6e1ysz	154	61	States	States	NNP
cord-297652-ut6e1ysz	154	62	Sciensano	Sciensano	NNP
cord-297652-ut6e1ysz	154	63	Epidemiologie	Epidemiologie	NNP
cord-297652-ut6e1ysz	154	64	des	des	FW
cord-297652-ut6e1ysz	154	65	Maladies	Maladies	NNP
cord-297652-ut6e1ysz	154	66	Infectieuses	Infectieuses	NNP
cord-297652-ut6e1ysz	154	67	.	.	.
cord-297652-ut6e1ysz	155	1	Available	available	JJ
cord-297652-ut6e1ysz	155	2	online	online	JJ
cord-297652-ut6e1ysz	155	3	Screening	screening	NN
cord-297652-ut6e1ysz	155	4	of	of	IN
cord-297652-ut6e1ysz	155	5	an	an	DT
cord-297652-ut6e1ysz	155	6	FDA	FDA	NNP
cord-297652-ut6e1ysz	155	7	-	-	HYPH
cord-297652-ut6e1ysz	155	8	approved	approve	VBN
cord-297652-ut6e1ysz	155	9	compound	compound	NN
cord-297652-ut6e1ysz	155	10	library	library	NN
cord-297652-ut6e1ysz	155	11	identifies	identify	VBZ
cord-297652-ut6e1ysz	155	12	four	four	CD
cord-297652-ut6e1ysz	155	13	small	small	JJ
cord-297652-ut6e1ysz	155	14	-	-	HYPH
cord-297652-ut6e1ysz	155	15	molecule	molecule	NN
cord-297652-ut6e1ysz	155	16	inhibitors	inhibitor	NNS
cord-297652-ut6e1ysz	155	17	of	of	IN
cord-297652-ut6e1ysz	155	18	Middle	Middle	NNP
cord-297652-ut6e1ysz	155	19	East	East	NNP
cord-297652-ut6e1ysz	155	20	respiratory	respiratory	JJ
cord-297652-ut6e1ysz	155	21	syndrome	syndrome	NN
cord-297652-ut6e1ysz	155	22	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	155	23	replication	replication	NN
cord-297652-ut6e1ysz	155	24	in	in	IN
cord-297652-ut6e1ysz	155	25	cell	cell	NN
cord-297652-ut6e1ysz	155	26	culture	culture	NN
cord-297652-ut6e1ysz	155	27	Treatment	treatment	NN
cord-297652-ut6e1ysz	155	28	with	with	IN
cord-297652-ut6e1ysz	155	29	Lopinavir	Lopinavir	NNP
cord-297652-ut6e1ysz	155	30	/	/	SYM
cord-297652-ut6e1ysz	155	31	Ritonavir	Ritonavir	NNP
cord-297652-ut6e1ysz	155	32	or	or	CC
cord-297652-ut6e1ysz	155	33	Interferon	Interferon	NNP
cord-297652-ut6e1ysz	155	34	-	-	HYPH
cord-297652-ut6e1ysz	155	35	β1b	β1b	NNP
cord-297652-ut6e1ysz	155	36	improves	improve	VBZ
cord-297652-ut6e1ysz	155	37	outcome	outcome	NN
cord-297652-ut6e1ysz	155	38	of	of	IN
cord-297652-ut6e1ysz	155	39	MERS	MERS	NNP
cord-297652-ut6e1ysz	155	40	-	-	HYPH
cord-297652-ut6e1ysz	155	41	CoV	cov	NN
cord-297652-ut6e1ysz	155	42	infection	infection	NN
cord-297652-ut6e1ysz	155	43	in	in	IN
cord-297652-ut6e1ysz	155	44	a	a	DT
cord-297652-ut6e1ysz	155	45	nonhuman	nonhuman	NN
cord-297652-ut6e1ysz	155	46	primate	primate	NN
cord-297652-ut6e1ysz	155	47	model	model	NN
cord-297652-ut6e1ysz	155	48	of	of	IN
cord-297652-ut6e1ysz	155	49	common	common	JJ
cord-297652-ut6e1ysz	155	50	marmoset	marmoset	NN
cord-297652-ut6e1ysz	155	51	A	a	DT
cord-297652-ut6e1ysz	155	52	systematic	systematic	JJ
cord-297652-ut6e1ysz	155	53	review	review	NN
cord-297652-ut6e1ysz	155	54	of	of	IN
cord-297652-ut6e1ysz	155	55	lopinavir	lopinavir	NNP
cord-297652-ut6e1ysz	155	56	therapy	therapy	NN
cord-297652-ut6e1ysz	155	57	for	for	IN
cord-297652-ut6e1ysz	155	58	SARS	SARS	NNP
cord-297652-ut6e1ysz	155	59	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	155	60	and	and	CC
cord-297652-ut6e1ysz	155	61	MERS	MERS	NNP
cord-297652-ut6e1ysz	155	62	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	155	63	-	-	:
cord-297652-ut6e1ysz	155	64	A	a	DT
cord-297652-ut6e1ysz	155	65	possible	possible	JJ
cord-297652-ut6e1ysz	155	66	reference	reference	NN
cord-297652-ut6e1ysz	155	67	for	for	IN
cord-297652-ut6e1ysz	155	68	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	155	69	disease-19	disease-19	CD
cord-297652-ut6e1ysz	155	70	treatment	treatment	NN
cord-297652-ut6e1ysz	155	71	option	option	NN
cord-297652-ut6e1ysz	156	1	Systematic	systematic	JJ
cord-297652-ut6e1ysz	156	2	review	review	NN
cord-297652-ut6e1ysz	156	3	of	of	IN
cord-297652-ut6e1ysz	156	4	treatment	treatment	NN
cord-297652-ut6e1ysz	156	5	effects	effect	NNS
cord-297652-ut6e1ysz	156	6	COVID-19-The	COVID-19-The	NFP
cord-297652-ut6e1ysz	156	7	search	search	VBP
cord-297652-ut6e1ysz	156	8	for	for	IN
cord-297652-ut6e1ysz	156	9	effective	effective	JJ
cord-297652-ut6e1ysz	156	10	therapy	therapy	NN
cord-297652-ut6e1ysz	157	1	A	a	DT
cord-297652-ut6e1ysz	157	2	trial	trial	NN
cord-297652-ut6e1ysz	157	3	of	of	IN
cord-297652-ut6e1ysz	157	4	Lopinavir	Lopinavir	NNP
cord-297652-ut6e1ysz	157	5	-	-	HYPH
cord-297652-ut6e1ysz	157	6	Ritonavir	Ritonavir	NNP
cord-297652-ut6e1ysz	157	7	in	in	IN
cord-297652-ut6e1ysz	157	8	adults	adult	NNS
cord-297652-ut6e1ysz	157	9	hospitalized	hospitalize	VBN
cord-297652-ut6e1ysz	157	10	with	with	IN
cord-297652-ut6e1ysz	157	11	severe	severe	JJ
cord-297652-ut6e1ysz	157	12	Covid-19	covid-19	NN
cord-297652-ut6e1ysz	157	13	Why	Why	NNPS
cord-297652-ut6e1ysz	157	14	re	re	JJ
cord-297652-ut6e1ysz	157	15	-	-	JJ
cord-297652-ut6e1ysz	157	16	purposing	purpose	VBG
cord-297652-ut6e1ysz	157	17	HIV	HIV	NNP
cord-297652-ut6e1ysz	157	18	drugs	drug	NNS
cord-297652-ut6e1ysz	157	19	Lopinavir	Lopinavir	NNP
cord-297652-ut6e1ysz	157	20	/	/	SYM
cord-297652-ut6e1ysz	157	21	ritonavir	ritonavir	NNS
cord-297652-ut6e1ysz	157	22	to	to	TO
cord-297652-ut6e1ysz	157	23	inhibit	inhibit	VB
cord-297652-ut6e1ysz	157	24	the	the	DT
cord-297652-ut6e1ysz	157	25	SARS	SARS	NNP
cord-297652-ut6e1ysz	157	26	-	-	HYPH
cord-297652-ut6e1ysz	157	27	Cov2	Cov2	NNP
cord-297652-ut6e1ysz	157	28	protease	protease	NN
cord-297652-ut6e1ysz	157	29	probably	probably	RB
cord-297652-ut6e1ysz	157	30	wo	will	MD
cord-297652-ut6e1ysz	157	31	n't	not	RB
cord-297652-ut6e1ysz	157	32	work-	work-	VB
cord-297652-ut6e1ysz	158	1	but	but	CC
cord-297652-ut6e1ysz	158	2	re	re	JJ
cord-297652-ut6e1ysz	158	3	-	-	NN
cord-297652-ut6e1ysz	158	4	purposing	purposing	JJ
cord-297652-ut6e1ysz	158	5	Ribavirin	Ribavirin	NNP
cord-297652-ut6e1ysz	158	6	might	may	MD
cord-297652-ut6e1ysz	158	7	since	since	IN
cord-297652-ut6e1ysz	158	8	it	-PRON-	PRP
cord-297652-ut6e1ysz	158	9	has	have	VBZ
cord-297652-ut6e1ysz	158	10	a	a	DT
cord-297652-ut6e1ysz	158	11	very	very	RB
cord-297652-ut6e1ysz	158	12	similar	similar	JJ
cord-297652-ut6e1ysz	158	13	binding	binding	NN
cord-297652-ut6e1ysz	158	14	site	site	NN
cord-297652-ut6e1ysz	158	15	within	within	IN
cord-297652-ut6e1ysz	158	16	the	the	DT
cord-297652-ut6e1ysz	158	17	RNA	RNA	NNP
cord-297652-ut6e1ysz	158	18	-	-	HYPH
cord-297652-ut6e1ysz	158	19	polymerase	polymerase	NN
cord-297652-ut6e1ysz	158	20	Pharmacy	pharmacy	NN
cord-297652-ut6e1ysz	158	21	Checker	Checker	NNP
cord-297652-ut6e1ysz	158	22	Helping	help	VBG
cord-297652-ut6e1ysz	158	23	People	People	NNS
cord-297652-ut6e1ysz	158	24	Safely	safely	RB
cord-297652-ut6e1ysz	158	25	Find	find	VB
cord-297652-ut6e1ysz	158	26	More	More	JJR
cord-297652-ut6e1ysz	158	27	Affordable	affordable	JJ
cord-297652-ut6e1ysz	158	28	Medicine	medicine	NN
cord-297652-ut6e1ysz	159	1	The	the	DT
cord-297652-ut6e1ysz	159	2	antiviral	antiviral	JJ
cord-297652-ut6e1ysz	159	3	effect	effect	NN
cord-297652-ut6e1ysz	159	4	of	of	IN
cord-297652-ut6e1ysz	159	5	interferon	interferon	NN
cord-297652-ut6e1ysz	159	6	-	-	HYPH
cord-297652-ut6e1ysz	159	7	beta	beta	NN
cord-297652-ut6e1ysz	159	8	against	against	IN
cord-297652-ut6e1ysz	159	9	SARS	SARS	NNP
cord-297652-ut6e1ysz	159	10	-	-	HYPH
cord-297652-ut6e1ysz	159	11	Coronavirus	Coronavirus	NNP
cord-297652-ut6e1ysz	159	12	is	be	VBZ
cord-297652-ut6e1ysz	159	13	not	not	RB
cord-297652-ut6e1ysz	159	14	mediated	mediate	VBN
cord-297652-ut6e1ysz	159	15	by	by	IN
cord-297652-ut6e1ysz	159	16	MxA	MxA	NNP
cord-297652-ut6e1ysz	159	17	protein	protein	NN
cord-297652-ut6e1ysz	160	1	Interferon	interferon	NN
cord-297652-ut6e1ysz	160	2	-	-	HYPH
cord-297652-ut6e1ysz	160	3	β	β	NNP
cord-297652-ut6e1ysz	161	1	1a	1a	NNP
cord-297652-ut6e1ysz	161	2	and	and	CC
cord-297652-ut6e1ysz	161	3	SARS	SARS	NNP
cord-297652-ut6e1ysz	161	4	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	161	5	replication	replication	NN
cord-297652-ut6e1ysz	162	1	Interferon	Interferon	NNP
cord-297652-ut6e1ysz	162	2	-	-	HYPH
cord-297652-ut6e1ysz	162	3	β	β	NNP
cord-297652-ut6e1ysz	162	4	and	and	CC
cord-297652-ut6e1ysz	162	5	mycophenolic	mycophenolic	JJ
cord-297652-ut6e1ysz	162	6	acid	acid	NN
cord-297652-ut6e1ysz	162	7	are	be	VBP
cord-297652-ut6e1ysz	162	8	potent	potent	JJ
cord-297652-ut6e1ysz	162	9	inhibitors	inhibitor	NNS
cord-297652-ut6e1ysz	162	10	of	of	IN
cord-297652-ut6e1ysz	162	11	Middle	Middle	NNP
cord-297652-ut6e1ysz	162	12	East	East	NNP
cord-297652-ut6e1ysz	162	13	respiratory	respiratory	JJ
cord-297652-ut6e1ysz	162	14	syndrome	syndrome	NN
cord-297652-ut6e1ysz	162	15	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	162	16	in	in	IN
cord-297652-ut6e1ysz	162	17	cell	cell	NN
cord-297652-ut6e1ysz	162	18	-	-	HYPH
cord-297652-ut6e1ysz	162	19	based	base	VBN
cord-297652-ut6e1ysz	162	20	assays	assay	NNS
cord-297652-ut6e1ysz	162	21	Husband	husband	NN
cord-297652-ut6e1ysz	162	22	and	and	CC
cord-297652-ut6e1ysz	162	23	Wife	Wife	NNP
cord-297652-ut6e1ysz	162	24	Poison	poison	NN
cord-297652-ut6e1ysz	162	25	Themselves	-PRON-	PRP
cord-297652-ut6e1ysz	162	26	Trying	try	VBG
cord-297652-ut6e1ysz	162	27	to	to	IN
cord-297652-ut6e1ysz	162	28	Self	self	NN
cord-297652-ut6e1ysz	162	29	-	-	HYPH
cord-297652-ut6e1ysz	162	30	medicate	medicate	VB
cord-297652-ut6e1ysz	162	31	with	with	IN
cord-297652-ut6e1ysz	162	32	Chloroquine	Chloroquine	NNP
cord-297652-ut6e1ysz	162	33	Comparison	Comparison	NNP
cord-297652-ut6e1ysz	162	34	of	of	IN
cord-297652-ut6e1ysz	162	35	hydroxychloroquine	hydroxychloroquine	NNP
cord-297652-ut6e1ysz	162	36	and	and	CC
cord-297652-ut6e1ysz	162	37	chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	162	38	use	use	NN
cord-297652-ut6e1ysz	162	39	and	and	CC
cord-297652-ut6e1ysz	162	40	the	the	DT
cord-297652-ut6e1ysz	162	41	development	development	NN
cord-297652-ut6e1ysz	162	42	of	of	IN
cord-297652-ut6e1ysz	162	43	retinal	retinal	JJ
cord-297652-ut6e1ysz	162	44	toxicity	toxicity	NN
cord-297652-ut6e1ysz	162	45	Pharmacokinetics	Pharmacokinetics	NNP
cord-297652-ut6e1ysz	162	46	of	of	IN
cord-297652-ut6e1ysz	162	47	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-297652-ut6e1ysz	162	48	and	and	CC
cord-297652-ut6e1ysz	162	49	its	-PRON-	PRP$
cord-297652-ut6e1ysz	162	50	clinical	clinical	JJ
cord-297652-ut6e1ysz	162	51	implications	implication	NNS
cord-297652-ut6e1ysz	162	52	in	in	IN
cord-297652-ut6e1ysz	162	53	chemoprophylaxis	chemoprophylaxis	NNP
cord-297652-ut6e1ysz	162	54	against	against	IN
cord-297652-ut6e1ysz	162	55	calaria	calaria	NNP
cord-297652-ut6e1ysz	162	56	caused	cause	VBN
cord-297652-ut6e1ysz	162	57	by	by	IN
cord-297652-ut6e1ysz	162	58	Plasmodium	Plasmodium	NNP
cord-297652-ut6e1ysz	162	59	vivax	vivax	NN
cord-297652-ut6e1ysz	162	60	Chloroquine	Chloroquine	NNP
cord-297652-ut6e1ysz	162	61	and	and	CC
cord-297652-ut6e1ysz	162	62	beyond	beyond	IN
cord-297652-ut6e1ysz	162	63	:	:	:
cord-297652-ut6e1ysz	163	1	Exploring	explore	VBG
cord-297652-ut6e1ysz	163	2	anti	anti	JJ
cord-297652-ut6e1ysz	163	3	-	-	JJ
cord-297652-ut6e1ysz	163	4	rheumatic	rheumatic	JJ
cord-297652-ut6e1ysz	163	5	drugs	drug	NNS
cord-297652-ut6e1ysz	163	6	to	to	TO
cord-297652-ut6e1ysz	163	7	reduce	reduce	VB
cord-297652-ut6e1ysz	163	8	immune	immune	JJ
cord-297652-ut6e1ysz	163	9	hyperactivation	hyperactivation	NN
cord-297652-ut6e1ysz	163	10	in	in	IN
cord-297652-ut6e1ysz	163	11	HIV	HIV	NNP
cord-297652-ut6e1ysz	163	12	/	/	SYM
cord-297652-ut6e1ysz	163	13	AIDS	AIDS	NNP
cord-297652-ut6e1ysz	163	14	Design	Design	NNP
cord-297652-ut6e1ysz	163	15	and	and	CC
cord-297652-ut6e1ysz	163	16	synthesis	synthesis	NN
cord-297652-ut6e1ysz	163	17	of	of	IN
cord-297652-ut6e1ysz	163	18	hydroxyferroquine	hydroxyferroquine	NNP
cord-297652-ut6e1ysz	163	19	derivatives	derivative	NNS
cord-297652-ut6e1ysz	163	20	with	with	IN
cord-297652-ut6e1ysz	163	21	antimalarial	antimalarial	JJ
cord-297652-ut6e1ysz	163	22	and	and	CC
cord-297652-ut6e1ysz	163	23	antiviral	antiviral	JJ
cord-297652-ut6e1ysz	163	24	activities	activity	NNS
cord-297652-ut6e1ysz	163	25	Repurposing	repurposing	NN
cord-297652-ut6e1ysz	163	26	of	of	IN
cord-297652-ut6e1ysz	163	27	clinically	clinically	RB
cord-297652-ut6e1ysz	163	28	developed	develop	VBN
cord-297652-ut6e1ysz	163	29	drugs	drug	NNS
cord-297652-ut6e1ysz	163	30	for	for	IN
cord-297652-ut6e1ysz	163	31	Tteatment	Tteatment	NNP
cord-297652-ut6e1ysz	163	32	of	of	IN
cord-297652-ut6e1ysz	163	33	Middle	Middle	NNP
cord-297652-ut6e1ysz	163	34	East	East	NNP
cord-297652-ut6e1ysz	163	35	respiratory	respiratory	JJ
cord-297652-ut6e1ysz	163	36	syndrome	syndrome	NN
cord-297652-ut6e1ysz	163	37	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	163	38	infection	infection	NN
cord-297652-ut6e1ysz	163	39	In	in	IN
cord-297652-ut6e1ysz	163	40	Vitro	Vitro	NNP
cord-297652-ut6e1ysz	163	41	Antiviral	antiviral	JJ
cord-297652-ut6e1ysz	163	42	activity	activity	NN
cord-297652-ut6e1ysz	163	43	and	and	CC
cord-297652-ut6e1ysz	163	44	projection	projection	NN
cord-297652-ut6e1ysz	163	45	of	of	IN
cord-297652-ut6e1ysz	163	46	optimized	optimize	VBN
cord-297652-ut6e1ysz	163	47	dosing	dosing	NN
cord-297652-ut6e1ysz	163	48	design	design	NN
cord-297652-ut6e1ysz	163	49	of	of	IN
cord-297652-ut6e1ysz	163	50	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	163	51	for	for	IN
cord-297652-ut6e1ysz	163	52	the	the	DT
cord-297652-ut6e1ysz	163	53	treatment	treatment	NN
cord-297652-ut6e1ysz	163	54	of	of	IN
cord-297652-ut6e1ysz	163	55	severe	severe	JJ
cord-297652-ut6e1ysz	163	56	acute	acute	JJ
cord-297652-ut6e1ysz	163	57	respiratory	respiratory	JJ
cord-297652-ut6e1ysz	163	58	syndrome	syndrome	NN
cord-297652-ut6e1ysz	163	59	coronavirus	coronavirus	NN
cord-297652-ut6e1ysz	163	60	2	2	CD
cord-297652-ut6e1ysz	164	1	(	(	-LRB-
cord-297652-ut6e1ysz	164	2	SARS	SARS	NNP
cord-297652-ut6e1ysz	164	3	-	-	HYPH
cord-297652-ut6e1ysz	164	4	CoV-2	CoV-2	NNP
cord-297652-ut6e1ysz	165	1	)	)	-RRB-
cord-297652-ut6e1ysz	165	2	Breakthrough	Breakthrough	NNP
cord-297652-ut6e1ysz	165	3	:	:	:
cord-297652-ut6e1ysz	165	4	Chloroquine	chloroquine	NN
cord-297652-ut6e1ysz	165	5	phosphate	phosphate	NN
cord-297652-ut6e1ysz	165	6	has	have	VBZ
cord-297652-ut6e1ysz	165	7	shown	show	VBN
cord-297652-ut6e1ysz	165	8	apparent	apparent	JJ
cord-297652-ut6e1ysz	165	9	efficacy	efficacy	NN
cord-297652-ut6e1ysz	165	10	in	in	IN
cord-297652-ut6e1ysz	165	11	treatment	treatment	NN
cord-297652-ut6e1ysz	165	12	of	of	IN
cord-297652-ut6e1ysz	165	13	COVID-19	covid-19	JJ
cord-297652-ut6e1ysz	165	14	associated	associated	JJ
cord-297652-ut6e1ysz	165	15	pneumonia	pneumonia	NN
cord-297652-ut6e1ysz	165	16	in	in	IN
cord-297652-ut6e1ysz	165	17	clinical	clinical	JJ
cord-297652-ut6e1ysz	165	18	studies	study	NNS
cord-297652-ut6e1ysz	165	19	Request	request	NN
cord-297652-ut6e1ysz	165	20	for	for	IN
cord-297652-ut6e1ysz	165	21	Emergency	Emergency	NNP
cord-297652-ut6e1ysz	165	22	Use	Use	NNP
cord-297652-ut6e1ysz	165	23	Authorization	Authorization	NNP
cord-297652-ut6e1ysz	165	24	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-297652-ut6e1ysz	165	25	and	and	CC
cord-297652-ut6e1ysz	165	26	azithromycin	azithromycin	NNP
cord-297652-ut6e1ysz	165	27	as	as	IN
cord-297652-ut6e1ysz	165	28	a	a	DT
cord-297652-ut6e1ysz	165	29	treatment	treatment	NN
cord-297652-ut6e1ysz	165	30	of	of	IN
cord-297652-ut6e1ysz	165	31	COVID-19	covid-19	NN
cord-297652-ut6e1ysz	165	32	:	:	:
cord-297652-ut6e1ysz	165	33	Results	result	NNS
cord-297652-ut6e1ysz	165	34	of	of	IN
cord-297652-ut6e1ysz	165	35	an	an	DT
cord-297652-ut6e1ysz	165	36	open	open	JJ
cord-297652-ut6e1ysz	165	37	-	-	HYPH
cord-297652-ut6e1ysz	165	38	label	label	NN
cord-297652-ut6e1ysz	165	39	non	non	JJ
cord-297652-ut6e1ysz	165	40	-	-	JJ
cord-297652-ut6e1ysz	165	41	randomized	randomized	JJ
cord-297652-ut6e1ysz	165	42	clinical	clinical	JJ
cord-297652-ut6e1ysz	165	43	trial	trial	NN
cord-297652-ut6e1ysz	165	44	No	no	DT
cord-297652-ut6e1ysz	165	45	evidence	evidence	NN
cord-297652-ut6e1ysz	165	46	of	of	IN
cord-297652-ut6e1ysz	165	47	rapid	rapid	JJ
cord-297652-ut6e1ysz	165	48	antiviral	antiviral	JJ
cord-297652-ut6e1ysz	165	49	clearance	clearance	NN
cord-297652-ut6e1ysz	165	50	or	or	CC
cord-297652-ut6e1ysz	165	51	clinical	clinical	JJ
cord-297652-ut6e1ysz	165	52	benefit	benefit	NN
cord-297652-ut6e1ysz	165	53	with	with	IN
cord-297652-ut6e1ysz	165	54	the	the	DT
cord-297652-ut6e1ysz	165	55	combination	combination	NN
cord-297652-ut6e1ysz	165	56	of	of	IN
cord-297652-ut6e1ysz	165	57	hydroxychloroquine	hydroxychloroquine	NN
cord-297652-ut6e1ysz	165	58	and	and	CC
cord-297652-ut6e1ysz	165	59	azithromycin	azithromycin	NNP
cord-297652-ut6e1ysz	165	60	in	in	IN
cord-297652-ut6e1ysz	165	61	patients	patient	NNS
cord-297652-ut6e1ysz	165	62	with	with	IN
cord-297652-ut6e1ysz	165	63	severe	severe	JJ
cord-297652-ut6e1ysz	165	64	COVID-19	covid-19	JJ
cord-297652-ut6e1ysz	165	65	infection	infection	NN
cord-297652-ut6e1ysz	165	66	The	the	DT
cord-297652-ut6e1ysz	165	67	Bill	Bill	NNP
cord-297652-ut6e1ysz	165	68	and	and	CC
cord-297652-ut6e1ysz	165	69	Melinda	Melinda	NNP
cord-297652-ut6e1ysz	165	70	Gates	Gates	NNP
cord-297652-ut6e1ysz	165	71	Foundation	Foundation	NNP
cord-297652-ut6e1ysz	165	72	.	.	.
cord-297652-ut6e1ysz	166	1	Three	three	CD
cord-297652-ut6e1ysz	166	2	Weeks	Weeks	NNPS
cord-297652-ut6e1ysz	166	3	,	,	,
cord-297652-ut6e1ysz	166	4	Two	two	CD
cord-297652-ut6e1ysz	166	5	Drug	Drug	NNP
cord-297652-ut6e1ysz	166	6	Trials	Trials	NNPS
cord-297652-ut6e1ysz	166	7	:	:	:
cord-297652-ut6e1ysz	166	8	An	an	DT
cord-297652-ut6e1ysz	166	9	Update	update	NN
cord-297652-ut6e1ysz	166	10	on	on	IN
cord-297652-ut6e1ysz	166	11	the	the	DT
cord-297652-ut6e1ysz	166	12	Therapeutics	Therapeutics	NNP
cord-297652-ut6e1ysz	166	13	Accelerator	Accelerator	NNP
cord-297652-ut6e1ysz	166	14	with	with	IN
cord-297652-ut6e1ysz	166	15	Trevor	Trevor	NNP
cord-297652-ut6e1ysz	166	16	Mundel	Mundel	NNP
cord-297652-ut6e1ysz	166	17	Funding	Funding	NNP
cord-297652-ut6e1ysz	166	18	:	:	:
cord-297652-ut6e1ysz	166	19	This	this	DT
cord-297652-ut6e1ysz	166	20	research	research	NN
cord-297652-ut6e1ysz	166	21	received	receive	VBD
cord-297652-ut6e1ysz	166	22	no	no	DT
cord-297652-ut6e1ysz	166	23	external	external	JJ
cord-297652-ut6e1ysz	166	24	funding	funding	NN
cord-297652-ut6e1ysz	166	25	.	.	.
cord-297652-ut6e1ysz	167	1	The	the	DT
cord-297652-ut6e1ysz	167	2	author	author	NN
cord-297652-ut6e1ysz	167	3	declares	declare	VBZ
cord-297652-ut6e1ysz	167	4	no	no	DT
cord-297652-ut6e1ysz	167	5	conflict	conflict	NN
cord-297652-ut6e1ysz	167	6	of	of	IN
cord-297652-ut6e1ysz	167	7	interest	interest	NN
cord-297652-ut6e1ysz	167	8	.	.	.